WHO Practical Guide For Infection Prevention and Control 2025
WHO Practical Guide For Infection Prevention and Control 2025
implementation
of national action
plans for infection
prevention and control
Practical guide
Development and
implementation
of national action
plans for infection
prevention and control
Practical guide
Development and implementation of national action plans for infection prevention and control: practical guide
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO
licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the
work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses
any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you
must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work,
you should add the following disclaimer along with the suggested citation: “This translation was not created by the World
Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English
edition shall be the binding and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of
the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
Suggested citation. Development and implementation of national action plans for infection prevention and control:
practical guide. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures
or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from
the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests
solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply
the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or
area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps
represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or
recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted,
the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the
published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the
interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.
Contents
Acknowledgementsv
Abbreviations and acronyms viii
Glossaryix
Before you start: how to navigate this practical guide xi
Part 1.
Introduction to the practical guide 1
1.1. Quick summary2
1.2. Background and introduction2
1.3. Purpose3
1.4. Target audience3
1.5. Development methodology4
1.6. Key considerations5
Part 2.
Recap on strategic directions, key actions, indicators and targets 7
2.1. Quick summary8
2.2. Recap on the vision, objectives, strategic directions, key actions, indicators and targets8
Part 3A.
Developing and implementing your infection prevention and control
national action plan 27
3A.1. Quick summary28
3A.2. The five steps of implementation28
3A.3. Spotlight on governance29
References133
Annexes139
Annex 1. IPC core components and the eight strategic directions140
Annex 2. Key WHO documents143
Annex 3. Stakeholder mapping grid 148
Annex 4. SWOT analysis: example of a national SWOT analysis for AMR surveillance152
Annex 5. Sample evaluation matrix for activity prioritization 154
Annex 6. Sample IPC national action plan template 155
Annex 7. Template for detailed operational plan and budget 156
Annex 8. Country story: Integrating policies and professionals to build a robust IPC framework
in China (strategic direction 1, Political commitment and policies)157
Annex 9. A new national IPC programme to enhance quality of care in Nepal (strategic direction 2,
Active IPC programme)161
Annex 10. Insights and suggestions for integration and coordination between IPC and other key
programmes165
Annex 11. Country story: IPC and role model hospitals: a demonstration of how coordination and
integration can become a reality to reduce AMR in Egypt (strategic direction 3, IPC integration and
coordination)175
Annex 12. Assessment framework summary (national and facility level) for education and training179
Annex 13. Strategic direction 4: country story – Addressing the educational needs of the new IPC
professional in Canada (strategic direction 4, IPC knowledge among health and care workers and
career pathways for IPC professionals)181
Annex 14. Country story: From research to action: strengthening IPC in Sierra Leone using
operational data (strategic direction 5, Data for action)185
Annex 15. Communications and advocacy mapping template190
Annex 16. Country story: A decade of success: strengthening IPC advocacy and communication
during Qatar IPC Week (strategic direction 6, Advocacy and communication)191
Annex 17. Country story: Integrating research into the activities of the national IPC unit in Norway
(strategic direction 7, Research and development)195
Annex 18. Country story: Promoting partnership and teamwork to strengthen IPC across Nigeria
(strategic direction 8, Collaboration and stakeholder support)199
Acknowledgements
Acknowledgements
The World Health Organization (WHO) gratefully acknowledges the many individuals and organizations who
contributed to the development of this practical guide to implementation.
The development of the guide was coordinated by the Department of Integrated Health Services (IHS), Universal
Health Coverage and Life Course Division of the WHO. Benedetta Allegranzi (Department of IHS) coordinated the
overall development process and was a co-writer of the document. Claire Kilpatrick (infection prevention and
control (IPC) consultant, Department of IHS) co-led the writing of the document together with Julie Storr (IPC
consultant, Department of IHS). Peter Bischoff (IPC consultant, Department of IHS), Mandy Deeves (Department of
IHS), Giovanni Satta (Department of IHS), Maha Talaat (IPC consultant, Department of IHS) and Ermira Tartari (IPC
consultant, Department of IHS) contributed to the writing of some sections of the document.
The following WHO staff and consultants provided input to the document: Omar Abouelata, (WHO Country Office,
Cairo, Egypt); Lucia Alonso (WHO Regional Office for the Americas, Washington, DC, United States of America);
Gertrude Avortri (WHO Regional Office for Africa, Brazzaville, Congo); April Baller (Department of Country Readiness
Strengthening, WHO Health Emergencies Programme); Landry Cihambanya (WHO Regional Office for Africa,
Brazzaville, Congo); Ana Paula Coutinho Rehse (WHO Regional Office for Europe, Copenhagen, Denmark); Daniela
Demiscan (WHO Country Office, Chişinău, Republic of Moldova); Rudi Eggers (Department of IHS); Aina Erastus
(WHO Country Office, Windhoek, Namibia); Sergey Eremin (Department of Surveillance, Prevention and Control,
Antimicrobial Resistance [AMR] Division); Bobson Derrick Fofanah (WHO Country Office, Freetown, Sierra Leone);
Bruce Gordon (Environment, Climate Change and Health Department); Monica Guardo (WHO Country Office,
Mexico City, Mexico); Alaa Hashish (WHO Country Office, Muscat, Oman); Iman Heweidy (WHO Regional Office for
the Eastern Mediterranean, Cairo, Egypt); Claudia Hoyos (WHO Country Office, Quito, Ecuador); Benedikt Huttner
(Control and Response Strategies Unit, AMR Division); Ivan Ivanov (Environment, Climate Change and Health
Department); Vannda Kab (WHO Country Office, Phnom Penh, Cambodia); Nirmal Kandel (Evidence and Analytics
for Health Security Unit); Catherine Kane (Health Workforce Department); Bahtygul Karriyeva (WHO Country Office,
Moscow, Russian Federation); Pierre Claver Kariyo (WHO Regional Office for Africa, Ougadougou, Burkina Faso);
Zhao Li (WHO Regional Office for the Western Pacific, Manila, Philippines); Margaret Montgomery (Environment,
Climate Change and Health Department); Dorothy Ngajilo (Environment, Climate Change and Health Department);
Kathy O’Neill (Department of IHS); Pilar Ramon-Pardo (WHO Regional Office for the Americas, Washington, DC,
United States of America); Paul Rogers (Department of IHS); Yang Ruikan (WHO Country Office, Beijing, China);
Rana Saleh (WHO Country Office, Cairo, Egypt); Murad Sultan (WHO Country Office, Dakka, Bangladesh); Ayda Taha
(Department of IHS); Aparna Singh Shah (WHO Regional Office for South-East Asia, New Delhi, India); Anuj Sharma
(WHO Country Office, New Delhi, India); Lina Yu (Evidence and Analytics for Health Security Unit).
WHO acknowledges the following experts for their strategic and/or technical input for the development of this
guide: Majid Al Shamrani (WHO Collaborating Centre for IPC and AMR, Riyadh, Saudi Arabia); Yewande Alimi
(Africa Centres for Disease Control and Prevention, Addis Abba, Ethiopia); Chedly Azzouz (Infection Control
Africa Network, Tunis, Tunisia); Colin Brown (WHO Collaborating Centre for Reference and Research on AMR and
Healthcare-Associated Infections, London, United Kingdom of Great Britain and Northern Ireland); Tania Bubb
(Association for Professionals in Infection Control and Epidemiology); Natalie Bruce (Public Health Agency Canada,
Ottawa, Canada); Lauren Clack (University of Zurich, Zurich, Switzerland); Maya Chavez (Médecins Sans Frontières
[MSF; Doctors Without Borders] International); Ben Cowling (WHO Collaborating Centre for Infectious Disease
Epidemiology and Control and University of Hong Kong, Hong Kong SAR, China); Jessica Dangles (Certification
Board of Infection Control and Epidemiology, Arlington, United States of America); Neelam Dhingra (Joint
v
Development and implementation of national action plans for infection prevention and control: practical guide
Commission International, Geneva, Switzerland); Tim Eckmanns (Robert Koch Institute, Berlin, Germany); Christine
Fears (Healthcare Infection Society, London, United Kingdom of Great Britain and Northern Ireland); Carole Fry
(WHO Collaborating Centre for Reference and Research on AMR and Healthcare-Associated Infections, London,
United Kingdom of Great Britain and Northern Ireland); Stephan Harbarth (WHO Collaborating Centre on IPC and
AMR and Geneva University Hospitals, Geneva, Switzerland); Gerry Hansen (Infection Prevention and Control
Association Canada, Canada); Emilio Hornsey (Infection Prevention Society, United Kingdom of Great Britain and
Northern Ireland); Kalisvar Marimuthu (National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore);
Devin Jopp (Association for Professionals in Infection Control and Epidemiology [APIC], United States of America);
Lata Kapoor (Ministry of Health, New Delhi, India); Moi Lin Ling (Asia Pacific Society of Infection Control, Singapore);
Stacey Mearns (Resolve to Save Lives, United States of America); Sally Mohy El Din (Ministry of Health, Cairo, Egypt);
Florence Mulonda (Ministry of Health, Windhoek, Namibia); Nico Mutters (European Committee on Infection
Control [EUCIC] and University of Bonn, Bonn, Germany); (Babacar Ndoye (IPC consultant, WHO Regional Office
for Africa, Brazzaville, Congo); Ramatu Elizabeth Ngauja (Ministry of Health, Freetown, Sierra Leone); Amal Saif Al
Maani (Ministry of Health, Muscat, Oman); Andreas Sandgren (Ministry of Health, Stockholm, Sweden); Supriya
Sarkar (Ministry of Health, Dhaka, Bangladesh); Stephan Stenmark (Ministry of Health, Stockholm, Sweden); Angela
Paraschiv (Ministry of Health, Chişinău, Republic of Moldova); Elena Pavlovna Igonina (Ministry of Health, Moscow,
Russian Federation); Pierre Yves Oger (United Nations International Children’s Fund [UNICEF], New York, United
States of America); Colette Ouellet (Infection Prevention and Control Association Canada, Canada), Diamantis
Plachouras (European Centre for Disease Prevention and Control, Stockholm, Sweden); Kemal Rasa (World Surgical
Infection Society, Kocaeli, Türkiye); Tania Villa Reyes (Ministry of Health, Mexico City, Mexico); Gabriel Rodriguez
(Ministry of Health, Mexico City, Mexico); Atsushi Samura (The Global Fund, Geneva, Switzerland); Massimo Sartelli
(Global Alliance for Infections in Surgery and Macerata Hospital, Macerata, Italy); Juliette Severin (International
Society of Antimicrobial Chemotherapy and Erasmus MC, Rotterdam, The Netherlands); Peixin Song (Nanjing Drum
Tower Hospital; Public Health Research Center, Nanjing University, Nanjing, China); Thomas Talbot (Society for
Healthcare Epidemiology of America and Vanderbilt University Medical Center, Nashville, United States of America);
Valeria Torres (Ministry of Health, Quito, Ecuador), Koy Virya (Ministry of Health, Phnom Penh, Cambodia); Kristy
Weinshel (Society for Healthcare Epidemiology of America, United States of America).
WHO particularly acknowledges the external review and written contribution to this practical guide by the following
experts: Emine Alp Meşe (European Committee on Infection Control [EUCIC], Ankara, Türkiye); Birgitta Lytsy
(International Federation of Infection Control, Uppsala, Sweden); Shaheen Methar (University of Stellenbosch and
Infection Control Africa Network, Cape Town, South Africa).
WHO particularly acknowledges the written contribution to and approval of the country examples by the following
individuals: Samira Abdisamed (Ministry of Public Health, Doha, Qatar); Omar Abouelata (WHO Country Office,
Cairo Egypt); Kimat Adhikari (WHO Country Office, Kathmandu, Nepal); Jameela Al Ajmi (Ministry of Public Health,
Doha, Qatar); Rekayahouda Baaboura (Ministry of Public Health, Doha, Qatar); Syed Hassan Bin Usman Shah
(Ministry of Public Health, Doha, Qatar); Hanne Eriksen-Volle (Norwegian Institute of Public Health, Oslo, Norway);
Siri Feruglio (Norwegian Institute of Public Health, Oslo, Norway); Bobson Derrick Fofanah (WHO Country Office,
Freetown, Sierra Leone); Dhouha Hamdani (Ministry of Public Health, Doha, Qatar); Iman Heweidy (WHO Regional
Office for the Eastern Mediterranean, Cairo, Egypt); Bjørn Gunnar Iversen (Norwegian Institute of Public Health,
Oslo, Norway); Gerry Hansen (Infection Prevention and Control Association Canada, Canada); Ibrahim Franklyn
Kamara (WHO Country Office, Freetown, Sierra Leone); Joseph Sam Kanu (Ministry of Health, Freetown, Sierra
Leone); Yara Mohsen Khalaf (WHO Country Office, Cairo, Egypt); Olena Komarcheva (Ministry of Public Health, Doha,
Qatar); Shaffi Fazaludeen Koya (WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt); Sally Mohy El Din
(Ministry of Health and Population, Cairo, Egypt); Ramatu Elizabeth Ngauja (Ministry of Health, Freetown, Sierra
Leone); Eman Radwan (Ministry of Public Health, Doha, Qatar); Tochi Okwor (Nigeria Centre for Disease Control,
Abuja, Nigeria); Bala Rai (Ministry of Health and Population, Kathmandu, Nepal); Yang Ruikan (WHO Country Office,
vi
Acknowledgements
Beijing, China); Rana Sherif Saleh (WHO Country Office, Cairo, Egypt); Anders Skyrud Danielsen (Norwegian Institute
of Public Health, Oslo, Norway); Peixin Song (Nanjing Drum Tower Hospital; Public Health Research Center, Nanjing
University, China); Rony Zachariah (Special Programme for Research and Training in Tropical Diseases).
All external experts mentioned completed a declaration of interest form in accordance with the WHO declaration of
interests’ policy for experts. No potential conflicts were identified.
Core funds from WHO headquarters and the WHO Hub for Pandemic and Epidemic Intelligence (Berlin, Germany)
supported the development and publication of this document. WHO acknowledges the financial support of
the Centers for Disease Control and Prevention, USA. All technical and funding inputs from institutions and
individuals from the USA preceded 20 January 2025. Funds from the European Commission, Directorate-General for
International Partnerships, also supported the development and publication of this document.
vii
Abbreviations and acronyms
AMR antimicrobial resistance
AMS antimicrobial stewardship
AWaRE Access, Watch, Reserve
CDC Centers for Disease Control and Prevention
ECDC European Centre for Disease Prevention and Control
e-SPAR electronic States Parties self-assessment annual reporting
GAPMF Global action plan and monitoring framework
GLAAS Global analysis and assessment of sanitation and drinking water
GLASS Global antimicrobial resistance and use surveillance system
HAI health care-associated infection
HHSAF hand hygiene self-assessment framework
IPC infection prevention and control
IPCAT2 infection prevention and control assessment tool
IPCAT-MR infection prevention and control assessment tool minimum requirements
IPCAF infection prevention and control assessment framework
IPCAF-MR infection prevention and control assessment framework minimum requirements
NHSN National Healthcare Safety Network
NAP national action plan
OHS occupational health service
PAHO Pan American Health Organization
QIPCW Qatar Infection Prevention and Control Week
SD strategic direction
SMART specific, measurable, actionable, realistic and timely
SORT IT Structured Operational Research and Training IniTiative
SPAR States Parties Self-Assessment Annual Reporting
SWOT strengths, weaknesses, opportunities and threats
TDR Special Programme for Research and Training in Tropical Diseases
TrACSS (Global database for) Tracking antimicrobial resistance country self-assessment survey
UNICEF United Nations Children’s Fund
WASH water, sanitation, waste management and hygiene
WHO World Health Organization
viii
Glossary
Accountability: the obligation to report, or give account of, one’s actions – for example, to a governing authority
through scrutiny, contract, management, regulation and/or to an electorate (1).
Champion: a particular type of stakeholder who is a supporter, but also more broadly aware and committed to the
transformational changes your team is driving towards achieving impact; potential to be strong advocates and help
sustain change over the long haul (2).
Culture: a set of values that you translate in practices and behaviours to effect change within an organization or
group of stakeholders (2).
Decision maker: a particular type of stakeholder who has a relatively high position and/or power to influence
decisions for action related to implementation (2).
Governance: refers to the processes, systems and structures through which authority is exercised, decisions are
made and resources are managed.1
Infection prevention and control (IPC) minimum requirements: IPC standards that should be in place at both
national and health facility level to provide minimum protection and safety to patients, health care workers and
visitors, based on the WHO core components for IPC programmes. The existence of these requirements constitutes
the initial starting point for building additional critical elements of the IPC core components according to a stepwise
approach based on assessments of the local situation (3).
IPC programme: based on the eight WHO core components for IPC which are the foundation for establishing or
strengthening effective programmes at the national and facility level (4).
IPC committee: a multidisciplinary group with interested stakeholders across the health care facility, which
interacts with and advises the IPC team. For example, the IPC committee could include senior facility leadership;
senior clinical staff; and leads of other relevant complementary areas, such as biosafety, pharmacy, microbiology
or clinical laboratory, waste management, water, sanitation and hygiene services and quality and safety, where in
place (5).
IPC professional: health care professional (medical doctor, nurse or other health-related professional) who has
completed a certified postgraduate IPC training course, or a nationally or internationally recognized postgraduate
course on IPC, or another core discipline including IPC as a core part of the curriculum, as well as IPC practical and
clinical training (5).
IPC focal point: IPC professional (according to the above definition) appointed to be in charge of IPC at the national,
sub-national or health care facility/organization level (5).
1
Health Systems and Governance Team. Geneva: World Health Organization, personal communication, 2025.
ix
Development and implementation of national action plans for infection prevention and control: practical guide
Multimodal improvement strategy: a multimodal strategy comprises several components or elements (three
or more, usually five) implemented in an integrated way with the aim of improving an outcome and changing
behaviour. It includes tools, such as bundles and checklists, developed by multidisciplinary teams that take into
account local conditions. The five most common elements include: (i) system change (availability of the appropriate
infrastructure and supplies to enable IPC good practices); (ii) education and training of health workers and key
players (for example, managers); (iii) monitoring infrastructures, practices, processes and outcomes and providing
data feedback; (iv) reminders in the workplace/communications; and (v) culture change within the establishment or
the strengthening of a safety climate (3).
Multi-sectoral taskforce (at the national level): an entity that spans sectors outside of those usually involved in
national IPC committees and may include technical, policy and civil society actors. Such an entity may also involve
private sector, insurers and community representatives.2
Stakeholders: those with an interest in or influence over the issue. Defining the role of stakeholders is important for
successful stakeholder engagement (6).
Stakeholder mapping: the first step in securing multi-stakeholder engagement, developing a collaboration agenda
and, importantly, multi-sectoral action. Stakeholder mapping is a way to learn the perspectives of stakeholders,
their affiliation, area they represent, and what interests and/or perspectives and influences they bring to the issue. It
offers a structured approach for gathering and assessing information on different stakeholders who are relevant to
implementation of the IPC national action plan (policy, strategy, or intervention) (6).
References*
1. WHO global strategy on people-centred and integrated health services: interim report. Geneva: World Health
Organization; 2015 (https://iris.who.int/handle/10665/155002).
2. Implementation playbook, pocket edition: a quick-reference guide to delivering impact for health, with tools
and templates. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/376467).
3. Minimum requirements for infection prevention and control programmes. Geneva: World Health Organization;
2019 (https://apps.who.int/iris/handle/10665/330080). Licence: CC BY-NC-SA 3.0 IGO.
4. Adapted from: Guidelines on core components of infection prevention and control programmes at the
national and acute health care facility level. Geneva: World Health Organization; 2016 (https://iris.who.int/
handle/10665/251730). Licence: CC BY-NC-SA 3.0 IGO.
5. Global report on infection prevention and control 2024. Geneva: World Health Organization; 2024 (https://iris.
who.int/handle/10665/379632). Licence: CC BY-NC-SA 3.0 IGO.
6. Adapted from: Implementation guide for the medical eligibility criteria and selected practice recommendations
for contraceptive use guidelines. Implementation guide toolkit. Stakeholder mapping guide. Geneva: World
Health Organization; 2018 (https://www.who.int/publications/i/item/9789241513579).
* All references were accessed on 2 April 2025.
2
Infection Prevention and Control Unit. Geneva: World Health Organization, unpublished data, 2025.
x
Before you start: how to navigate this
practical guide
This practical guide is in three parts and includes annexes. Ideally, each part should be read in sequence. However, it
may be helpful to read across different parts at the same time. Fig. 1 summarizes how to use the practical guide and
a quick summary is provided at the start of each section to help orientate readers.
• Part 1 provides a summary of the background and introduction to the guide and should be read first to support
the implementation journey. It is estimated that Part 1 should take no more than 10 minutes to read.
• In Part 2, those using the guide are reminded of how the infection prevention and control (IPC) national action
plan (NAP) will support achievement of the World Health Organization (WHO) global IPC strategy, including its
eight strategic directions, and the WHO global action plan and monitoring framework (GAPMF) on IPC. You can
review all the targets, indicators and actions to help develop the IPC NAP. This is essential reading to set up all
future actions and should take around 15 minutes to read.
• Part 3A guides on how to develop or update an IPC NAP. This part is the true starting point for IPC NAP
development and implementation, considering a 5-step implementation cycle, and signposts users to tools and
templates. The time taken to work through Part 3A will depend on a country’s situation – users are advised to
work at their own pace.
• In Part 3B, for each of the eight strategic directions of the WHO global strategy on IPC, targeted activities are
provided together with a list of considerations, tools and templates to inform the IPC NAP. It contains useful tips
on how to address some known challenges. The time taken to work through Part 3B will depend on a country’s
situation – users are advised to work at their own pace.
• The annexes contain the supplementary materials referred to in Parts 1–3, including action plan templates, a
stakeholder mapping grid and country stories.
• Icons are used across this practical guide to support usability and navigation. They highlight different sections
of the guide that provide useful further reading; clicking on the icons will take the user directly to the relevant
section.
The SD highlights a strategic direction of relevance; clicking on this will take the user directly to the strategic
direction.
The highlights a tool or resource of relevance; clicking on this will take the user directly to tool or resource
reference.
The highlights another page or section of relevance in the guide; clicking on this will take the user directly to
the page.
To return to your previous page, use Alt + Left Arrow (PC) or Command + Left Arrow (Mac).
xi
Development and implementation of national action plans for infection prevention and control: practical guide
Abbreviations: IPC, infection prevention and control; NAP, national action plan.
xii
Part 1.
Introduction to the
practical guide
Abbreviations: HAI, health care-associated infection; LMICs: low- and middle-income countries; HICs, high-income countries; EU/EEA, European
Union/European Economic Area.
a
Global estimates based on key review and WHO report published in 2011; EU/EEAestimates
based on 2012–2023 data from the European Centre
for Disease Prevention and Control point prevalence survey.
2
Part 1. Introduction to the practical guide
• The GAPMF directly refers to WHO recommendations and standards included in the guidelines on
IPC core components (4) and minimum requirements (5). A recap on the core components for IPC
programmes and how these relate to all eight strategic directions can be found in Annex 1 .
• Guides to the implementation of the core components for IPC programmes at both the national (6) and
facility levels (7) exist and many countries using this practical guide will be familiar with one or both of
these manuals to support previous and ongoing IPC implementation efforts. This guide builds upon
these.
• Where relevant, any existing implementation manuals are signposted for reference. In addition, a range
of implementation resources, which also exist in relation to fields such as AMR and quality and patient
safety are signposted throughout.
• The GAPMF also directly refers to the essential water, sanitation, waste management and hygiene (WASH)
standards in health care, as well as the IPC sections of the global patient safety action plan and the global
action plan on AMR. Referring to these documents will provide additional useful details when using this
practical guide. Further details can be found in Annex 2 .
Abbreviations: AMR, antimicrobial resistance; GAPMF, global action plan and monitoring framework; IPC, infection prevention and control; WASH,
water, sanitation, waste management and hygiene.
1.3. Purpose
The purpose of this practical guide is to:
• provide a practical, stepwise approach to the development and implementation of an IPC NAP;
• outline a suite of tools, resources and inspirational country stories to help prioritize, cost, implement, monitor
and evaluate NAP activities.
• In many countries this will be the national focal point for IPC;
• Where an IPC focal point does not exist, a responsible person(s) (for example, within the ministry of health,
public health and other national institutes) should be appointed and empowered to lead on the development
and/or updating and implementation of the IPC NAP.
A list of those who may lead this work or be concerned with using this practical guide are listed in Box 1.2.
3
Development and implementation of national action plans for infection prevention and control: practical guide
• those working in associated programmes such as AMR, patient safety, WASH, emergencies/emergency
preparedness and quality of care (non-exclusive list);
• political leaders and policy-makers (including those responsible for programme planning and financing
at the ministry of health);
• accreditation bodies;
• others working in occupational health or involved in International Health Regulations and One Health;
• educational institutions and professional and scientific organizations, societies and unions;
• key partners and donors;
• community and civil society;
• media and communication professionals.
Abbreviations: AMR, antimicrobial resistance; WASH, water, sanitation, waste management and hygiene.
4
Part 1. Introduction to the practical guide
• development of a third draft capturing all comments received, with ongoing internal WHO discussions to refine
the content and summarize important ideas for design/usability;
• a final review by the regional IPC focal points was also requested;
• the practical guide was then finalized and professionally edited.
5
Part 2.
Recap on strategic
directions, key
actions, indicators
and targets
Table 2.1. Core targets of the IPC monitoring framework at the global and national level
Eight core targets at globala level
1. Increase of proportion of countries with a costed and approved national action plan and monitoring framework on IPC (>
80% by 2030)
2. Increase of proportion of countries with legislation /regulation to address IPC (> 80% by 2030)
3. Increase of proportion of countries having an identified protected and dedicated budget allocated to the national IPC
programme and action plan (> 90% by 2030)
4. Increase of proportion of countries meeting all WHO IPC Minimum Requirements for IPC programmes at national level
(through WHO IPC portal) (> 90% by 2030)
5. Increase of proportion of countries with national IPC programmes at Level 4 or 5 per SPAR 9.1 and Level D and E in TrACSS (>
90% by 2030)
6. Increase of the proportion of countries with basic water (1), sanitation (2), hygiene (3), and waste services (4) in all health care
facilities (100% by 2030)
7. Increase of proportion of countries that have achieved their national targets on reducing HAIs (> 80% by 2030)
8. Increase of proportion of countries with a national HAI surveillance system (> 90% by 2030)
Four core targets at nationalb level
1. Increase of proportion of facilities meeting all WHO IPC Minimum Requirements for IPC programmes (> 90% by 2030)
2. Increase in the proportion of facilities with a dedicated and sufficient funding for WASH services and activities (100% by 2030)
3. Increase of proportion of facilities providing training to all frontline clinical and cleaning staff upon employment and
annually and to managers upon employment (> 90% by 2030)
4. Increase of proportion of tertiary/secondary health care facilities having an HAI and related AMR surveillance system (> 80%
by 2030)
Abbreviations: HAI, health care-associated infections; IPC, infection prevention and control; SPAR: States Parties self-assessment annual
reporting; TrACSS, Tracking antimicrobial resistance country self-assessment survey; AMR, antimicrobial resistance.
ᵃ Reflecting progress at national level.
ᵇ Reflecting progress at facility level.
Source: WHO (3).
8
Part 2. Recap on strategic directions, key actions, indicators and targets
Strategic directions
Political commitment
SD1 and policies SD5 Data for action
Advocacy and
SD2 Active IPC programmes SD6 communications
Research and
SD3 Active IPC programmes SD7 development
Vision 2030
“By 2030, everyone accessing or providing
health care is safe from associated infections.”
9
Development and implementation of national action plans for infection prevention and control: practical guide
Reporting on progress
• At the national/subnational and facility levels, countries are strongly encouraged both to monitor and evaluate
progress in implementing their action plans and provide information for global reporting through WHO.
• Reporting will take place on a biennial basis to WHO on the core global and national indicators and targets and,
as relevant to local conditions, reporting will also take place on any additional contextual national indicators.
• The mechanism for reporting will be through data collection at the facility and national level by using WHO
standardized IPC monitoring tools measuring the indicators included in the GAPMF. The WHO Global IPC portal
(11) (Fig. 2.2) will provide the opportunity to enter the data in a common platform where reports and data
summaries can be downloaded by users. Raw data can also be requested to WHO by the country authorities for
their own use. The WHO Secretariat will perform aggregated analyses to assess the achievement of the global
and national targets and report to the World Health Assembly.
10
Recap on strategic directions, key actions, indicators and target
Table 2.2. Strategic direction 1: political commitment and policies
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Develop a NAP and monitoring • IPC NAP and monitoring framework WHO Global IPC portal (11) GLOBAL
framework for IPC, outlining costs developed, costed, validated, and IPCAT2 (12) – 1.1.7 Core target 1/top 8 global targets
and sources of financing. approved by the ministry of health or IPCAT2 – 1.2.2 • Proportion of countries with a costed
other relevant national authorities IPCAT2 – 1.2.3 and approved NAP and monitoring
within the context of national health e-SPAR (13) – SPAR (14) 9.1: IPC framework on IPC.
plans. programmes • Increase of proportion of countries
with a costed and approved NAP and
2. Establish the legal framework for IPC • Legislation/regulations in place No current indicators monitoring framework for IPC:
to mandate the implementation of to address IPC (including IPC □ 30% by 2026
IPC programmes nationally and at professionals) in the public health □ 50% by 2028
all levels. regulatory framework. □ >80% by 2030.
3. Develop the national financial • National financial investment case No current indicators
investment case aligned with the developed based on global models Core target 2/top 8 global targets
global business case for IPC. (2026). • Proportion of countries with
□ 50% by 2026
12
Development and implementation of national action plans for infection prevention and control: practical guide
□ 75% by 2028
□ >90% by 2030
□ baseline (2021–2022): 41%.
Facility level
Demonstrate the commitment and Adequate dedicated budget available for e-SPAR
support of health care facility senior IPC (that is, to fund the IPC programme SPAR 9.1: IPC programmes
managers to IPC through an adequate and team and the annual action plan,
dedicated budget allocation to the IPC including equipment for IPC practices). WHO Global IPC portal
programme and team, including funding IPCAF – 1.9
to implement the annual action plan.
Abbreviations: NAP, national action plan; IPC, infection prevention and control; IPCAT2, infection prevention and control assessment tool 2; e-SPAR, electronic States Parties self-assessment annual
reporting; IPCAT-MR, infection prevention and control assessment tool-minimum requirements; WASH, water, sanitation, waste management and hygiene; GLAAS, Global analysis and assessment of
sanitation and drinking-water, IPCAF, infection prevention and control assessment framework.
Table 2.3. Strategic direction 2: active IPC programmes
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Establish a national IPC programme • All WHO IPC minimum requirements WHO IPC Global portal GLOBAL
and/or demonstrate evidence of for IPC met at national level (to IPCAT-MR – all indicators (national level) Core target 4/top 8 global targets
improvement of IPC programmes, be assessed through the WHO IPC IPCAF-MR (18-20) - all indicators (tools • Proportion of countries meeting all
including WASH (namely, meet WHO Global portal). for primary, secondary and tertiary WHO minimum requirements for
minimum requirements at national • Proportion of health care facilities health care facilities) IPC programmes at national level
and health care facility levels). meeting all WHO minimum WHO/UNICEF Joint Monitoring (through the WHO IPC Global portal).
requirements for IPC at facility level Programme for Water Supply, • Increase of the proportion of
(to be assessed through the WHO IPC Sanitation and Hygiene data (21) countries meeting all WHO minimum
Global portal). requirements for IPC programmes at
• Proportion of health care facilities national level to:
with basic WASH and waste services □ 30% by 2026
(according to each indicator, to be □ 60% by 2028
assessed through the definitions of □ >90% by 2030
the WHO/UNICEF Joint Monitoring □ baseline (2021‒2022): 4%.
Programme for Water Supply, Core target 5/top 8 global targets
Sanitation and Hygiene). • Proportion of countries with national
Development and implementation of national action plans for infection prevention and control: practical guide
Key actions Indicator(s) Existing indicator(s) Targets
NATIONAL
Core target 1/top 4 national targets
• Proportion of health care facilities
meeting all WHO IPC minimum
Key actions Indicator(s) Existing indicator(s) Targets
Development and implementation of national action plans for infection prevention and control: practical guide
Table 2.4. Strategic direction 3: IPC integration and coordination
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Ensure inclusion of IPC principles, • Desk review and situational analysis WHO Global IPC portal GLOBAL
standards and indicators within of integration of IPC within other IPCAT2: all indicators in section 1.3 Core top target 6/top 8 global targets
strategies and documents of programmes completed (by 2028). Professional organizations • Proportion of countries with costed
other complementary national • Key existing IPC principles, IPCAT2 – 6.1.2 road maps (namely, national plans)
programmes.1 standards and indicators identified, for WASH in health care facilities.
appropriately included, and cross- • Increase of the proportion of
referenced within other national countries with costed road maps
complementary programmes as (namely, national plans) for WASH in
appropriate (by 2030). health care facilities to:
□ 80% by 2024
2. Ensure that the IPC programme • Desk review and situational WHO Global IPC portal □ 90% by 2028
is aligned with and contributes to analysis of integration of other IPCAT2: all indicators in section 1.3 □ 100% by 2030
other complementary national complementary programmes within □ baseline (2022): 63%.
programmes’ strategies and the IPC programme completed (by
documents. 2028)
• Key existing policies, principles,
standards and indicators from
other complementary programmes
identified, appropriately included,
and cross-referenced within IPC
documents and programmes, as
appropriate (by 2030).
3. Ensure that IPC clinical practices • Clinical packages (for example, No current existing indicators or
and appropriate prescribing of policies and standard operating systems
antimicrobial agents (that is, procedures) available for integrating
antimicrobial stewardship) are IPC and appropriate antimicrobial
embedded in policies related to prescribing within clinical care (such
patient care pathways/programmes as surgery, maternal and neonatal
at the national, sub-national and care) (by 2028).
health care facility levels for tertiary,
secondary and primary health care.
1
Examples of programmes/areas of work complementary to IPC programmes include those on AMR, occupational health, patient safety, public health emergencies, quality of care, WASH and health care
waste, and specific infectious diseases (such as HIV infection and tuberculosis).
Facility level
1. Establish an IPC committee ensuring • IPC committee established with WHO Global IPC portal
representation of and collaborative representation of and collaborative IPCAF – 1.6.
activities with other complementary activities with other complementary IPCAF – 1.7
programmes (for tertiary/secondary programmes (by 2026).
health care facilities).
2. Ensure that both IPC clinical • Standard operating procedures No current existing indicators or
practices and appropriate available integrating IPC and systems
antimicrobial prescribing are appropriate antimicrobial
embedded in all patient care prescribing within clinical care (for
pathways/wards. example, surgery, maternal and
neonatal care) (by 2028).
• Increased compliance with IPC
practices in specific wards and
among specialized professionals
(for example, injection safety, hand
hygiene and waste management in
surgical wards, operating theatres
and critical care units) demonstrated
(by 2030).
• Increased compliance with
Development and implementation of national action plans for infection prevention and control: practical guide
Table 2.5. Strategic direction 4: IPC knowledge among health and care workers and career pathways for IPC
professionals
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Develop a national curriculum for • Curriculum for IPC professionals WHO Global IPC portal NATIONAL
IPC professionals aligned with WHO developed or an international • IPCAT2 – 3.2.1- 3.2.3 Core target 3/top 4 national targets
IPC core competencies for IPC or curriculum endorsed and in use • Proportion of health care facilities
endorse an international curriculum. (2028). providing and/or requiring training
• Proportion of countries with a for all frontline clinical and cleaning
curriculum for IPC professionals staff upon employment (and
developed and in use (indicator for annually) and to managers upon
global target). employment.
• Increase of the proportion of health
2. Establish a national postgraduate • Postgraduate IPC certification No current existing indicators or care facilities providing and/or
IPC certificate programme (including programme established OR systems requiring training for all frontline
training courses on emergency requirement for an existing clinical and cleaning staff upon
preparedness on specific situations) certificate (2030). employment (and annually) and to
for IPC professionals that are • Proportion of colleges and managers upon employment:
aligned with existing international universities offering postgraduate □ 30% by 2026
standards, or require existing IPC training. □ 60% by 2028
certificates. • Proportion of countries with an IPC □ >90% by 2030.
certificate programme or equivalent
or requiring existing certificates GLOBAL
(indicator for global target). Additional targets (global)
3. Develop and establish a national • IPC pre-graduate curriculum for WHO Global IPC portal • Proportion of countries with a
IPC curriculum (or adopt an all relevant health care disciplines • IPCAT2 – 3.2.1 curriculum for IPC professionals
international one) for pre-graduate developed and endorsed by the • IPCAT-MR core component 3.1-3.4; developed or endorsed, and in use.
training and education for all appropriate national or international 5.1; 6.4 • Increase of proportion of
relevant health care disciplines body ensuring that quality and countries with a curriculum for
(for example, medical, nursing and standards (national/International) IPC professionals developed or
midwifery schools), endorsed by the are met (by 2028). endorsed, and in use:
appropriate national or international □ 30% by 2026
body, and integrate it within • IPC pre-graduate curriculum No current existing indicators or □ 50% by 2028
health educational curricula, with integrated within health educational systems □ >80% by 2030.
embedded evaluation mechanisms. curricula, with embedded evaluation • Proportion of countries with an IPC
mechanisms (by 2030). certificate programme or equivalent
or requiring existing certificates.
• Increase of proportion of countries
with an IPC certificate programme or
Key actions Indicator(s) Existing indicator(s) Targets
4. Develop a national in-service • National in-service IPC curriculum WHO Global IPC portal equivalent:
curriculum on IPC (or adopt an developed (by 2026). • IPCAT2 – 3.2.4; 3.2.5 □ 30% by 2026
international one) for all health and • National (or sub-national) IPC • IPCAT-MR – core component 3.1-3.4; □ 50% by 2028
care workers, in particular frontline training programme to support 6.4 □ >80% by 2030.
clinical, cleaning and management in-service training created (by 2028), • Proportion of countries having IPC
staff and create a national (or introduced and regularly updated training programme for staff
subnational) training programme to (2030). • Increase of proportion of countries
support in-service IPC training. • Proportion of countries with a having an IPC training programme
national IPC in-service curriculum on for staff:
IPC (indicator for global target). □ 30% by 2026
□ 50% by 2028
5. Mandate that all health and care • Legal mechanism or well-defined No current existing indicators or □ >80% by 2030.
workers, in particular frontline strategies established to mandate systems
clinical, cleaning and management IPC in-service training (2028).
staff, receive education and training
in standard operating procedures for • Proportion of health care facilities WHO Global IPC portal
IPC upon employment and regularly providing and/or requiring • IPCAF – 3.3-4
(for instance, annually) thereafter. mandatory training for all frontline • IPCAF-MR (tools for primary,
clinical, and cleaning staff upon secondary and tertiary health care
employment and annually, as well as facilities) – indicators 3.1-2
for managers upon employment.
Development and implementation of national action plans for infection prevention and control: practical guide
• Proportion of hospitals with at least WHO Global IPC portal
one full-time IPC professional per • IPCAF – 1.3
250 beds. • IPCAF-MR – 1.1 (tool for secondary
health care facilities); 1.2 (tool for
tertiary health care facilities)
Facility level
1. Make implementation plans • All WHO minimum requirements WHO Global IPC portal
and provide resources (human for IPC training and education met, IPCAF-MR: all indicators in core
and financial) to achieve all according to the health care facility component 3 (tools for primary,
WHO minimum requirements level (by 2030). secondary and tertiary health care
for IPC training and education facilities)
and to progressively achieve all
requirements of core component 3
on IPC education and training.
Abbreviations: IPC, infection prevention and control; IPCAT-MR, infection prevention and control assessment tool-minimum requirements; ; IPCAT2, infection prevention and control assessment tool 2;
IPCAF, infection prevention and control assessment framework; IPCAF-MR, infection prevention and control assessment framework-minimum requirements.
Table 2.6. Strategic direction 5: data for action
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Establish and/or strengthen national • National strategic plan for IPC WHO Global IPC portal GLOBAL
IPC monitoring systems and ensure monitoring in place, including an IPCAT2 – 6.1.1 + 6.1.2 + 6.1.6 + 6.3.6 Core target 8/top 8 global targets
that health care facilities participate integrated IPC monitoring system IPCAT-MR – 6.2 + 6.5 • Proportion of countries with a
in the national IPC monitoring for collection, analysis and feedback e-SPAR - SPAR C.9.2: HAI surveillance national surveillance system for HAI
networks. of data. WHO IPC Global portal and related AMR, including for early
• Proportion of tertiary/secondary IPCAF-MR tools for secondary/tertiary warning to detect epidemic- and
health care facilities with an IPC care facilities)– 6.2-6.4. pandemic-prone pathogens causing
monitoring system for collection, HAIs.
analysis and feedback of data. • Increase of proportion of countries
• Proportion of countries with a with a national HAI and related AMR
national IPC monitoring system surveillance system to:
(indicator for global reporting). □ 30% by 2026
□ 50% by 2028
2. Establish and/or strengthen a • National strategic plan for HAI and WHO Global IPC portal □ >80% by 2030.
national HAI and related AMR related AMR surveillance (with a IPCAT2 – all indicators in core
surveillance system, including for focus on priority infections based component 4 NATIONAL
Development and implementation of national action plans for infection prevention and control: practical guide
Key actions Indicator(s) Existing indicator(s) Targets
Facility level
1. Make implementation plans and Percentage met of WHO minimum WHO Global IPC portal
provide resources (human and requirements for HAI surveillance (only IPCAF-MR (tools for secondary/ tertiary
financial) to achieve all WHO for tertiary and secondary health care care facilities): all indicators in core
minimum requirements for HAI facilities). component 4
surveillance according to the health IPCAF – indicators 4.1-15
care facility level and to progressively
achieve all requirements of core
component 4 on HAI surveillance.
2. Make implementation plans and Percentage met of WHO minimum WHO Global IPC portal
provide resources (human and requirements for IPC monitoring and IPCAF – 6.1-8
financial) to achieve all WHO feedback.
minimum requirements for IPC
monitoring and feedback according
to the health care facility level
and to progressively achieve all
requirements of core component
6 on multimodal strategies for
implementing IPC activities.
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection; AMR, antimicrobial resistance; IPCAT2, infection prevention and control assessment tool 2; IPCAF, infection
prevention and control assessment framework; IPCAT-MR, infection prevention and control assessment tool-minimum requirements; e-SPAR, electronic States Parties Self-assessment Annual Reporting.
Table 2.7. Strategic direction 6: advocacy and communications
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Develop and deploy a national IPC • National advocacy strategy and No current existing indicators or GLOBAL
advocacy and communications implementation plan, including systems. Global additional target
strategy and implementation plan the identification of local experts/ • Proportion of countries having
(as a stand-alone or a part of wider champions, developed and a national advocacy and
strategies, for example, on AMR, implemented (by 2026). communication strategy and
patient safety or WASH), aligned for implementation plan
consistency with the WHO global • Increase of proportion of countries
strategy and including engaging having a national advocacy and
local champions and the community. communication strategy and
implementation plan to:
Facility level □ 30% by 2026
□ 50% by 2028
1. Organize events and/or • At least one event/communication No current existing indicators or □ >80% by 2030.
communications and campaigns organized each year. systems.
on IPC priority topics (for example,
hand hygiene, AMR and WASH),
including patient and community
Development and implementation of national action plans for infection prevention and control: practical guide
Table 2.8. Strategic direction 7: research and development
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Develop a country-specific national • National research agenda and No current existing indicators or GLOBAL
research agenda and priorities for priorities for IPC developed. systems. Global additional target
IPC (as a stand-alone or part of • Proportion of countries with a
wider strategies, for example, AMR, national IPC research agenda.
patient safety and WASH) adapted • Increase of proportion of countries
from the global research agenda having a national IPC research
and including a multi-sectoral and agenda to:
multidisciplinary approach. □ 30% by 2026
□ 50% by 2028
2. Prioritize, fund and implement • Biennial number of scientific No current existing indicators or □ >80% by 2030.
research projects on IPC in selected publications/publicly available systems.
health care facilities, according to reports of research results on priority
local priorities. IPC topics.
Facility level
1. Seek research funds for projects on • Grant proposals for IPC research No current existing indicators or
IPC, according to the health care projects submitted systems.
facility’s priorities.
2. Implement research projects on IPC No current existing indicators or
and report on the results. systems.
Abbreviations: IPC, infection prevention and control; AMR, antimicrobial resistance; WASH, water, sanitation, waste management and hygiene.
Table 2.9. Strategic direction 8: collaboration and stakeholder support
Key actions Indicator(s) Existing indicator(s) Targets
National level
1. Map national partners, professional • National research agenda and No current existing indicators or GLOBAL
societies, civil society organizations, priorities for IPC developed. systems. Global additional target
patient advocacy and community • National agenda for collaboration • Proportion of countries with a
groups, and international developed to improve the national multi-sectoral/multi-
organizations relevant for IPC with a collaborating agenda on IPC (by partner taskforce that includes a
multi-sectoral and multidisciplinary 2028). strong focus on IPC/WASH in health
approach. • Profiles of IPC national stakeholders care.
(such as organizations, societies, • Increase of the proportion of
partners, donors supporting and/or countries with a national multi-
working on IPC) regularly updated sectoral/multi-partner taskforce that
(by 2030). includes a strong focus on IPC and
WASH in health care facilities to:
2. Encourage and implement multi- • Proportion of countries with a multi- No current existing indicators or □ 30% by 2026
stakeholder activities and/or sectoral taskforce that includes a systems. □ 50% by 2028
initiatives, according to country strong focus on IPC/WASH in health □ >80% by 2030.
needs, including data sharing on IPC, care facilities.
HAI, AMR and WASH. • Number of joint IPC activities with
Facility level
Use this five-step approach to support preparing for action, baseline assessment,
developing and executing the plan, evaluating impact, and sustainability. The ultimate
goal is the execution of a realistic, achievable, costed and sustainable IPC NAP.
Abbreviations: IPC, infection prevention and control; NAP, national action plan.
Source: WHO (6).
• If you are already familiar with the five-step cycle and confident in your implementation approach
or if you have already developed an IPC NAP and have the tools and resources for implementation,
you could choos to rapidly review Part 3A, focusing on the action checks at the end of each
step.
• For a systematic and comprehensive IPC NAP development, working through the five steps in Part
3A is critical.
• On completion of Part 3A, all users are recommended to go to Part 3B , which provides
additional activities and considerations to achieve each strategic direction for IPC.
• Each step contains links and references to tools and resources, where relevant. Additional tools
and resources are listed in Tables 3A.2, 3A.12 and 3A.14 .
28
Part 3A. Developing and implementing your infection prevention and control national action plan
29
Development and implementation of national action plans for infection prevention and control: practical guide
• Establish an inclusive meeting schedule and agenda for all those who should attend, focusing on the relevance
of an IPC NAP for the country context and to consider implementation plans/actions within existing structures.
• Confirm the jurisdiction for the creation and maintenance of policies and procedures, reporting and
communications.
• Outline the necessary commitment to IPC NAP sensitization, within the timeline of activities.
• Outline the benefits of implementing and improving IPC over time using the IPC NAP (see also strategic
direction 6 SD6 ). Use the communication and engagement plan templates in the WHO Implementation
playbook, pocket edition (8).
• Start to explore validated tools, approaches and available expertise and data sources that can be used for the
development of your IPC NAP and associated monitoring plans (see steps 2 and 4). Use Annex 1 of the WHO
Implementation playbook, pocket edition (8), it includes a number of key tools and templates that will
support this, for example, ‘Context analysis wheel’, ‘Assessing readiness for action criteria’, ‘Issue tree’, ‘Problem
statement’. The WHO National health planning tools (24) is an on-line repository of tools designed to assist
health authorities at both national and sub-national level in elaborating health policies, strategies and plans; it
also includes tools on leadership and governance.
• Explore the evaluation approaches that can be used to report against the NAP, that is, systems and tools that
already exist, and start to consider the review and reporting schedule for the team.
• Explore the readiness and commitment to undertaking evaluations and reporting mechanisms.
• Prepare to consider health care facility-level implementation and evaluation, including pilot testing where
appropriate, and a method for gathering lessons learned for sharing across facilities.
• Outline and discuss the reality of NAP development and implementation in the national and health care facility
context, exploring how long it may take to achieve.
• Build in strategies to manage changes in the workforce and the perceived burden of the IPC NAP development
and implementation work.
• Table 3A.2 at the end of this section features additional tools and resources.
Stakeholder engagement
• Identify stakeholders. Use a stakeholder mapping tool such as the WHO stakeholder mapping guide and tool
(9). The WHO Stakeholder network analysis tools to support collaboration for better health (25) can
also help this process.
• Explore whether stakeholder mapping exercises have already been undertaken for IPC or for related
programmes, for example, AMR, patient safety, quality, WASH, and source available documents.
• Explore all existing lists of potential stakeholders, for example, where multiple sectors and stakeholders are
already convened, such as attendee lists at cross-sector meetings/forums/conferences and/or networks and
initiative lists.
• Consider listing all persons who may have an interest in the IPC NAP and its implementation and all those who
might influence this now and potentially in the future.
• Outline stakeholders’ level of influence, type of influence, priority of engagement and the role and type of
engagement that is needed (see Table 3A.1 that is partially populated for illustration; the full template can be
found in Annex 3 ).
• Explore the level and phase (when) at which stakeholders should be engaged, including according to each
strategic direction and their objectives/targets. Those with a high level of influence may be prioritized at the
outset of the implementation of a particular strategic direction.
• Explore and create a draft outline of how to engage key stakeholders, including the resources that may be
30
Part 3A. Developing and implementing your infection prevention and control national action plan
required (see also strategic direction 6 SD6 ). Consider a spectrum of engagement spanning four elements:
inform – consult – involve – collaborate – co-create (Fig. 3A.2 ).
• Develop a realistic timeframe to engage and communicate with stakeholders, taking account of local
circumstances and drivers that you should be familiar with following the mapping exercise and initial
IMPLEMENTATION GUIDE TOOLKIT
communications.
STAKEHOLDER MAPPING GUIDE
Fig. 3A.2. Spectrum of engagement
Less More
engagement engagement
In
Co
In
Co
Co
vo
fo
-C
la
rm
su
l
ve
bo
re
lt
at
ra
e
te
Inform – provide information Collaborative – to partner in each aspect of
decision-making
Consult – to obtain feedback
Co-Create – to empower to make decisions
Involve – to ensure that concerns are
consistently understood and considered
• Start to gather written and verbal commitments from stakeholders and influencers for use in influencing key
leaders, decision-makers and funders, for example, for inclusion in newsletters, web pages and social media
(see also Part 3B , strategic direction 6 SD6 ).
• Plan and publicize a ‘kick off’ meeting (face-to-face or virtually). Attempt to hold at least one face-to-face
meeting with all identified team members, leaders and stakeholders present. Ensure equitable voices at
meetings/discussions, especially where patient representatives are included.
• Elaborate and share the agreed meeting schedule.
• Clearly describe all roles and responsibilities, including by using existing examples of approaches to
implementation, such as leads, supervisors, engagers, influencers, creators, informers, and confirm that
people are clear and happy with what they have been allocated for NAP development and implementation, for
example, in the kick off meeting.
• Plan the timeline for revisiting engagement with other programmes/stakeholders as part of the IPC NAP, that is,
are meetings being attended, do people remain engaged over time?
• Establish the engagement of health care facility-level stakeholders. As previously noted, this is also important at
this stage in relation to pilot testing, sharing of implementation and improvement examples (see Fig. 3A.2 ).
REFERENCES
31
1. Stakeholder Mapping. BSR (Business for Social Responsibility). November 2011. Available at https://www.bsr.org/reports/BSR_Stakeholder_Engage-
ment_Stakeholder_Mapping.final.pdf. Accessed 1 April 2018.
Development and implementation of national action plans for infection prevention and control: practical guide
*Based on the WHO stakeholder mapping guides and tools listed in tools and resources. The full template is shown in Annex 3 .
Source: WHO (9).
32
Part 3A. Developing and implementing your infection prevention and control national action plan
“An important step is to advocate for an IPC budget line item at national level, even if it’s
small. One can do a lot with this recognition and also take the opportunity to leverage existing
resources.”
“Trying to estimate the direct and indirect costs of an IPC programme using currently
available tools, which are designed for high-income contexts can be a challenge. However,
using basic information and best estimates can be useful. Do not fix solely on demonstrating
cost effectiveness - equally important is empowering the person in charge to influence policy.”
33
Development and implementation of national action plans for infection prevention and control: practical guide
• Ethiopia’s recent success in securing government funding for the country’s first-ever
national budget for IPC represents a milestone for the country and global health security
efforts. Securing this dedicated budget line was not an overnight success. It resulted
from two years of dedicated work by Ethiopia’s government ministries and the health
advocacy community working in partnership with Resolve to Save Lives. This assured
sustained IPC funding—starting with 3.2million Birr (about US$58,000) in the first year—is
a strategic investment by national decision-makers that strengthens essential components
of the country’s capacity to respond to future public health threats. One step in budget
advocacy is to conduct a landscape analysis that documents the need for funding and
identifies approaches for targeted advocacy campaigns.
• Instrumental to this process was gaining a deep understanding of the Ethiopian
government’s budget cycle, which follows a three-year schedule. Although every country
has its own timetable and process for developing its national budget, they all have a
specified process involving budget proposals, ministry and legislative hearings, and
a series of committee and full legislative floor votes before budgets are approved and
implemented. It is difficult to effectively advocate for budget allocations without an
intimate knowledge of the relevant budget development processes. In Ethiopia, this
comprises four phases—budget preparation, approval, execution and control—running
each year from November through July.
• In Ethiopia, as in many countries, the two main government agencies involved in IPC are
the Ministries of Health and Finance, although others with overlapping portfolios, such
as WASH programme implementation, are also involved. Each has its own priorities and
crafting understanding and consensus between them is crucial to moving forward
with the budget process. While the Ministry of Finance sets budget guidelines and
34
Part 3A. Developing and implementing your infection prevention and control national action plan
ceilings by sector, the Ministry of Health identifies funding requests for specific divisions
and programmes. The planning department in most ministries of health plays a critical
role in determining budget allocations within the health sector and negotiating with
the ministry of finance during budget development. Ultimately, the ministry of finance
compiles the final, consolidated budget for final approvals, so providing clear requests and
documenting their justification to the ministry of finance is essential. Another important
step is to identify the individuals within each ministry who are able to push the agenda
forward. While it is important to keep senior leaders informed and engaged, mid-career
staff are often well-placed to champion projects and advise their senior colleagues.
Representatives of non-governmental stakeholder organizations can also play important
roles in advocating for key programmatic and funding decisions. As it can take time to
identify these potential champions, a point person within the organization spearheading
advocacy for the budget line must meet with a large number of individuals.
• Once the ministries of health and finance are in agreement about establishing a dedicated
budget line and the amount to be funded, in most countries, it must be then shepherded
through the legislative process for final approval. The dedicated IPC budget line was
ultimately approved as part of the overall Ethiopian national budget.
“Yes, it's important that a budget is in place but this can take time and be hard to achieve. We
cannot always wait for that before starting work. Many of us must use the resources that we
have today."
Table 3A.2. Additional tools and resources to support step 1 (preparing for action)*
• Making the business case for infection prevention and control. Arlington, VA: Association for Professionals in Infection
Control and Epidemiology (APIC); 2017 (https://apic.org/Resource_/store/books/preview/SLS7003P_Preview.pdf).
• HAI cost calculator tools. Arlington, VA: Association for Professionals in Infection Control and Epidemiology (APIC); 2020
(https://www.ahrq.gov/hai/tools/clabsi-cauti-icu/implement/apic-cost-calculator.html).
• Bartles R, Reese S, Gumbar A. Closing the gap on infection prevention staffing recommendations: Results from the beta
version of the APIC staffing calculator. Am J Infect Control. 2024;52(12):1345-1350. doi: 10.1016/j.ajic.2024.09.004.
• Wozniak TM, Graves N, Barnett AG. How much do superbugs cost Australian hospitals? An evidence-based open-access
tool. Infect Dis Health. 2018 Mar;23(1):54-56. https://www.idhjournal.com.au/article/S2468-0451(17)30227-4/fulltext.
• Kickbusch I, Gleicher D. Governance for health in the 21st century. Copenhagen: World Health Organization Regional Office
for Europe; 2012 (https://iris.who.int/handle/10665/326429).
• Health systems governance for universal health coverage: Action plan. Geneva: World Health Organization; 2014 (https://
iris.who.int/handle/10665/341159).
• Barbazza E, Tello JE. A review of health governance: definitions, dimensions and tools to govern. Health Policy. 2014;
116(1):1–11. doi: 10.1016/j.healthpol.2014.01.007.
• Quality health services: a planning guide. Geneva: World Health Organization; 2020 (https://iris.who.int/
handle/10665/336661). Licence: CC BY-NC-SA 3.0 IGO.
35
Development and implementation of national action plans for infection prevention and control: practical guide
• Quality toolkit: navigating tools to improve the quality of health services. Geneva: World Health Organization; 2025
(https://qualityhealthservices.who.int/quality-toolkit/qt-home).
To support step 1, review the specific activities and considerations for each strategic direction by clicking on the boxes below
☑ IPC NAP lead(s) appointed and a multidisciplinary support team secured, as well as champions.
Stakeholder engagement
☑ IPC NAP implementation stakeholders listed and categorized by influence and role.
☑ Specific stakeholder roles and responsibilities drafted and ongoing engagement and periodic reviews proposed.
☑ Sustainable funding explored, including cycles for securing long-term financing and stakeholder contributions.
☑ An investment case for the IPC NAP drafted, including any connections with other health programmes and involvement of
national authorities, partners and donors.
☑ Other resources identified, including necessary human resources for IPC NAP implementation.
☑ Monitoring and reporting systems, including laboratory services, explored and confirmed.
36
Part 3A. Developing and implementing your infection prevention and control national action plan
Box 3A.1. List of existing national and facility IPC assessment tools
Abbreviations: HHSAF, hand hygiene self-assessment framework; IPCAT2, infection prevention and control assessment tool 2; IPCAT-MR,
infection prevention and control assessment tool-minimum requirements; IPCAF, infection prevention and control assessment framework;
IPCAF-MR, infection prevention and control assessment framework - minimum requirements.
• Use locally-available tools that have been validated and contain key indicators reflecting the indicators and
targets included in the WHO GAPMF (3), WHO core components (4) and minimum requirements (5).
• Review and discuss the relevance of other existing assessments used in other programmes that have included
or addressed IPC-related matters. For example, the open access Global Database of the Tracking AMR country
self-assessment survey (TrACSS) (31), Global AMR and use surveillance system (GLASS) (32), States
Parties Self-Assessment Annual Reporting (SPAR) (13), WASH FIT (33), United Nations Global analysis
and assessment of sanitation and drinking water (GLAAS) (17), WHO Patient safety assessment manual
(34), and other health system assessments such as WHO national health planning tools (24).
• Consider focusing on specific aspects of existing assessment tools to inform the current status related to each
37
Development and implementation of national action plans for infection prevention and control: practical guide
Table 3A.4. Tools for strategic direction 1: political commitment and policies
Strategic direction Assessment tool Relevant section Area assessed
1: political
commitment and IPCAT2 1.1.7 IPC budget
policies IPCAT-MR 1.4 IPC budget
IPCAF 1.9 IPC budget
IPCAF-MR 1.9 IPC leadership support and funding
IPCAT2 1.2.2 IPC national plan
IPCAT2 1.2.3 National monitoring frameworks
e-SPAR-SPAR C9.1 IPC programmes
GLAAS Finance WASH budgets and funding
Abbreviations: IPC, infection prevention and control; IPCAT2, infection prevention and control assessment tool 2; IPCAT-MR, infection prevention
and control assessment tool-minimum requirements; IPCAF, infection prevention and control assessment framework; e-SPAR, electronic States
Parties self-assessment annual reporting; GLAAS, Global analysis and assessment of sanitation and drinking-water; WASH, water, sanitation,
waste management and hygiene.
38
Part 3A. Developing and implementing your infection prevention and control national action plan
Table 3A.6. Tools for strategic direction 3: IPC integration and coordination
Strategic direction Assessment tool Relevant section Area assessed
3: IPC integration
and coordination IPCAT2 1: 1.1.8, 1.2.5, 1.3 (in IPC committee; collaboration in the context of
particular, 1.3.1 to 1.3.5) surveillance; programme linkages
IPCAT-MR 4.1 Collaboration in the context of surveillance
Abbreviations: IPC, infection prevention and control; IPCAT2, infection prevention and control assessment tool 2; IPCAT-MR, infection prevention
and control assessment tool-minimum requirements.
Table 3A.7. Tools for strategic direction 4: IPC knowledge among health and care workers and career
pathways for IPC professionals
Strategic direction Assessment tool Relevant section Area assessed
4: IPC knowledge
among health IPCAT2 3.2.1- 3.2.5 National IPC curricula
and care workers IPCAT-MR Core component 3.1-3.4; National programme, curricula and monitoring;
and career 5.1; 6.4: national expertise in implementation; mechanism
pathways for IPC for training auditors
professionals
IPCAF 1.3 and 3.3-4 IPC staff-bed ratio; facility-level training frequency
IPCAF-MR All core component 3 Facility-level training of workforce, including IPC
indicators, particularly staff
3.1-2.
IPCAF-MR 1.1 (secondary care IPC staff-bed ratio
secondary facilities)
IPCAF-MR tertiary 1.2 (tertiary care facilities) IPC staff-bed ratio
Abbreviations: IPC, infection prevention and control; IPCAT2, infection prevention and control assessment tool 2; IPCAT-MR, infection prevention
and control assessment tool-minimum requirements. IPCAF-MR, infection prevention and control assessment framework-minimum requirements.
39
Development and implementation of national action plans for infection prevention and control: practical guide
Table 3A.11. Tools for strategic development 8: collaboration and stakeholder support
Strategic direction Assessment tool Relevant section Area assessed
8: collaboration
and stakeholder No formal WHO / /
support assessment tool
available
40
Part 3A. Developing and implementing your infection prevention and control national action plan
an engaging format that motivates their involvement in the IPC NAP implementation plans.
• Share information with other national leaders and decision-makers, including ministers, using impactful
presentations and other locally relevant approaches.
• Share targeted information with other relevant programme leads to address joint areas of implementation and
improvement going forward (see also strategic direction 3 SD3 and strategic direction 8 SD8 ).
To support step 2, review the specific activities and considerations for each strategic direction by clicking on the boxes below
Table 3A.12. Additional tools and resources to support step 2 (baseline assessment)*
• WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health
sector. Annex 1: Situational analysis. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352204).
Licence: CC BY-NC-SA 3.0 IGO.
*All tools and resources were accessed on 10 April 2025.
41
Development and implementation of national action plans for infection prevention and control: practical guide
42
Part 3A. Developing and implementing your infection prevention and control national action plan
• Explore and confirm sustainability of all actions before implementing the IPC NAP.
• Outline surge strategy actions, that is, how to react when adjustments to the IPC NAP are needed during
emergencies/outbreaks, for example.
• Table 3A.14 at the end of this section features additional tools and resources.
Table 3A.14. Additional tools and resources to support step 3 (developing and executing the plan)*
• Strategizing national health in the 21st century: a handbook. Geneva: World Health Organization; 2016 (https://iris.who.
int/handle/10665/250221).
• Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the
national level. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/345251. Licence: CC BY-NC-SA
3.0 IGO.
• WHO benchmarks for strengthening health emergency capacities. Geneva: World Health Organization; 2023 (https://iris.
who.int/handle/10665/375815). Licence: CC BY-NC-SA 3.0 IGO. See also the associated digital platform (https://www.who.
int/publications/i/item/9789241515429). The WHO benchmarks tool provides operational actions and a reference library
to guide implementation.
• WHO advocacy video on the core components. Geneva: World Health Organization; 2018 (https://www.youtube.com/
watch?v=LZapz2L6J1Q).
• Health care without avoidable infections - peoples' lives depend on it advocacy video. Geneva: World Health Organization;
2017 (https://youtu.be/K-2XWtEjfl8?si=sPf1CuFX8oM77xHr).
43
Development and implementation of national action plans for infection prevention and control: practical guide
To support step 3, review the specific activities and considerations for each strategic direction by clicking on the boxes below
44
Part 3A. Developing and implementing your infection prevention and control national action plan
Maintain assessments
• Use the IPC NAP to guide all necessary evaluation activities.
• Activate follow-up assessments, using the standardized, valid tools and approaches used in step 2 where
appropriate, according to your NAP. Confirm and reiterate modalities for follow-up assessments.
• Repeat assessments at least annually in the first instance; note that ongoing monitoring and evaluation of
action plans should take place over many years.
• Refer back to Tables 3A.4–3A.11 for the assessment tools specific to each strategic direction.
• Undertake refresher training on assessments methodology, if needed.
• Evaluate the IPC NAP against the allocated budget, including for each strategic direction that has been
prioritized, including reviewing the impact that infrastructure and resources are having on IPC NAP
implementation progress.
• Document all the processes involved, not just outcome evaluations, in order to evaluate these to support
sustainability of IPC NAP implementation.
• Integrate ongoing assessments into other national monitoring and evaluation programmes as appropriate,
addressing all available sources of data and technical expertise (see also strategic direction 3 SD3 ).
• Confirm whether the use of the national health information system can support data collection going forward.
45
Development and implementation of national action plans for infection prevention and control: practical guide
Global reporting
To support step 4, review the specific activities and considerations for each strategic direction by clicking on the boxes below
46
Part 3A. Developing and implementing your infection prevention and control national action plan
Step 5 – Sustainability
Further review of the acceptability and long-term impact of the IPC NAP to ensure its sustainability are important
steps in the cycle of implementation. This also allows a review of the next steps for its update and identification of
long-term priorities in order to achieve the agreed-upon indicators and targets.
47
Development and implementation of national action plans for infection prevention and control: practical guide
To support step 5, review the specific activities and considerations for each strategic direction by clicking on the boxes below
Bringing the five-step implementation cycle to life in Sierra Leone – adapting it to the local
context
• First, the NAP development and review committee members were identified and roles
defined. Members agreed upon the terms of reference and a workplan.
• Next, a situational analysis was conducted, using a stakeholder consensus approach and
a workshop to review results and undertake a SWOT analysis.
• The first draft of the IPC NAP was developed at the stakeholder engagement workshop.
Activities and sub-activities for each strategic intervention and an operational plan were
outlined. This work included the Ministry of Health and Sanitation, Ministry of Finance,
civil society, academic institutions, Private, health partners, donors and policy-level
stakeholders. The AMR costing and budgeting tool was used, adapting it to the local
context. Potential funding sources for all budgeted activity were confirmed.
• An ongoing monitoring and evaluation plan with clear indicators, baseline and targets,
data sources and reporting timeline was developed.
• Further meetings were convened to review and validate the IPC NAP, focusing on ensuring
that the NAP was in line with other national priorities and the global IPC strategy. All final
documents were submitted for endorsement by appropriate national authorities.
IPC focal person, WHO Country Office, Sierra Leone
48
Part 3A. Developing and implementing your infection prevention and control national action plan
49
Part 3B.
Implementation
of each strategic
direction
To review a specific strategic direction relevant to your context, click on the boxes below
52
Part 3B. Implementation of each strategic direction
Î To recap on the actions, indicators and targets for achieving strategic direction 1 – refer to
Part 2, Table 2.2 .
Î Ensure that you have considered all of the activities in Part 3A and focus on the action checks
at the end of each step.
Î Work through this section and you will have the elements that will support achievement of
the following national indicators for strategic direction 1 in the context of your IPC NAP.
Indicators
1. IPC NAP and monitoring framework developed, costed, validated and approved by the
ministry of health or other relevant national authorities within the context of national
health plans.
2. Legislation/regulations in place to address IPC (including IPC professionals) in a public
health regulatory framework.
3. National financial investment case developed based on global models (2026). Dedicated
budget (in line with the IPC NAP) allocated to the IPC national programme and action plan
identified and available.
4. Proportion of health care facilities with adequately funded and dedicated budget for IPC.
5. Dedicated and sufficient funding allocated at the national level for WASH services and
activities.
• In some cases, national actions and action planning will be influenced by actions being
taken at the regional or global level.
• For example, a dependency is the ability of the WHO Secretariat and partners to engage
and motivate countries to rapidly implement the IPC GAPMF, including by disseminating
the results of the global investment case, which will play a critical role in supporting the
national investment case for IPC.
• Another example is the creation of IPC units within every WHO regional office and IPC focal
points located in each WHO country office. In many countries, this will be an important
factor to strongly support the successful implementation of IPC NAPs.
• Some of the activities across all strategic directions are linked in some way and this is
highlighted throughout the steps.
53
Development and implementation of national action plans for infection prevention and control: practical guide
54
Part 3B. Implementation of each strategic direction
Table 3B.1. Roles and responsibilities of the national IPC advisory committee (37)
Provide input to IPC policy, strategic plans (including for outbreaks), guidelines, standard operating procedures and
1.
management issues as needed, for effective, evidence-based practices.
Be an advocate for obtaining financial and human resources for IPC, including procurement of adequate supplies for
2.
IPC practices.
Set national and district goals for preventing HAIs with both endemic and epidemic potential and IPC quality indicators,
3.
and will review the progress toward these national goals, objectives and strategies.
Provide input into the development of a) training and education programmes for the facility level b) national
4. monitoring frameworks to measure implementation with policies, guidelines and standards c) surveillance and
epidemiology of HAI and HAI-related aspects of AMR.
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection; AMR, antimicrobial resistance.
Stakeholder engagement
• Review your stakeholder mapping conducted while working through Part 3A to identify those who can help
and where gaps may still exist in achieving political commitment and investment for the IPC NAP, for example,
external expertise, including those in other countries if necessary.
• Engage local experts/champions (if not already done) to achieve wide buy-in and to provide endorsements
in support of the legal framework and its implementation, as well as investment and business cases (see also
strategic direction 6 SD6 ).
• “Resources are not only financial, but also include partnerships and networks and political
commitment. Political commitment and governance play key roles!”
• “The top facilitator to garner political support is to use a top-down and bottom-up
approach.”
• “Getting political commitment is crucial to achieve the vision set out in the global strategy
- a whole-of-system and whole-of-government approach is needed to bridge the gaps and
stop working in silos.”
55
Development and implementation of national action plans for infection prevention and control: practical guide
The assessments listed will help present the case for political commitment and accountability on IPC by, for
example, providing evidence on the situation with regards to current IPC and WASH budget gaps, including gaps in
implementing the IPC core components and minimum requirements.
• Consider conducting epidemiological studies on the frequency and consequences of HAIs and AMR (for
example, a prevalence survey), and/or using existing HAI surveillance data.
• If outbreaks have recently occurred in health care facilities, include information and data in briefing documents
and key messages for politicians and decision-makers.
• Analyse data regarding costs of HAIs and AMR and include them in briefing documents and key messages for
politicians and decision-makers.
• Evaluate if there are local or international successful examples of IPC interventions that led to improvement of
practices and/or reduction of harm due to HAIs and AMR and prepare engaging stories with a specific focus on
demonstrating the impact and sustainability of IPC.
• Collate baseline assessment data that you consider will be powerful in influencing and securing political
engagement and will be most relevant to your context, based on your understanding of the drivers that
influence policy-makers in your country, for example, data on outbreaks, extra length of stay due to HAI and
associated costs where known.
• Undertake additional fact-finding exercises to identify drivers for political commitment including those that will
be most attractive to political leaders, for example, public and media statements or patient feedback (see also
strategic direction 6 SD6 ).
• Conduct cost investment analysis.
56
Part 3B. Implementation of each strategic direction
Translate all findings into the IPC NAP and implement the NAP
• Highlight priorities within the existing IPC NAP to achieve and maintain political commitment and policies, a
legal framework (if not already in place) and regulations – discussing with the IPC team and multidisciplinary
group/committee and regulatory bodies.
• Describe the IPC investment, based on all exploratory and assessment exercises – frame this in a way that will
reach policy-makers, for example, their priorities and language, rather than technical speak.
• Outline a schedule of events to raise awareness of the IPC NAP among a range of policy- and decision-makers,
including those working across different programmes and considering the need for approvals for IPC political
commitment and policies.
• Secure political commitment using the multidisciplinary group and the meeting/engagement timeline.
• Validate any legal instruments.
• Support amendment of any existing government legislation that supports the IPC NAP and programme as
necessary (see also strategic direction 2 SD2 ).
• Outline the necessary actions to evaluate progress and outcomes/impact, for example, number of ministers
committed to IPC, allocation of budget, and adherence to the legal framework.
• Outline the necessary surge capacity actions and investments for when these might be needed and achieve
commitment for these (this links IPC programmatic work with outbreak preparedness work).
• See additional tools and resources in Table 3B.3 .
57
Development and implementation of national action plans for infection prevention and control: practical guide
Maintain assessments
• Use the IPC NAP to guide ongoing evaluations.
• Activate follow-up assessments, that is, the same as in step 2, using approved tools and approaches.
• Evaluate the political commitment/policies, legal framework and established regulations.
• Assess a wide range of ministry documents indicating political commitment to IPC.
• Assess ministry communications and personal communications by policy-makers and champions showing
commitment to IPC.
• Assess where commitments and regulation were acted upon and maintained, including if IPC was addressed
within other programmes, particularly WASH, AMR and public health emergencies.
Refresh the IPC NAP with a focus on sustainability for political commitment
and policies
• Outline necessary activities to sustain political commitments and policies based on all learning in steps 1–4.
• Prepare and issue policy briefs to secure engagement on a long-term basis and to demonstrate the value of
IPC based on ongoing assessment results (see also strategic direction 6 SD6 ). Review existing policy briefs for
inspiration, for example, the Africa Centres for Disease Prevention and Control (CDC) policy brief for the legal
framework on infection prevention and control (38).
• Maintain committee/group meeting schedules and stakeholder relationships, especially when the political
landscape changes, in order to update the IPC NAP and secure political support for actions by the national IPC
programme.
• Commit to actively achieving ongoing political commitment, endorsements and approvals for the
implementation of IPC policies, a legal framework, regulation and investments (see also strategic direction 2 SD2
and strategic direction 6 SD6 ).
58
Part 3B. Implementation of each strategic direction
• Water, sanitation and hygiene in health care facilities: practical steps to achieve universal access to quality care. Geneva:
World Health Organization; 2019 (https://iris.who.int/handle/10665/311618). Licence: CC BY-NC-SA 3.0 IGO.
• WASH in health care facilities. Country progress tracker. Geneva: World Health Organization & United Nations Children’s
Fund; 2025 (http://www.washinhcf.org/country-progress-tracker).
• Toolkit on mainstreaming of gender equality, disability and social inclusion (GEDSI) in WASH in health-care facilities. New
Delhi: World Health Organization. Regional Office for South-East Asia; 2023 (https://iris.who.int/handle/10665/373608).
Licence: CC BY-NC-SA 3.0 IGO.
59
Development and implementation of national action plans for infection prevention and control: practical guide
Find out more about implementing strategic direction 1 in the country story in Annex 8 .
60
Part 3B. Implementation of each strategic direction
Î To recap on the actions, indicators and targets for achieving strategic direction 2 – refer to
Part 2, Table 2.3 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action checks at
the end of each step.
Î Work through this section and you will have the elements that will support achievement of
the following national indicators for strategic direction 2 in the context of your IPC NAP.
Indicators
1. All WHO IPC minimum requirements for IPC met at national level.
2. Proportion of health care facilities meeting all WHO minimum requirements for IPC at
facility level.
3. Proportion of health care facilities with basic WASH and waste services.
4. Proportion of tertiary/secondary care health facilities with an active IPC programme.
5. Proportion of primary care facilities with an IPC link person.
6. Proportion of facilities with implemented interventions based on multimodal strategies to
reduce specific HAIs according to local priorities.
7. Evidence-based IPC guidelines and policies available at the national level.
• In some cases, national actions and action planning will be influenced by actions being
taken at the regional or global level.
• One example is that one of the global actions of strategic direction to be undertaken by the
WHO Secretariat is to work across the three levels of WHO to support countries to establish
or strengthen active national IPC programmes.
• Some of the activities and considerations across all strategic directions are linked in some
way and this is highlighted throughout the steps.
61
Development and implementation of national action plans for infection prevention and control: practical guide
All countries should ensure the existence of active IPC programmes (Table 3B.5 ) at the national and
health care facility levels in both the public and private sectors. “Active” is defined as a functioning
programme with annual work plans (objectives and action plans) and supported by dedicated human
resources and financing. Implementation considerations and guidance on this already exist in the WHO
Guidelines on the core components for IPC programmes (4) and the Interim manuals for their
implementation at the national and facility level (6,7).
IPC guidelines IPC education and HAI surveillance Multimodal strategies Monitoring/audit
training of IPC practices and
feedback
IPC programme is IPC programme A multidisciplinary The national IPC focal A multidisciplinary
mandated to produce provides guidance and technical group for point has knowledge technical group for IPC
guidelines. recommendations for HAI surveillance is of implementation monitoring is in place.
in-service IPC training established at the science and the
at the facility level. national level by the application of
national IPC focal point. multimodal
strategies-
Evidence-based IPC programme A national strategic The national IPC focal A strategic plan for
scientific knowledge provides content and plan for HAI point coordinates/ IPC monitoring is in
and international/ support for IPC training surveillance is supports the local place, including an
national standards of health workers at the developed by the implementation of IPC integrated system for
inform guideline facility level. multidisciplinary improvements. the collection, analysis
development. technical group. and feedback of data.
The guidelines cover A national IPC The national IPC focal Multimodal strategies A minimal set of core
all acute health care curriculum for the point/team is trained are included as the indicators for health
facilities (both public in-service training of in HAI surveillance best approach for care facilities in the
and private.) health and care workers concepts and methods. implementation in country is defined.
has been developed IPC guidelines, as well
and aligned with as IPC education and
national guidelines. training programmes.
The guidelines are A national system and A mechanism to train
regularly reviewed (at schedule of monitoring national and local
least once every five and evaluation of auditors is in place.
years) and updated training and education
to reflect the current is in place (at least
evidence base. annually).
62
Part 3B. Implementation of each strategic direction
IPC guidelines IPC education and HAI surveillance Multimodal strategies Monitoring/audit
training of IPC practices and
feedback
The IPC programme Hand hygiene
actively addresses compliance monitoring
adaptation and and feedback is
standardization identified as a key
to reflect local national indicator,
conditions. at the very least for
reference hospitals.
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection.
63
Development and implementation of national action plans for infection prevention and control: practical guide
implementation will be evaluated over time, as well as HAI targets (see also strategic direction 5 SD5 ).
• Explore and secure close coordination plans with the national reference laboratory to support the IPC
programme activities.
• Secure IPC champions – invest in ways to secure their protected time and develop their capacity, capability and
leadership skills – plan for their supervision and outline how they will be dedicated to implementation of the
IPC programme, guidelines and multimodal improvement strategies.
• Review the opportunities for establishing and enhancing an active IPC programme, including a multimodal
improvement strategy, IPC guidelines and IPC targets, at least across tertiary and secondary health care
facilities, such as annual budget cycles, outbreak situations, etc.
• Start to prepare short explanatory documents on the importance of an IPC programme, guidelines and targets
in tertiary and secondary settings and what they can achieve, for example, a two-page document targeted at
leaders who can influence progress (see also strategic direction 6 SD6 ).
• Start to write and explore the approval processes for the IPC programme plan and terms of reference for
necessary committees, etc.
• Start to facilitate the collation of examples of excellence/vignettes on improvement in particular (see also
strategic direction 6 SD6 ).
• Outline how the standard operating procedures based upon the national IPC guidelines and targets will be
written for different levels (secondary and tertiary, and primary if possible) and approved.
• Explore the contents of a comprehensive guideline dissemination strategy.
• Establish a mechanism to alert all those who need to be aware about the existence of or proposed plans for the
IPC programme as part of the IPC NAP.
• Explore the expected timeframe for executing/addressing the active IPC programme, guideline development,
adaptation and implementation, and HAI targets, for example, by looking at other programmes that have been
successful (see also strategic direction 5 SD5 ).
• Set up a process for timely guideline development, adaptation or updates, for example, by reviewing the latest
HAI reports, exploring the availability of new international guidance, etc.
• Outline how all plans will link with the overall IPC NAP development, roll-out and updates.
“We recognized that we had to first train committed IPC professionals so that they would be
able to understand IPC, its epidemiology, and how to advocate for its importance, thereby
increasing political will.”
“We found that the national action plan on AMR work provided a good opportunity for
advocating for a multimodal strategy. For addressing AMR in the IPC strategic pillar, we proposed
activities as part of a multimodal approach.”
“We selected “model” IPC hospitals. In these hospitals, the selected IPC professionals made
up a team that was tasked to lead the guideline writing and provide the necessary technical
expertise for its development.”
64
Part 3B. Implementation of each strategic direction
Table 3B.6. Example of roles and responsibilities of the national IPC team (6)
Roles of the IPC national team
1. Develop and implement the national IPC programme, including setting formal objectives and plans and establishing a
formal IPC group or committee.
2. Develop and disseminate national guidelines and support implementation.
3. Develop and coordinate a programme of continuous education and training.
4. Develop and coordinate systems for HAI surveillance, including an alert system for outbreak detection, including
monitoring, audit and feedback of IPC indicators.
5. Facilitate access to the essential infrastructures, materials and equipment necessary for safe IPC practices. Support and
promote adequate workload, staffing and bed occupancy levels (that is, an enabling environment).
6. Build effective linkages with related national programmes.
7. Promote and support the implementation of multimodal improvement strategies to achieve improvements at the health
care facility level.
2. National guidelines
2.1. Develop or strengthen national policies and standards of practice (including technical, evidence-based guidelines
for the prevention of relevant risks informed by local risk assessment and/or adapted to local conditions) regarding IPC
activities in health care facilities.
2.2. Prepare dissemination plans and a programme of support for local implementation.
2.3. Ensure that a system is in place for the documentation and dissemination of successful local or national initiatives to
highlight examples of effective interventions and their implementation.
6. Programme linkages
6.1. Ensure that effective relationships and collaborations (see also strategic direction 3 SD3 ) are built with related teams,
programmes and other ministries including: WASH; environmental authorities and waste management; those responsible
for the prevention and containment of AMR, including antimicrobial stewardship programmes, tuberculosis, HIV and other
priority public health programmes; national referral laboratories and laboratory biosafety programmes; occupational
health; quality and safety programmes; patient associations/civil society bodies; scientific professional organizations;
65
Development and implementation of national action plans for infection prevention and control: practical guide
training establishments/academia; relevant teams or programmes in other ministries; relevant sub-national bodies, such as
provincial or district health offices; immunization programmes; and maternal and child health programmes.
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection; AMR, antimicrobial resistance; WASH, water,
sanitation, waste management and hygiene.
Stakeholder engagement
• Build relationships with the main stakeholders who will help drive forward the IPC programme, guideline
implementation and the multimodal approach. Establish networks at national and health facility levels if not
already in place (see also Part 3A and strategic direction 8 SD8 ).
• Identify existing or external expertise required for IPC guideline preparation, adaptation or updates specifically.
• Engage stakeholders from other health programmes, such as WASH, AMR, quality and safety, if not already
involved in the IPC programme work, as well as other specialists where necessary, for example, waste
management, logistics, environmental hygiene, behavioural scientists.
• Start to enlist the support of the identified stakeholders to advocate for implementation of the IPC programme
and guidelines, particularly through the use of a multimodal approach, depending on the prevailing culture in
the country (autocratic, technocratic, etc.) – engage health leaders, health workers, the public, etc.
• Engage those who have championed multimodal improvement strategies in their work and/or consider how to
enlist new champions based on the collated vignettes.
• Explore existing non-governmental organizations and networks and outline how they could (continue to)
champion and embed the IPC programme, guidelines and multimodal improvement strategies.
• Start to sensitize all those involved regarding the expected outcomes from the IPC programme (see also
strategic direction 6 SD6 ).
66
Part 3B. Implementation of each strategic direction
“Implementation of the workplan activities relies on funding. When considering how to meet
the indicator of having an “active” IPC programme it is important to focus on the adequacy of
the budget for IPC. One suggestion is to consider the number (proportion) of work plan activities
funded by domestic funding through government or partner/donors. Although this will differ
across countries, one approach could be to aim for at least 50% of workplan activities to be
funded. Achieving such an aim would be considered as having an adequate budget.”
67
Development and implementation of national action plans for infection prevention and control: practical guide
• Consider a short survey of a cross-section of health care facilities to drill into specific aspects of the NAP and its
understanding and to provide more comprehensive information for action.
• Consider conducting epidemiological studies on the frequency and consequences of HAIs and AMR (for
example, a national prevalence survey or incidence studies on specific types of HAIs) in order to decide on the
appropriate target for HAI reduction in your country.
• Consider inviting health care facilities (all or a sample, depending on feasibility) to undertake the WHO HHSAF
(22) as an initial proxy for the use of a multimodal improvement strategy.
• Consider undertaking or promoting safety culture assessment surveys (for example, Agency for Healthcare
Research and Quality hospital survey on patient safety culture (41).
• Understand what national guidelines/guidance exist on IPC topics and assess the priority areas that need to be
covered and/or require updates.
• Assess if contents of existing guidelines have been implemented, for example, through mapping the assessment
results listed here with guideline content and conducting surveys.
• Undertake inventories of existing capacities and resources that influence the implementation of guidelines
using, for example, the ‘workforce indicators of staffing need’ tool (42).
• Assess the availability of IPC champions.
• See additional tools and resources in Table 3B.8 .
“In Sierra Leone, baseline assessment was conducted using a group consensus approach. The
IPCAT2/IPCAT-MR was used to generate a SWOT table (strengths, weaknesses, opportunities
and threats) to guide priority setting within the operation plan. This collective analysis, using the
IPCAT-MR, was applied during stakeholder consultative meetings to develop the action plan.”
68
Part 3B. Implementation of each strategic direction
“We provided workshops for facility administrators to build awareness about this approach
(multimodal strategies) and its importance.”
69
Development and implementation of national action plans for infection prevention and control: practical guide
Maintain assessments
• Use the IPC NAP to drive repeat assessments undertaken in step 2.
• Monitor guideline and multimodal improvement strategy implementation and adherence as it relates to HAI
reduction.
• Monitor the input of IPC champions and the impact on the IPC programme.
• Review the inventory of capacities to be sure that the IPC programme can be sustained.
• Hand hygiene, ward infrastructure, knowledge and perception surveys. Geneva: World Health Organization; 2025 (https://
www.who.int/teams/integrated-health-services/infection-prevention-control/hand-hygiene/monitoring-tools). See also
the additional resources’ list at the end of strategic direction 2 SD2 .
• WHO National health planning tools. Geneva: World Health Organization; 2010 (https://extranet.who.int/nhptool/).
• Bartles R, Reese S, Gumbar A. Closing the gap on infection prevention staffing recommendations: results from the beta
version of the APIC staffing calculator. Am J Infect Control. 2024;52(12):1345-1350. doi: 10.1016/j.ajic.2024.09.004.
• WHO multimodal strategy video. Geneva: World Health Organization; 2021 (https://youtu.be/
pcKBIltlE3c?si=_0ZPdATLaOSx8ATD).
• Resource considerations for investing in hand hygiene improvement in health care facilities. Geneva: World Health
Organization; 2021 (https://iris.who.int/handle/10665/341128). Licence: CC BY-NC-SA 3.0 IGO.
70
Part 3B. Implementation of each strategic direction
• Understanding accelerators and overcoming barriers - the journey for developing or adapting an infection prevention
and control guideline: An easy to follow country approach. Copenhagen: World Health Organization. Regional Office for
Europe; 2022 (https://www.who.int/andorra/publications/m/item/understanding-accelerators-and-overcoming-barriers-
--the-journey-for-developing-or-adapting-an-infection-prevention-and-control-guideline--an-easy-to-follow-country-
approach). Licence: CC BY-NC-SA 3.0 IGO.
• See WHO guidelines on hand hygiene, surgical site infection, bloodstream infection, safety engineered syringes, and
decontamination. Geneva: World Health Organization; 2025 (https://www.who.int/teams/integrated-health-services/
infection-prevention-control).
• Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the
national level. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/345251). Licence: CC BY-NC-SA
3.0 IGO.
• Core competencies for infection prevention and control professionals. Geneva: World Health Organization; 2020 (https://
iris.who.int/handle/10665/335821). Licence: CC BY-NC-SA 3.0 IGO.
• Strategic toolkit for assessing risks: a comprehensive toolkit for all-hazards health emergency risk assessment. Geneva:
World Health Organization; 2021 (https://iris.who.int/handle/10665/348763). Licence: CC BY-NC-SA 3.0 IGO.
• Guidance for after action review (AAR). Geneva: World Health Organization; 2019 (https://iris.who.int/
handle/10665/311537). Licence: CC BY-NC-SA 3.0 IGO.
• Lack of national IPC focal point and/or any other responsible person(s) for an IPC programme,
including a NAP: focus on the urgent need to secure a national focal point and leadership for
the IPC programme. As a starting point, identify a focal point in the ministry of health to take
forward the work. Make a list of the national, sub-national and local authorities and leaders and
professional groups/bodies. Engage influential leaders and stakeholders to advocate for an IPC
focal point. Focus on how this will strengthen health service resilience, prevent catastrophic
outbreaks, prevent the spread of AMR and support the achievement of health service quality and
safety. Focus on available data (global and regional, if none at national level) and highlight how the
situation is contrary to international IPC guideline recommendations. Set up a series of advocacy
and sensitization meetings. Establish even an interim team to include national champions, quality
and safety colleagues – identify who might form the national IPC lead, team and committee. Draft a
preliminary budget and develop together a budget case for presentation to the ministers of health
and finance.
• Lack of investment in IPC, including lack of sufficient budget via direct government financing,
especially at health care facility level: fundraise alongside other leaders/programmes and
potentially through options such as the inclusion of IPC in social health insurance schemes. Start
the IPC programme with whatever small funding is available – funding can come later during
different implementation steps.
• Overambitious plans and budget with unrealistic activities/priorities, leading to an unfunded
and unachievable NAP: aim to adopt a systematic approach to an IPC programme and NAP
implementation, including use of the tools and resources and learning from country examples (the
information provided in this practical guide).
• A lack of perceived benefit of the IPC programme, for example, lack of support for guideline
development, a multimodal improvement strategy, etc.: provide information and statements of
71
Development and implementation of national action plans for infection prevention and control: practical guide
peoples’ personal experiences of IPC, AMR, WASH, quality and safety, including the use of available
guidelines, multimodal improvement strategies and targets. Outline entry points, such as focusing
on one specific area of IPC to start with, in order to show results and scale-up an IPC programme
and its implementation. From other examples, practically outline the elements of the multimodal
improvement strategy in the IPC NAP, national IPC policy documents, guidelines, standard
operating protocols, etc.
• Lack of competency and technical expertise of the national IPC team, in order to provide the
required guidance and support for implementation: explore external support/capacity where this
is necessary to build competency, while avoiding a shift in the responsibility/leading role for the
development of the IPC NAP to external/international partners for example.
• Governance and coordination hampered by a lack of institutionalization or harmonization of
related ministries/programmes at the national level or institutionalization within inappropriate
directorates: unstable situations, a fragmentation and lack of coordination, cooperation and
joined-up networks necessary to implement actions will hinder projects – institutional reform
may be required to support harmonious and effective working. For example, if the IPC national
programme is anchored within environmental health services without direct hierarchical links with
facilities, this is not conducive to effective working. Establish an organizational structure of national
and sub-national IPC programmes into existing health systems, including clearly defined functions
at the operational level based on context (with personnel roles, committees/teams, reporting lines
and linkages with other programmes). Mitigations can include (a) building on previous examples of
cooperation across disciplines and sectors (for example, in the development of AMR NAPs) and (b)
periodic partner engagement meetings to discuss work plans and priorities.
• A negative impact of political instability and conflict on IPC: build a case for IPC inclusion in
fragile, conflict-affected and vulnerable settings using the WHO Early Warning, Alert and Response
System (43) and Health Resources and Services Availability Monitoring System (44), water
quality monitoring, and other types of epidemiological and monitoring approaches that indicate a
risk. Plan to follow up to see how well (or not) risks are being mitigated and the level of sustainability
of current approaches. Use facilitators for action, including culturally competent field staff that are
supporting the ministry of health and local health authorities. Ministries in fragile, conflict-affected
and vulnerable contexts usually appreciate dedicated support to develop localized and context-
specific standard operating protocols, assessment tools, including training for health and care
workers and community-based volunteers. Explore how to offer context-specific IPC supplies and
materials (hard goods) to engage these poorly resourced settings. Use the resource: WHO Quality of
care in fragile, conflict-affected and vulnerable settings: taking action (45).
72
Part 3B. Implementation of each strategic direction
☑ Stakeholders and necessary experts from across IPC, WASH, AMR and other areas at national and facility level identified
and engaged in the IPC programme, with co-funding opportunities and cross-programme collaborations.
☑ An active IPC programme established, maintained and budgeted.
☑ IPC leadership representation in high-level committees achieved.
☑ A technical working group for IPC guideline development formed.
☑ Global/national IPC standards and multimodal improvement strategies reviewed and referenced and a structured review
and update cycle for guidelines established.
☑ Assessment tools collated – at least to monitor the IPC core component minimum requirements and with a focus on a
multimodal improvement strategy.
☑ Monitoring, evaluation and feedback of the IPC programme established and undertaken in coordination with laboratories,
including its impact over time and as a regular meeting agenda item.
☑ IPC and multimodal improvement strategy guidelines issued.
☑ IPC NAP updated.
☑ A dissemination strategy for IPC guidelines WASH and a multimodal improvement strategy implemented, including WASH.
Find out more about implementing strategic direction 2 in the country story in Annex 9 .
73
Development and implementation of national action plans for infection prevention and control: practical guide
Î To recap on the actions, indicators and targets for achieving strategic direction 2 – refer to
Part 2, Table 2.4 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action checks at
the end of each step.
Î Work through this section and you will have the elements that will support achievement of
the following national indicators for strategic direction 3 in the context of your IPC NAP.
Î Associated with this chapter, insights and suggestions for integration and coordination
between IPC programmes and the following complementary programmes can be found in
Annex 10 : AMR; occupational health and safety of health and care workers; patient safety;
and quality of care.
Indicators
1. Desk review and situational analysis of the integration of IPC within other programmes4
completed (by 2028).
2. Key existing IPC principles, standards and indicators identified, appropriately included and
cross-referenced within other national complementary programmes, as appropriate (by
2030).
3. Desk review and situational analysis of integration of other complementary programmes
within the IPC programme completed (by 2028).
4. Key existing policies, principles, standards and indicators from other complementary
programmes identified, appropriately included and cross-referenced within IPC
documents and programmes, as appropriate (by 2030).
5. Clinical packages (for example, policies and standard operating procedures) available
for integrating IPC and appropriate antimicrobial prescribing within clinical care (such as
surgery, maternal and neonatal care) (by 2028).
• In some cases, national actions and action planning will be influenced by actions at the
global level.
4
Including – but not limited to – AMR, quality of care, patient safety, WASH, occupational health and health emergencies, as well as HIV,
tuberculosis, hepatitis, maternal/child health, clinical and surgical care.
74
Part 3B. Implementation of each strategic direction
• Implementation of strategic direction 3 at the global level involves, for example, that the
WHO Secretariat (at all three levels) ensures the integration and collaboration among all
programmes and teams, which work on areas complementary to IPC.
• If this is done, particularly at the regional and country level (for example, by organizing
joint country missions or meetings and by proposing unified approaches in WHO
documents and implementation resources), it will provide a solid example to inspire
countries to follow this approach and will highlight the positive effect of achieving
consistency and avoiding duplications among programmes and initiatives.
• Ensuring consistency of IPC principles and standards promoted by WHO and international
and national stakeholders and partners is critical to avoid conflicting messages and for
countries to feel confident and supported in IPC implementation and integration. In
particular, this is important when WHO and partners promote and support IPC under
different lenses, for example, through AMR reduction programmes, WASH initiatives, or
preparing and responding to outbreaks and other public health emergencies.
• Using the same or similar monitoring systems to track the impact of their activities and
supporting countries to collect common, agreed indicators in line with the WHO IPC
monitoring framework is another critical priority, which should be embraced by WHO and
international and national stakeholders and partners in the context of their role to achieve
strategic direction 3.
• Some of the activities and considerations across all strategic directions are linked in some
way and this is highlighted throughout the steps below.
• For example, development of actions and implementation related to strategic
directions 1 SD1 and 2 SD2 will be an important facilitator in many countries in the
achievement of the key actions of strategic direction 3.
• Furthermore, a number of the key actions within strategic direction 3 are linked with or
dependent on actions within strategic direction 5 SD5 and strategic direction 8 SD8 .
75
Development and implementation of national action plans for infection prevention and control: practical guide
“We don’t need to break the silos because IPC is a distinct discipline requiring expertise and
dedicated resources and the same applies to other programmes, but we need to bridge the silos.”
Stakeholder engagement
• Review the stakeholder list developed in Part 3A and, where relevant, explore and engage the main stakeholders
to improve coordination and integration between IPC and other programmes. Maintaining a stakeholder
mapping using the mapping tools (9) will ensure a targeted, country specific list of stakeholders to achieve
integration.
• Discuss with stakeholders and partners how to improve coordination and integration mechanisms between IPC
and other health priorities and programmes and vice-versa as part of national and sub-national coordination
mechanisms and meetings, including IPC committee meetings. Ask for draft suggestions of approaches/
mechanisms for integration and coordination.
“Integration and coordination requires sharing some resources (human and financial) across
different programmes to make it happen, with the confidence that a stronger collaboration will
pay back these efforts.”
National lead for IPC and AMR in Nigeria (Nigeria Centre for Disease Control and Prevention)
76
Part 3B. Implementation of each strategic direction
• Map all existing national programmes complementary to the IPC programme (for example, AMR, WASH,
outbreak preparedness and response, patient safety and quality of care, occupational health, vaccination) and
those for which IPC is critical to deliver safe care (for example, maternal, neonatal, surgical or cancer care).
Identify these programmes from across the entire health system; do not focus only on acute care. For example,
identify programmes/services in charge of primary health care, rehabilitation or elderly care.
• Conduct a desk review and situational analysis regarding the integration of IPC within other programmes5
considering the specificities of each of these programmes in assessing the areas of interest. This entails
reviewing other programmes’ action plans and monitoring frameworks and identifying activities and indicators
that are relevant for IPC. Ideally, it should also include a review of the main technical documents and tools
issued by these programmes to check if key principles and concepts are consistent and aligned with those
promoted by the IPC programme.
• Conduct a desk review and situational analysis of the integration of other complementary programmes1 within
the IPC programme. This entails reviewing the IPC action plans and ensuring that they are aligned with those
of other complementary programmes, with a view to avoiding duplications and promoting other programmes’
initiatives and resources within IPC activities. This should also ideally include a review of the main technical
documents and tools issued by these programmes and the identification of key principles and concepts that are
relevant for IPC.
• Conduct a desk review of policies and clinical packages related to patient care pathways/programmes at the
national, sub-national and facility levels to check if key IPC principles and practices are included and promoted
to achieve high-quality care and ensure patient and health and care worker safety.
5
Including – but not limited to – AMR, quality of care, patient safety, WASH, occupational health and health emergencies, as well as HIV,
tuberculosis, hepatitis, maternal/child health, clinical and surgical care.
77
Development and implementation of national action plans for infection prevention and control: practical guide
• Meet with the complementary programmes’ focal points and/or teams on a one-to-one basis to target feedback
of the results and to start to highlight which documents and areas of work are relevant for IPC.
• Convene stakeholders and partners to share the results of the reviews and discuss their role in supporting
collaborations and integration.
Translate all findings in the IPC NAP and implement the NAP
• Outline the plans for integration and collaboration in the IPC NAP with clear objectives, roles and
responsibilities, deliverables and timelines that incorporate the necessary time for discussions and input across
programmes and joint activities.
• Outline specifically the steps to develop and cost WASH in health care facilities as part of both the IPC NAP and
WASH in health care facilities’ action plans, and IPC as part of occupational health and safety programmes
specifically.
• Specify the opportunities for partnering and networking, for example, joint training, assessments, guidance
documents, reports, advocacy campaigns, etc.
• Jointly prepare communications to highlight integration and coordination activities (see also strategic
direction 6 SD6 ).
• Outline ways to knowledge exchange, for example, existing communities of practice, etc. and where they
already exist, consider how they could promote each other and conduct any joint activities.
• Describe alignment of IPC and HAI indicators across programmes in the IPC NAP.
• Describe ongoing plans for evaluating the effectiveness and impact of the integration and coordination
activities.
• Outline opportunities for joint fundraising as applicable.
78
Part 3B. Implementation of each strategic direction
79
Development and implementation of national action plans for infection prevention and control: practical guide
donors together and develop joint proposals where the diversification of objectives for specific
areas of work is maintained, but integration is also valued.
• Complementary programmes at different stages of institutionalization: if other programmes
are more advanced, it could be a challenge for IPC to become integrated. Institutionalization of
the IPC programme at a very high level of the administrative hierarchy can enable coordination
and integration with other programmes.
Find out more about implementing strategic direction 3 in the country story in Annex 11 .
80
Part 3B. Implementation of each strategic direction
Î To recap on the actions, indicators and targets for achieving strategic direction 4 – refer
to Part 2, Table 2.5 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action
checks at the end of each step.
Î Work through this section and you will have the elements that will support achievement
of the following national indicators for strategic direction 4 in the context of your IPC
NAP.
Indicators
81
Development and implementation of national action plans for infection prevention and control: practical guide
• Implementation of strategic direction 4 at the global level through the actions by WHO,
international and national stakeholders and partners (strong collaborations between them
– described in more detail in strategic direction 8 SD8 ). This will be an important facilitator
in many countries for the achievement of the key actions of strategic direction 4 at the
national level.
• One of the global actions involves working across the three levels of WHO to help countries
to enhance active national IPC programmes, which will support the implementation of
strategic direction 4.
• A number of the key actions within strategic direction 4 are also linked with or dependent
on actions within other strategic directions.
• For example, many of the activities and considerations required to build education and
training initiatives and career pathways for IPC professionals depend on investment
and funding for an active IPC programme (strategic direction 1 SD1 ) and the existence
of an active IPC programme (strategic direction 2 SD2 ), thus providing a foundation for
developing an education curriculum for health and care workers and implementing
training programmes for IPC.
82
Part 3B. Implementation of each strategic direction
Box 3B.1. Key activities for the working group, according to country needs
1. Make a desk review of any existing programme/curriculum on education in the field of IPC in your
country at all levels (pre-service, in-service or postgraduate).
2. Discuss the results and the quality of resources retrieved and the possible adaptation of any of the
existing resources for the national level.
3. Develop a national curriculum for IPC professionals aligned with the WHO IPC core competencies or
endorse an international curriculum.
4. Develop (or adopt an international one) a national IPC curriculum for pre-graduate training and
education for all relevant health care disciplines (for example, medical, nursing and midwifery
schools), endorsed by the appropriate national or international body, and integrate it within health
educational curricula with embedded evaluation mechanisms.
5. Develop (or adopt an international one) a national in-service IPC curriculum for all frontline clinical,
cleaning and management staff to support in-service IPC training.
6. Work with ministries to mandate that all health and care workers with direct patient contact, in
particular frontline clinical, cleaning and management staff, receive education and training tailored to
their roles/job duties in IPC standard operating protocols upon employment and annually.
7. Develop monitoring and evaluation mechanisms for assessing the impact of IPC education and
training.
• Explore the alignment of education and training activities with existing IPC policies and programme activities
and vice-versa by mapping content and setting review dates for when evidence and policy changes are made.
• Explore (with the subgroup) the feasibility of and approach to integrating IPC with other educational curricula
for the agreed, relevant target audiences (for example, health and care workers, WASH workers, patient safety
and quality of care curricula, etc.). See also strategic direction 3 SD3 .
• Explore a strategy for in-service planning and structures (for example, asynchronous teaching/learning, ‘train-
the-trainers’).
• Explore the evaluation methods that can be used to report against the education and training indicators in the NAP.
• Prepare to consider facility-level implementation and evaluation, including pilot testing in facilities for
each level of curricula (pre- and postgraduate and in-service), and how this can be scaled-up in educational
institutions and health care facilities across the country.
Stakeholder engagement
• Review the stakeholder list developed in Part 3A (see also strategic direction 8 SD8) and, where relevant,
identify additional stakeholders, champions, leaders and networks required to drive forward IPC education
and training efforts. These should be specifically focused on the development of the national curriculum
for IPC professionals, national postgraduate IPC certificate programme, national IPC curriculum for pre-
graduate training, and education and national in-service IPC curriculum for all frontline clinical, cleaning and
management staff, including the creation of a career pathway for IPC professionals.
• Engage local academic institutions (public and private), including universities and others with a mandate on
health workforce education, those who have a key role in curricula development and endorsement, and in
training delivery.
• Explore and start to discuss interdisciplinary collaboration between health care professionals, educators and
policy-makers/national regulators – use the subgroup where possible.
83
Development and implementation of national action plans for infection prevention and control: practical guide
• Hold initial meetings with, for example, clinical leads to explore other existing health worker education and
training efforts in the country to identify joint areas of collaboration – invite people to the working group where
possible.
• Ensure that all stakeholders understand how education and training are key to improving IPC practices and
reducing HAI (see also strategic direction 5 SD5 and strategic direction 6 SD6 ).
• Explore which experts can be engaged in and give time to actual curriculum development and delivery, if
needed.
• Explore partnerships that can also offer opportunities for faculty development and student exchange
programmes, allowing for mentorship following training.
• Start to secure collaboration with recognized accreditation bodies in order to plan programme certifcation to
ensure that graduates meet international standards.
84
Part 3B. Implementation of each strategic direction
• Focus on the content that is relevant to IPC education, training and career pathways (other results will also
indicate commitment to an active IPC programme, which will support education and training efforts).
• Collate research output on IPC supported by education efforts (see also strategic direction 7 SD7 ).
Pre-service education
Understand what should be delivered regarding IPC pre-service education for health care programmes (for
example, those related to physicians, nurses, midwives, paramedics).
• IPCAT2 –3.2.5 (12) : IPC training is integrated into continuing medical, nursing and allied health professional
education and training.
• IPCAT2 – 3.3.1 (12) : a national system and schedule of monitoring and evaluation is in place to check on the
effectiveness of training and education, for example, at least annually.
• Explore if an IPC pre-service curriculum for all relevant health care disciplines has been developed and
endorsed by the appropriate national or international body, thus ensuring that national/international quality
and standards are met.
• Explore if an IPC pre-graduate curriculum is integrated within health educational curricula with embedded
evaluation mechanisms.
• Collate existing student and faculty satisfaction survey results.
In-service training
Understand what should be delivered regarding IPC education and training for in-service training in facilities.
• IPCAT2 – 3.1.1 (12) : the national IPC programme provides guidance and recommendations for in-service
training at the facility level (for example, frequency, expertise required, requirements for new employee
orientation, monitoring and evaluation approaches).
• IPCAT2 – 3.1.2 (12) : the national IPC programme provides content and support for IPC training of all health
and care workers at the facility level.
• IPCAT2 – 3.3.1 (12) : a national system and schedule of monitoring and evaluation is in place to check on the
effectiveness of training and education, for example, at least annually.
85
Development and implementation of national action plans for infection prevention and control: practical guide
• Review if a national policy on health facility education and training has been developed.
• Review if a national IPC curriculum for health facilities has been developed, approved and endorsed by an
appropriate professional society/body.
Postgraduate education
Understand what should be delivered regarding IPC postgraduate education for IPC professionals.
• IPCAT2 – 3.2.2 (12) : national IPC curricula developed (or under development) in collaboration with local
academic institutions for postgraduate courses.
• Review if an IPC postgraduate curriculum exists for IPC professionals in the country and if it aligns with the WHO
core competencies for IPC professionals.
Career pathway
Begin assessing the presence of a career pathway for IPC professionals, consider the following exploration and
assessment points.
• IPCAT2 - 1.1.2 (12) (and IPCAT-MR - 1.2 (15) ): an appointed infection preventionist(s) in charge of the
programme can be identified.
• IPCAT2 - 1.1.5 (12) (and IPCAT-MR - 1.5 (15) ): the appointed infection preventionist(s) has dedicated
time for the tasks (at least one full-time person).
• IPCAF - 1.3 (16) : at least one full-time (1:250 beds) IPC professional or equivalent available.
• Review if there is a curriculum for IPC professionals developed or an international curriculum endorsed and in
use, and/or a postgraduate IPC certification programme or requirement for an existing certificate with clearly
outlined pass rates.
• Investigate if a framework is available that outlines the steps to create a career pathway for IPC professionals.
• Conduct a desk review of IPC positions at the national, sub-national and facility levels and their requirements
within relevant organizations (for example, health care facilities, public health agencies and the ministry of
health) to start to inform the career pathway activities and if they align with the national IPC programme and
WHO IPC core competencies for IPC professionals.
• Investigate if certification in IPC is promoted and incorporated into position descriptions.
• Examine if membership in a national IPC society (or international society if a national one does not exist) is
promoted and supported for ongoing professional development.
• Analyse if the pay scale reflects the leadership qualities required in this position.
• Explore if there are options for promotion of IPC as part of a career pathway.
Refer to Annex 12 for an assessment framework summary of factors specifically related to IPC education and
training.
86
Part 3B. Implementation of each strategic direction
Focus on developing the presentation of results on education and training that includes IPC pre-service, in-service,
and postgraduate curricula for all health and care workers involved in service delivery and patient care (pre- and
in-service), including other personnel such as administrative and managerial staff, auxiliary service staff, cleaners
(in-service) and IPC specialists (postgraduate),
• If there is no national IPC in-service curriculum, but a facility level IPC in-service curriculum exists, explore if this
can be adapted to the national context and if it is aligned with existing national IPC guidelines.
• Review teaching methods employed where results are available. They should be grounded in adult education
principles and may include: train-the-trainer problem-based learning; hands-on workshops (including bedside
training); and peer-to-peer training innovative technologies (simulation, virtual reality, serious games).
• Review what career pathway opportunities exist for IPC professional in your country.
• Identify professional organizations to engage (based on the results of the desk review) in planning for and
promoting postgraduate IPC training.
• Prepare to present results that focus on these gaps and outline opportunities that will help IPC professionals
advance in this field.
87
Development and implementation of national action plans for infection prevention and control: practical guide
• Confirm models from other programmes or similar professions that can be leveraged when establishing the
foundational elements for an IPC career pathway.
Pre-graduate
• Outline priority programmes to target for curriculum development, focusing on professions with direct patient
contact.
• Describe steps to integrate IPC curriculum content into existing programmes (see Box 3B.2 examples).
• Outline the plan to develop the curriculum content with a clear timeline.
• Outline the necessary expertise required to develop this curriculum content.
• Use the following resources to support NAP development :
□ IPC in-service education and training curriculum (46)
□ WHO training webpage (tools and resources for training and education) (47)
□ IPC core competencies for health care providers; updated consensus document (48)
□ IPC education framework; NHS England (49).
In-service
• Develop a plan for training of IPC professionals that will prepare them to meet the competencies identified
in the WHO core competencies for IPC professionals; this may include developing a national curriculum or
adopting an existing one.
• Outline the necessary expertise to deliver this training.
• Use the following resources to support NAP development :
□ core competencies for IPC professionals (50);
□ Association for Professionals in Infection Control and Epidemiology (APIC) Infection Prevention Academic
88
Part 3B. Implementation of each strategic direction
pathway (51);
□ European Centre for Disease Prevention and Control (ECDC). Core competencies for infection control and
hospital hygiene professionals in the European Union (52);
□ Health Service Executive AMRIC Competency Framework for Infection Prevention and Control Practitioners
in Ireland (53);
□ see list of training resources available through the WHO Global Infection Prevention and Control Network
website (54).
Career pathway
• Develop a plan for the ongoing development of IPC professionals that will prepare them to meet the
competencies identified in the WHO core competencies for IPC professionals:
□ this includes promoting membership to the local IPC society.
• Use the following resources to support NAP development :
□ Infection preventionist career development and advancement guide (55);
□ definition of infection preventionist and sample job description (56, 57);
□ certification board of IPC and epidemiology (58).
Pre-graduate
In-service
89
Development and implementation of national action plans for infection prevention and control: practical guide
Career pathway
• Link IPC training with the job descriptions for IPC professionals (56, 57).
• Promote IPC training as part of ongoing professional development initiatives.
Box 3B.2. IPC pre-graduate curricula integration examples
• Nursing education: IPC standard precautions’ modules integrated into nursing school curricula, including
the importance of IPC in both inpatient and outpatient settings. Include case studies, hands-on training,
and assessments aligned with real-case scenarios.
• Medical education: IPC in medical education, including within courses on microbiology, public health,
infectious diseases and epidemiology. Can be aligned with modules on antimicrobial stewardship and
patient safety, for example.
• Public health programmes: IPC content in public health degree programmes, particularly those focusing
on epidemiology and health promotion, including outbreak management, surveillance and the role of
public health in controlling infections.
• Health governance/administration: aspects of IPC included in health administration and management
training, with a focus on the integration of IPC policies into health care facility management and the
economic implications of service delivery.
Maintain assessments
• Conduct follow-up assessments using the tools used in step 2 in order to evaluate current status regarding (at
least) the implementation of the minimum requirements for education, training and career paths related to
IPC at both national and facility level (also links with evaluation of other aspects of the core components). A
minimum annual frequency is recommended in the first instance.
• Conduct other assessments regarding education and training efforts to evaluate the programme’s impact and
relevance over time.
90
Part 3B. Implementation of each strategic direction
91
Development and implementation of national action plans for infection prevention and control: practical guide
Find out more about implementing strategic direction 4 in the country story in Annex 13 .
92
Part 3B. Implementation of each strategic direction
Î To recap on the actions, indicators and targets for achieving strategic direction 5 – refer
to Part 2, Table 2.6 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action checks
at the end of each step.
Î Work through this section and you will have the elements that will support achievement
of the following national indicators for strategic direction 5 in the context of your IPC
NAP.
Indicators
1. National strategic plan for IPC monitoring in place, including an integrated IPC
monitoring system for collection, analysis and feedback of data.
2. Proportion of tertiary/secondary health care facilities having an IPC monitoring system
for collection, analysis and feedback of data.
3. National strategic plan for HAIs and related AMR surveillance (with a focus on priority
infections based on the local context) developed by a multidisciplinary technical group
(2026) within the context of a broader surveillance system.
4. National/sub-national systems for HAI and related AMR surveillance (including for
early warning to detect epidemic- and pandemic-prone pathogens causing HAIs),
established and supported (including financially) by government and national/sub-
national authorities (by 2028).
5. Proportion of tertiary/secondary health care facilities participating in the national/
sub-national or international network for surveillance of HAIs and related AMR, if
existing.
6. Proportion of tertiary/secondary health care facilities with a surveillance system for
HAIs and related AMR, including for early warning with the ability to detect outbreaks,
epidemic- and pandemic-prone pathogens.
7. Hand hygiene compliance monitoring and feedback established as a key national
indicator, at the very least for reference hospitals (by 2026). National programme for
improving HH compliance in place (by 2026).
8. National hand hygiene monitoring system (compliance or product consumption)
established and implemented (by 2028).
9. Proportion of health care facilities at all levels monitoring hand hygiene and providing
data through the national system.
93
Development and implementation of national action plans for infection prevention and control: practical guide
94
Part 3B. Implementation of each strategic direction
• Explore ways that IPC monitoring data can feed into accreditation/regulation/certification processes as
accountability levers for facilities (see also strategic direction 1 SD1 ).
• Establish or build on existing mechanisms to outline how regular reporting on progress against the strategic
plan and the status of national goals (outcomes) will take place.
• Explore how and when timely and effective feedback can be presented and consider how to promote the
feedback of the performance against the strategic plan suitable to the local culture, preferably according to a
non-punitive institutional culture. See WHO surveillance practical handbook (60).
• Draw up a preliminary list of examples of excellence at the health facility level based on what is already known
and consider developing a suite of examples and vignettes. Hand hygiene measurement can be a good initial
starting point.
• See additional tools and resources in Table 3B.15 .
Stakeholder engagement
• Review the stakeholder list developed in Part 3A .
• Identify additional stakeholders, champions, leaders and networks required to drive forward development of
the national strategic plan for IPC monitoring, as well as the engagement of health care facilities.
• Consider how best to identify health facility leaders, frontline health workers and the public to sell the benefits
of IPC monitoring, audit and feedback (see also strategic direction 6 SD6 ).
• Discuss experiences of country adaptation of monitoring, audit and feedback approaches at existing meetings
to inform options for moving forward to meet the proposed objectives.
95
Development and implementation of national action plans for infection prevention and control: practical guide
• Use the national IPC assessment tool 2 (IPCAT2)and instruction tool (61).
• Consider the use of self or peer-evaluation with other countries, or a joint evaluation approach with experts
from countries and regional/global agencies (utilizing examples of where this has already been undertaken) to
review progress with the strategic plan and monitoring results. Reports can be accessed via the Electronic joint
external evaluation platform (62).
• Critique an example of a national SWOT analysis for AMR surveillance - annex 4 .
• Gather other baseline information from previously conducted assessments, where they exist.
96
Part 3B. Implementation of each strategic direction
Translate all findings into the IPC NAP and implement the NAP
• As part of the IPC NAP, focus on the development of a national strategic plan for IPC monitoring and the
establishment of a national programme for monitoring and improving hand hygiene practices in health care
facilities.
• Outline the practices/processes to be evaluated at the national level according to the local situation and
feasibility.
• Describe how monitoring, audit and feedback data will be collected, analyzed and fed back at the national and
facility levels as part of governance and IPC improvement efforts, also considering a benchmarking approach.
• Establish the frequency of monitoring activities and clear roles and responsibilities.
• Outline how you will build capacity in IPC monitoring, audit and feedback of data, for example, the training and
education of all relevant professionals to be involved (see also strategic direction 4 SD4 ).
• Outline the focus on hand hygiene monitoring, audit and feedback data, including the establishment of regular
hand hygiene compliance monitoring according to the WHO method, as a national indicator to be reported at
least by reference hospitals in the country.
• Define how you will promote the value of IPC monitoring, audit and feedback data (see also Part 3A and
strategic direction 6 SD6 ) and outline how monitoring contributes to a multimodal improvement approach (see
strategic direction 2 SD2 ).
Maintain assessments
• Undertake follow-up assessments at the agreed frequency using the tools used in step 2. A minimum annual
frequency is recommended in the first instance.
• Embed the plan into other national monitoring and feedback programmes as appropriate.
97
Development and implementation of national action plans for infection prevention and control: practical guide
• WHO Toolkit for Routine Health Information Systems Data. Geneva: World Health Organization; 2024 (https://www.who.
int/data/data-collection-tools/health-service-data/toolkit-for-routine-health-information-system-data/modules).
• Coker D, Phuong HTK, Nguyen LTP, Ninh T, Gupta N, Ha TTT et al. Establishing a standardized surveillance system for health
care-associated infections in Vietnam. Glob Health Sci Pract. 2022; 10(3):e2100284. doi: 10.9745/GHSP-D-21-00284 (See
Fig. 2 “Timeline of health care-associated infection surveillance implementation activities in 6 pilot hospitals, Vietnam”).
• KoboToolbox https://www.kobotoolbox.org/.
• Buy in and support for IPC monitoring, audit and feedback across health facilities can be a
challenge: lessons from countries that have successfully expanded their approach to monitoring
and feedback are summarized below.
□ Train a cadre of monitoring, audit and feedback experts to undertake periodic external
monitoring, audit and feedback. Identify at an early stage how the data will be used, for
example, the process of feedback to stakeholders, linkage of results to incentives (that is, non-
punitive) and improvement plans.
□ Integrate monitoring, audit and feedback with existing health management information systems.
□ Demonstrate the value of monitoring, audit and feedback to facility administrators, for example,
presentation of data, workshops.
□ Leverage outbreaks to secure commitment and resources and use as a foundation for
improvement.
• The perceived burden associated with the process of gathering and analyzing data: this
challenge can be exacerbated when relying on manual methods, which are often time-consuming,
prone to errors, and difficult to manage, especially when dealing with large volumes of information.
98
Part 3B. Implementation of each strategic direction
Aim to shift to electronic data collection methods, such as using specialized applications like
the open source data capture platform KoboToolbox. Outline the advantages of the efficient and
reliable collection of data via mobile devices or tablets, which significantly reduce the time and
effort needed for data entry.
Find out more about implementing strategic direction 5 in the country story in Annex 14 .
99
Development and implementation of national action plans for infection prevention and control: practical guide
Box 3B.3. Considerations for national HAI surveillance governance according to the WHO handbook on HAI
surveillance
• Ministries of health or alternative responsible national authorities should define a national governance
structure for the design, management, supervision, coordination, monitoring and evaluation of the
national HAI surveillance system in the context of the national IPC programme. Governance should
include specific structures with detailed responsibilities, for example, who is responsible for the design,
implementation, and monitoring of the HAI surveillance system, as well as clear roles and responsibilities
for each structure.
• The national HAI surveillance system lead should be specified if different from the national IPC
programme lead/focal point and should have sufficient expertise, experience and time to manage and
coordinate the national HAI surveillance system. The HAI surveillance lead should be supported by a HAI
surveillance team based on the anticipated workload.
• The national HAI surveillance lead/team, in collaboration with the national IPC programme lead (if
different), have the responsibility to convene the technical multidisciplinary HAI surveillance group.
This group is assigned to develop a written national HAI strategic surveillance plan, participate in the
development of a standardized national HAI surveillance protocol for data collection, develop a HAI
surveillance training programme, and participate in the monitoring and evaluation of the national HAI
surveillance system.
• The technical multidisciplinary HAI surveillance group should include all necessary expertise, for
example, health care epidemiologists, microbiologists, public health professionals, IPC and infectious
disease specialists, statisticians, data managers and informatics experts.
• Monitoring of the implementation of the national HAI surveillance plan should be the responsibility of the
national IPC committee, which is part of the national IPC programme structure and different from the
technical multidisciplinary HAI surveillance group.
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection.
• Identify joint areas of work across surveillance programmes and plans (see also strategic direction 3 SD3 ).
• Explore alignment and opportunities for collaboration between HAI and AMR surveillance programmes and
International Health Regulations-related teams and activities (see also strategic direction 8 SD8 ). Other
100
Part 3B. Implementation of each strategic direction
important systems and services to be considered include laboratory national systems, emergency programmes,
occupational services (list not exclusive).
• Focus on how to strengthen laboratory capacity to support both AMR and IPC programmes, as well as building
upon global information/efforts (for example, in the context of the GLASS) (32).
• Discuss with those in charge of accreditation/regulation/certification systems and explore ways that HAI data
can be used and fed into these processes as accountability levers for facilities (see also strategic direction 1 SD1 ).
• Focus on processes to regularly review data quality, including assessment of case report forms, integration of clinical
microbiology results, data accuracy, and denominator determination (that is, total exposed population), etc.
• Outline the approach for regular communication with the national reference laboratory and focus on the
alignment of priorities.
• Start to outline how you will advocate for HAI surveillance resources with leadership, focusing on the expected
net benefit (see also strategic direction 6 SD6 ).
• Consider how to adopt reliable case defin itions by referring to the WHO HAI surveillance handbook (60).
• Consider the role of specialist training, supportive supervision or other related mentorship for professionals
and leads in charge of HAI surveillance.
• Explore whether hospital-based HAI surveillance programmes are adequately linked to national or sub-national
HAI surveillance networks.
• See additional tools and resources in Table 3B.18 .
Stakeholder engagement
• Review the stakeholder list developed in Part 3A and identify additional stakeholders, champions, leaders
and networks to drive forward HAI surveillance efforts needed to achieve the targets, where relevant. Focus
on stakeholders who will provide the additional, necessary technical capacity to establish or strengthen
surveillance systems and associated protocols.
• Focus on the level of influence, type of influence and where stakeholders can address resource requirements for
example.
101
Development and implementation of national action plans for infection prevention and control: practical guide
• Explore findings from other existing surveys and data collection from other policies and programmes.
Refer to the WHO Practical handbook on HAI surveillance (60) and GLASS resources (32) for detailed
guidance to develop a national strategic plan for HAI/AMR and establish or strengthen the system for HAI/AMR
surveillance.
102
Part 3B. Implementation of each strategic direction
Translate all findings into the IPC NAP and implement the NAP
• As part of the IPC NAP, incorporate the strategic plan for HAIs and related AMR surveillance, as well as in other
NAPs (such as the AMR NAP). See Box 3B.4 .
• Hold targeted meetings to outline the plan and seek approvals.
• Outline agreed-upon roles and timeframes for the plan (for example, use a Gantt chart to illustrate the schedule).
• Develop or update standardized surveillance protocols and HAI case definitions to be used, such as the WHO
HAI case definitions in the surveillance protocol (60), or other standardized definitions, for example, the
United States Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN)
(63) or the ECDC (64, 65) (the latter two may not be feasible in low-resource settings).
• Tailor the surveillance methodology according to the local context. Include the types of infections to be under
surveillance, data collection and analysis methods, data interpretation techniques, feedback mechanisms, and
methods for the monitoring and evaluation of the HAI surveillance system.
• Address microbiology capacity-building and training on surveillance methods, while focusing on IPC process
monitoring, such as hand hygiene compliance.
• Describe actions related to point prevalence surveys versus incidence (prospective surveillance).
• Describe processes for reporting, including identified diseases of potential concern or outbreaks. Focus on
clear lines of communication and timely dissemination, for example, with decision-makers for advocacy of
organizational and behavioural change (see strategic direction 6 SD6 ).
• Address public reporting and legislation requirements.
• Set benchmarks using initial surveillance data that can be used for comparison, as appropriate.
Box 3B.4. HAI surveillance strategic plan according to the WHO Practical handbook on HAI surveillance
Abbreviations: IPC, infection prevention and control; HAI, health care-associated infection.
103
Development and implementation of national action plans for infection prevention and control: practical guide
Maintain assessments
• Conduct follow-up assessments using the tools described in step 2.
• Assess the efficiency of data collection, analysis and dissemination systems using identified indicators.
• Evaluate the impact of data feedback in terms of informing IPC improvement strategies.
• WHO Toolkit for Routine Health Information Systems Data. Geneva: World Health Organization; 2024 (https://www.who.
int/data/data-collection-tools/health-service-data/toolkit-for-routine-health-information-system-data/modules).
• Possible funding source: Fleming Fund Country Grants focused on building laboratory capacity and establishing
surveillance systems (https://www.flemingfund.org/grants-funding/country-grants/).
“In Sierra Leone, we undertook operational research and engaged policy makers and critical
stakeholders including collaboration with US CDC to establish our national surveillance
programme.”
104
Part 3B. Implementation of each strategic direction
“In Guatemala, we had a meeting focused on surveillance led by the Ministry of Health and
Epidemiology to see how it was going to be established in the country; following this a team was
created and a professional was hired to focus on surveillance– it was a tremendously positive
approach.”
• Lack of skilled human resources to lead surveillance efforts both nationally and in facilities:
regional or global expertise can potentially support surveillance training to build human resource
capacity, as can country partnering schemes. Explore publications or other supportive materials
relative to guidance on HAI surveillance and data collection and reporting to support ongoing
training on the development of a surveillance system using agreed definitions.
• Lack of infrastructures, resources and materials for laboratory, especially at operational level:
leverage existing resources, for example, by partnering with external, fully-equipped laboratories
or through a hospital network. Explore memorandums of understanding for processing samples
and obtaining timely results without the need for extensive in-house facilities in the interim. Focus
on high-risk departments such as intensive care units and surgical wards where the risk of HAIs is
higher. Implement a phased roll-out: start with a pilot programme with a specific department or
unit and gradually expand as resources become available. Outline necessary discussions/meeting
agendas on HAI surveillance methods and definitions to highlight the necessary resources.
• Scaling-up surveillance from exemplar facilities can prove an initial challenge: in Viet Nam,
scale-up was addressed through a ‘model IPC hospital approach’. IPC leaders from each model
hospital were trained and six of the model hospitals were engaged to implement standardized
HAI surveillance. Bloodstream and urinary tract infections were prioritized. The surveillance
protocol was adapted from an existing CDC/NHSN version (63) through an expert consultation
process and shared with the select leaders of the core IPC model hospital cadre who demonstrated
an initiative to provide feedback for further local adaptation of the surveillance system. Regular
support visits to the surveillance hospitals were planned and conducted to evaluate and address
implementation challenges. Visits included refresher training, stakeholder interviews (IPC team,
microbiology laboratory, clinicians in units performing surveillance), assessment of case finding
and denominator data collection practices, as well as the review of completed surveillance forms to
assess quality and discuss use of data for local action. The model hospital network provided useful
learning for scale-up. Coordination and mentorship across participating hospitals was key.
• Data sharing is a common challenge: explore ways to improve willingness to share across
countries (level of aggregation/granularity is important). Approaches need to differ between
public and private facilities with a focus on transparency. Metrics should be relevant, feasible and
meaningful for those ultimately using it at local level (for example, clinicians, IPC teams). This
may be supported through scientific society conferences in the first instance if governments are
reluctant.
• Continuous interpretation and use of HAI surveillance data to inform ways to address IPC gaps
at facility level: build data collection systems over time and pair with ongoing IPC programme
105
Development and implementation of national action plans for infection prevention and control: practical guide
actions. Collated data is only useful if it is presented in a way that is understandable by audiences
and able to be easily acted upon.
• Challenges with analysis at the facility level: providing tools to help facilities better generate
and use data (for example, run chart templates), as well as human resource capacity-building is
essential.
☑ IPC surveillance linked to health facility accreditation and certification, where possible, and best practices showcased to
support long-term monitoring engagement.
Find out more about implementing strategic direction 5 in the country story in Annex 14 .
106
Part 3B. Implementation of each strategic direction
Î To recap on the actions, indicators and targets for achieving strategic direction 6 – refer
to Part 2, Table 2.7 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action checks
at the end of each step.
Î Work through this section and you will have the elements that will support achievement
of the following national indicators for strategic direction 6 in the context of your IPC
NAP.
Indicators
• In some cases, national actions and action planning will be influenced by actions at the
global level. For example, implementation of strategic direction 6 at the global level
includes the development of global and regional IPC advocacy and communications
strategies, which will be an important facilitator in many countries in the achievement
of successful development and implementation of a national advocacy and
communications strategy.
• Some of the activities and considerations across all strategic directions are linked in
some way and this is highlighted throughout the steps below.
107
Development and implementation of national action plans for infection prevention and control: practical guide
“Clarity in what IPC actually means requires advocacy to convince politicians, stakeholders
and partners, and to raise awareness and knowledge among professionals and patients. This
needs a targeted approach towards different audiences and depending on the topic. Plans and
information should consider the important role of social media to disseminate content.”
• Confirm the lead for the national advocacy and communications strategy and implementation plan within the
IPC /implementation team.
• Identify the counterpart(s) in the communications department in the ministry of health.
• Find out what additional communications’ expertise is available, including to inform risk-based communication
strategies on IPC, and explore the availability of behavioural and cultural insights’ expertise.
• Explore the possibility to integrate IPC advocacy and communications in any other national/ministry planning/
communications, in particular regarding complementary areas of work such as AMR, WASH and public health
emergencies (see also strategic direction 3 SD3 ).
• Identify the relevant national committees/groups for the presentation of ongoing communications and advocacy
activities, including alongside other programmes of work, and ensure that there is an agenda item for this topic.
• Establish how to play a lead role in influencing meeting discussions, including on indicators to be used in
monitoring and evaluating IPC communications reach.
• Outline IPC team roles and responsibilities regarding development of the national advocacy and
communication strategy and implementation plan for IPC, as well as inputs from communications’ expertise.
• Outline plans for the team and identified local experts or champions to attend training and coaching
sessions held/informed by communications experts in order to achieve communication competence in IPC
professionals/others (may include media training). For example, to meet core competencies 3.1, 3.15 (50).
• Review any local visual identity, slogans and messages already in place for IPC/hand hygiene and list/outline
these to anticipate that new IPC communications do not confuse or conflict and are trusted and clear.
• Explore and consider signing up to (if not already done) existing global/regional activities/campaigns. For
example, WHO World Hand Hygiene Day (66) and World Antimicrobial Awareness Week (67), as well as
those in complementary fields such as WASH and patient safety.
• Review ethical frameworks to address gender, equity and human rights issues, including potential harms and
unintended consequences (for example, increased anxiety) from planned IPC communications/advocacy, for
example, the APIC/Infection Prevention and Control (IPAC) Canada ethical IPC decision-making framework (68).
• Start to map out an implementation plan for the advocacy strategy in line with the IPC programme (see also
strategic direction 2 SD2 ) and the overall IPC NAP.
• Explore sources of meaningful information and data to establish the problem(s) requiring communications and
advocacy on IPC and to support evaluation plans (see also strategic direction 5 SD5 ). Collate the existing, most
prominent/popular messages and communication themes around IPC.
• Map the current context and levers, for example, current political, policy and public drivers, as they relate
to the anticipated IPC advocacy and communications’ strategy and implementation plan (see also strategic
direction 1 SD1 and annex 15 ).
108
Part 3B. Implementation of each strategic direction
Stakeholder engagement
• Secure multi-sectoral, influential stakeholder/champion representation with IPC, AMR and other insights,
as well as patient groups, in order to inform the national advocacy and communications’ strategy and
implementation plan. Do this from existing national IPC-related committees (see also Part 3A and Annex 4 –
stakeholder mapping grid – and strategic direction 8 SD8 ).
• Secure and include relevant stakeholders in the ongoing IPC advocacy and communication strategy work,
ensuring that they are clear on their roles and responsibilities.
• Further identify specific local experts/champions (who should be competent in communicating on IPC to
people and across groups) and community leaders to be part of the IPC advocacy strategy and implementation
plan roll-out.
• Prepare “trusted voices” from those listed/engaged to reach the proposed target audiences by planning to issue
the right communications at the right times.
• Inform all stakeholders of the advocacy and communication strategy and implementation plans using existing
meetings or other methods of communication, such as emails, including available tools and resources.
“There needs to be a clear definition of the target audience(s) depending on the situation or
topic, and the level of the system. A communication strategy, for example, could target patients
and families at a health facility level to influence practice and change behaviour.”
109
Development and implementation of national action plans for infection prevention and control: practical guide
110
Part 3B. Implementation of each strategic direction
“Defining priorities is helpful in communication strategies. A lot can be learned from success
stories such as from World Hand Hygiene Day and World AMR Awareness Week. There is a need
to highlight the many activities and strategies that are already happening around the world
and make a clear link to IPC.”
Translate all findings into the IPC NAP and implement the NAP
• Finalize the national advocacy and communication strategy and implementation plan and include it as part of
the IPC NAP.
• Outline specific goals, objectives, indicators, metrics and timeline for the advocacy and communication plan, as
necessary.
• Include surge plans for increased advocacy and communications necessary in the event of outbreaks.
• Launch the advocacy and communication strategy and implementation plan, with the aim to have IPC viewed
by a broad range of stakeholders/target audiences as a priority and a life-saving component of safe, quality care
(see Table 3B.21 ).
• Launch pre-prepared, tailored and consistent communications/messages, carefully considering the timing of
their release over a period of time and also simultaneously to target different audiences/levels as necessary.
• Support ongoing message preparation and translation of highly technical subject matters into messages that
can be understood by broad audiences.
• Use information already identified from verified science-based sources and adapt text to suit different target
audiences.
• Support the preparation of advocacy toolkits, for example, the SAVE LIVES: Clean Your Hands toolkit (71).
• Use and outline mechanisms to promote the agreed channels/platforms and local experts/champions for
communications in order to reach the target audiences over time.
• Undertake specific campaign activities, as appropriate/agreed.
• Support specific media engagement as relevant. Consider the example of a news release associated with the
launch of new WHO guidance aiming to reduce bloodstream infections from catheter use (73).
• Outline and share advocacy approaches for stakeholders and champions to use and encourage them to cascade
messages.
• Outline and share the approach to any conflict resolution from communication rebuttals/complaints and be ready
to challenge rumours using the right language, always in close collaboration with the communications’ lead.
111
Development and implementation of national action plans for infection prevention and control: practical guide
Table 3B.21. Template for a national advocacy strategy and implementation plan
Action description Target Person Start date Due date Necessary Intended
audience responsible resources outcome
Hold meetings
Hold training/ coaching
sessions
Perform assessments
Hold focus groups, run
surveys. Etc.
Identify local experts/
champions
Outline target audiences
(stakeholder map)
Outline platforms to be used
Outline the budget
Write the plan
Describe surge activities (that
is, increased communications
necessary during times of
outbreaks or media interest
or public petitions)
Issue the plan
Create, adapt or adopt
messages
Implement the plan (issue
messages)
Conduct campaign activities
Evaluate the plan
Sustain the plan through
regular contributions
to advocacy and
communications
Maintain assessments
• Use the IPC NAP and advocacy and communication strategy and implementation plan to guide the assessments
and evaluation activities.
• Activate follow-up assessments, that is, those in step 2 by using approved tools and approaches.
• Contribute to discussions on any changing landscapes around communication channels/platforms to be used
going forward.
• Review the target audiences that should be reached with IPC messages through assessing impact/reach
evaluations.
112
Part 3B. Implementation of each strategic direction
113
Development and implementation of national action plans for infection prevention and control: practical guide
• Implementation playbook, pocket edition: a quick-reference guide to delivering impact for health, with tools and
templates. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/376467.) Licence: CC BY-NC-SA 3.0
IGO.
• WHO dissemination tool: part of a toolkit associated with the Implementation guide for the medical eligibility criteria and
selected practice recommendations for contraceptive use guidelines. Geneva: World Health Organization; 2018 (https://
cdn.who.int/media/docs/default-source/reproductive-health/contraception-family-planning/dissemination-tool-bw.
pdf?sfvrsn=29308960_3).
• Example of knowledge, attitude and practice surveys for hand hygiene (facility level). Hand hygiene: monitoring tools.
Geneva: World Health Organization; 2025 (https://www.who.int/teams/integrated-health-services/infection-prevention-
control/hand-hygiene/monitoring-tools).
• Advocacy, communication and social mobilization for TB control - a guide to developing knowledge, attitude and practice
surveys. Geneva: World Health Organization; 2008 (https://iris.who.int/handle/10665/43790.)
• Example facts and figures: Key facts and figures. World hand hygiene day. Geneva: World Health Organization; 2025
(https://www.who.int/campaigns/world-hand-hygiene-day/key-facts-and-figures.)
• Advocacy action guide: a toolkit for strategic policy advocacy campaigns. Campaign for Tobacco-Free Kids and Consumers
International, 2019 (https://dfweawn6ylvgz.cloudfront.net/uploads/2019/01/Final-Advocacy-Action-Guide.pdf).
• Example of reports: World hand hygiene day 2023. Summary evaluation. Geneva: World Health Organization; 2023 (https://
iris.who.int/bitstream/handle/10665/376908/9789240093348-eng.pdf?sequence=1.)
• WHO advocacy video on the core components. Geneva: World Health Organization; 2017 (https://www.who.int/multi-
media/details/what-are-the-core-components-for-effective-infection-prevention-and-control).
• Cancer control: knowledge into action: WHO Guide for Effective Programmes. Module 6: Policy and advocacy. Advocacy
step 7: Developing and implementing the advocacy plan. Geneva: World Health Organization; 2008 (https://www.ncbi.nlm.
nih.gov/books/NBK195418/#:~:text=An%20advocacy%20plan%20should%20factor,of%20the%20cancer%20control%20
programme).
• WHO advocacy strategy for mental health, brain health and substance use. Geneva: World Health Organization; 2024
(https://iris.who.int/handle/10665/43790).
• Lacking the right expertise: targeted communication training, including media training,
undertaken where appropriate and possible, should achieve a level of communications’
competence in IPC national focal points – this links with the core competencies for IPC.
• Lacking roles and responsibilities to ensure effective oversight to timely communications:
ensure availability of a clear plan, which outlines the role that IPC focal points can play in advocacy
strategies alongside communications expertise, including evaluations of reach, as described
throughout this strategic direction.
• Lacking engaging resources, including the absence of credible sources, links to local situations,
and disconnects with local beliefs, and failing to achieve the intended outcomes in target
114
Part 3B. Implementation of each strategic direction
audiences: use existing global, regional, national facts and figures, for example, as well as the use of
focus groups insights, involving local champions, which consider and review proposed messaging
and how these are perceived.
☑ An advocacy strategy and implementation plan developed, including effective communication channels and trusted
messengers, ideas for advocacy toolkits, alignment with other national health strategies, ethical considerations and existing
branding of visuals and campaigns.
☑ Long-term processes for addressing the changing landscape of communications established, alongside communications
expertise and ministry of health priorities.
Find out more about implementing strategic direction 6 in the country story in Annex 16 .
115
Development and implementation of national action plans for infection prevention and control: practical guide
Î To recap on the actions, indicators and targets for achieving strategic direction 7 – refer to
Part 2, Table 2.8 .
Î Ensure you have considered all of the activities in Part 3A and focus on the action checks at
the end of each step.
Î Work through this section and you will have the elements that will support achievement of
the following national indicators for strategic direction 7 in the context of your IPC NAP.
Indicators
• In some cases, national actions and action planning will be influenced by actions at the
global level.
• For example, one of the indicators of strategic direction 7 at the global level is the
development of a global IPC research agenda. This includes a research gap analysis based
on country needs, taking a multi-sectoral and multidisciplinary approach into account,
and with a focus on AMR, WASH, public health emergencies and low-resource settings.
Implementation of strategic direction 7 at the global level will be an important facilitator in
many countries for the achievement of the additional activities/considerations described
here, including achieving a national research agenda.
• Some of the activities and considerations across all strategic directions are linked in some
way and this is highlighted throughout the steps below.
• For example, the availability of resources and dedicated funds for IPC as described in
strategic direction 1 SD1 , or the possible integration of a IPC research agenda with other
programmes, such as AMR (particularly, antimicrobial stewardship and AMR surveillance
and monitoring through the One Health approach) or patient safety, as mentioned in
strategic direction 3 SD3 .
116
Part 3B. Implementation of each strategic direction
“Lack of data and lack of research funding are often a stumbling block to provide good
evidence for decision making.”
• Identify existing or upcoming collaboration opportunities for research proposals/activities, and/or regional
funding opportunities, for example, a national programme of patient safety, AMR research, or national funds for
health research.
• Engage with the IPC committee/group to examine methodologies for formulating research questions and
prioritization strategies (for example, consensus versus metrics) for undertaking studies aligned with local
needs and context, including integrating research findings into practice, that could be taken into consideration
as part of the national research agenda.
Stakeholder engagement
• Review the stakeholder list developed in Part 3A . Where relevant, explore and engage the main stakeholders
to drive forward development of the country-specific national research agenda and priorities for IPC. The same
stakeholders may also be those driving forward funding and the implementation of research projects on IPC in
selected facilities, according to local priorities.
• Identify organizations and/or academic institutions (both within the context of national ministries and among
external partners) in the country or in other supporting countries/regions with similar interests/needs required
for collaboration and any regulatory compliance regarding IPC research. This includes national research
councils, professional societies, international organizations and donors potentially providing research funding
(see also strategic direction 8 SD8 and the stakeholder mapping list).
• Involve additional stakeholders in generating new evidence to inform IPC policies and interventions, as
appropriate. For example, policy-makers, experts from different disciplines, implementing partners, industry,
civil society and patient representative groups.
• Identify any conflicts of interest with regards to the areas of IPC research and set out mitigation measures,
including ongoing committee governance of those involved in the research agenda.
• Explore the possibility of including research support staff and students in the research agenda work and
publications.
117
Development and implementation of national action plans for infection prevention and control: practical guide
“Professional societies, where they exist, can be engaged and should be involved to influence
and establish national research agendas around IPC, to help coordinate efforts and funding.”
Head of HAI and AMR and co-director of a WHO Collaborating Centre, WHO European Region
118
Part 3B. Implementation of each strategic direction
“In our overall national action plan, we include a lot of research targets and have a big IPC
component in it.”
Head of HAI and AMR and co-director of a WHO Collaborating Centre, WHO European Region
“In Sierra Leone, we have identified research questions for specific IPC challenges and linked
these with AMR.”
Maintain assessments
• Revisit research priority needs using scoping exercises, etc.
• Record the number of funded proposals, research grants, projects implemented and publications on IPC
achieved in the last year or biennium across the country, including understanding whether they respond to the
identified research priorities.
119
Development and implementation of national action plans for infection prevention and control: practical guide
“Research should be used strategically throughout the implementation process, and should be
aligned globally to ensure everyone is pulling in the same direction.”
• Ali M, Seuc A, Rahimi A, Festin M, Temmerman M. A global research agenda for family planning: results of an exercise for
setting research priorities. Bull World Health Organ. 2013;92:93-8. doi: 10.2471/BLT.13.122242.
• Jones J, Hunter D. Qualitative research: Consensus methods for medical and health services research. BMJ.
1995;311(7001):376. doi.org/10.1136/bmj.311.7001.376.
• Evans CT, Jump RL, Krein SL, Bradley SF, Crnich CJ, Gupta K et al. Setting a research agenda in prevention of healthcare-
associated infections (HAIs) and multidrug-resistant organisms (MDROs) outside of acute care settings. Infect Control Hosp
Epidemiol. 2018;39(2):210-3. doi.org/10.1017/ice.2017.291.
• Hensman‑Crook A, Farquharson L, Truman J , Angell C. What matters to you? Public and pIatient involvement in the design
stage of research. Res Involv Engage. 2024; 10:100. doi.org/10.1186/s40900-024-00610-1.
120
Part 3B. Implementation of each strategic direction
• Livorsi DJ, Evans CT, Morgan DJ, Reisinger HS, Safdar N, Suda KJ et al. Setting the research agenda for preventing infections
from multidrug-resistant organisms in the Veterans Health Administration. Infect Control Hosp Epidemiol. 2018;39(2):186-
8. doi: 10.1017/ice.2017.302.
• Livorsi DJ, Branch-Elliman W, Drekonja D, Echevarria KL, Fitzpatrick MA, Goetz MB, et al. Research agenda for antibiotic
stewardship within the Veterans’ Health Administration, 2024–2028. Infect Control Hosp Epidemiol. 2024; 1-7. doi: 10.1017/
ice.2024.6.
• Lynch P, Jackson M, Saint S. Research priorities project, year 2000: establishing a direction for infection control and
hospital epidemiology. Am J Infect control. 2001;29(2):73-8. doi: 10.1067/mic.2001.112734.
• Marschall J, Snyders RE, Sax H, Newland JG, Guimarães T, Kwon JH. Perspectives on research needs in healthcare
epidemiology, infection prevention, and antimicrobial stewardship: what's on the horizon-Part II. Antimicrob Steward
Healthc Epidemiol. 2023;3(1):e212. doi: 10.1017/ash.2023.474.
• Marschall J, Snyders RE, Sax H, Newland JG, Guimarães T, Kwon JH. Perspectives on research needs in healthcare
epidemiology and antimicrobial stewardship: what’s on the horizon–Part I. Antimicrob Steward Healthc Epidemiol.
2023;3(1):e199. doi: 10.1017/ash.2023.474.
• Perencevich EN, Harris AD, Pfeiffer CD, Rubin MA, Hill JN, Baracco GJ, et al. Establishing a research agenda for preventing
transmission of multidrug-resistant organisms in acute-care settings in the Veterans Health Administration. Infection
Control Hosp Epidemiol. 2018;39(2):189-95. doi: 10.1017/ice.2017.309.
• Polašek O, Wazny K, Adeloye D, Song P, Chan KY, Bojude DA, et al. Research priorities to reduce the impact of COVID-19 in
low-and middle-income countries. J Glob Health. 2022;12. doi: 10.7189/jogh.12.09003.
• Chalkidou K, Li R, Culyer AJ, Glassman A, Hofman KJ, Teerawattananon Y. Health Technology Assessment: Global Advocacy
and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative
Processes, Not Just More Evidence on Cost-Effectiveness". Int J Health Policy Manag. 2017;6(4):233-236. doi: 10.15171/
IJHPM.2016.118.
• Baltussen R, Jansen MP, Mikkelsen E, Tromp N, Hontelez J, Bijlmakers L et al. Priority Setting for Universal Health Coverage:
We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness. Int J Health Policy
Manag 2016; 5(11): 615–618. doi: 10.15171/ijhpm.2016.83.
• Smith M, Crnich C, Donskey C, Evans CT, Evans M, Goto M, et al. Research agenda for transmission prevention within the
Veterans Health Administration, 2024–2028. Infect Control Hosp Epidemiol. 2024:1-10. doi: 10.1017/ice.2024.40.
• Suda KJ, Livorsi DJ, Goto M, Forrest GN, Jones MM, Neuhauser MM, et al. Research agenda for antimicrobial stewardship
in the Veterans Health Administration. Infection Control Hospital Epidemiol. 2018;39(2):196-201. doi: 10.1017/ice.2017.299.
• The WHO Global Observatory on Health Research and Development is a comprehensive source of information and
analyses on global health research and development: https://www.who.int/observatories/global-observatory-on-health-
research-and-development.
• Yokoe DS, Advani SD, Anderson DJ, Babcock HM, Bell M, Berenholtz SM et al. Introduction to a compendium of strategies
to prevent healthcare-associated infections in acute-care hospitals: 2022 updates. Infect Control Hosp Epidemiol. 2023;
44(10):1533-9. doi: 10.1017/ice.2023.158.
• Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Donà D, Burzo S et al. WHO global research priorities for antimicrobial
resistance in human health. Lancet Microbe. 2024; 5(11):100902. doi: 10.1016/S2666-5247(24)00134-4.
121
Development and implementation of national action plans for infection prevention and control: practical guide
Expert research
advisory panel
• The APIC report on Research gaps
impacting the practice of infection
prevention and control explains the
multi-step process undertaken to solicit
Membership survey #1
comprehensive input from individuals
working in IPC.
• Lack of available funds and resources to support research, including the existence of competing
priorities: countries can leverage international funding opportunities and collaboration networks.
This can involve engaging with small research projects in selected facilities or academic institutions
already receiving research funding, thus allowing the development of initial results that can support
further funding, or partnering with organizations, research institutions, professional and scientific
and societies, key partners and donors. This could also include partnerships with other countries or
international research consortia for the development of national and international research projects.
Consider cross-sectoral funding opportunities and prioritize proposals that address the identified
research gaps. Explore public-private partnerships: governments can seek to establish public-private
partnerships where private sector companies contribute to funding IPC research.
• Time constraints and lack of expertise, including lack of skills and knowledge can prevent health
care professionals from engaging in research activities: engaging established research networks and
collaborating with academic institutions and health care facilities that already have strong research
foundations can help pool expertise and share knowledge. Promoting interdisciplinary collaboration
between different professionals (for example, IPC, epidemiology, public health, microbiology)
can help to bridge knowledge gaps and enhance research capabilities. In addition, developing
mentorship programmes for less experienced staff can build research expertise over time. Securing
dedicated research coordinators or assistants to assist with research activities can also improve
capacity. Finally, leveraging the use of online training platforms and tools can support professionals
to enhance their skills without requiring a significant time commitment, as can promoting the
122
Part 3B. Implementation of each strategic direction
Find out more about implementing strategic direction 7 in the country story in Annex 17 .
123
Development and implementation of national action plans for infection prevention and control: practical guide
Î To recap on the actions, indicators and targets for achieving strategic direction 8 – refer to
Part 2, Table 2.9 .
Î Ensure that you have considered all of the activities in Part 3A and focus on the action checks
at the end of each step.
Î Work through this section and you will have the elements that will support achievement of
the following national indicators for strategic direction 8 in the context of your IPC NAP.
Indicators
1. National IPC stakeholders’ mapping exercise performed and available (2026) and
mechanisms in place for regular updates.
2. National agenda for collaboration to improve a collaborating agenda on IPC developed (by
2028).
3. Profiles of IPC national stakeholders (such as organizations, societies, partners, donors
supporting and/or working on IPC) regularly updated (by 2030).
4. Number of joint IPC activities with national IPC stakeholders in line with the NAP and local
needs and context (2030).
• In some cases, national actions and action planning will be influenced by actions at the
global level.
• For example, one of the indicators of strategic indicator 8 at the global level is the
undertaking of a global and regional mapping exercise with mechanisms in place for
regular updates. In many countries, this will be an important factor in the successful
development and implementation of a national mapping exercise.
• A number of the key actions within strategic direction 8 are linked with or dependent on
actions within all of the other strategic directions, especially strategic direction 3 SD3 .
124
Part 3B. Implementation of each strategic direction
125
Development and implementation of national action plans for infection prevention and control: practical guide
Table 3B.26. Lessons learned from focal country experience on the tools and tactics needed to establish and
sustain multi-sectoral collaboration for AMR action
Tool and tactis Lessons learned from focal country experience
Political
commitment • Political commitment and leadership are critical to drive the AMR agenda, mobilize resources, and
achieve action.
• Progress will not happen without someone in government at the right level, with the right decision-
making authority, to drive action on AMR.
• AMR data, champions and events can serve to raise AMR’s profile and keep it on the political agenda.
• Legal instruments, including presidential orders and international agreements, can be leveraged to
give AMR political visibility.
Resources
• It takes time, money, technical assistance and dedicated human resources to coordinate across
sectors and secure mutual trust, ownership and collaboration.
• Development partners have proven a strong source of support, especially in getting early AMR
efforts off the ground.
• In the long term, governments must take the lead in resourcing NAPs and funding activities to
combat AMR.
• In many countries, those responsible for AMR may require training and support to coordinate all
relevant stakeholders effectively.
Governance
mechanisms • Because AMR is a multisectoral issue, a NAP will necessarily be a ‘plan of plans’; that is, a plan linked
to many existing plans and programmes.
• There is no one-size-fits-all approach to AMR governance: countries must establish structures and
mechanisms to suit their own situations.
• To be effective in tackling AMR, governance structures should enable both vertical and horizontal
multisectoral collaboration.
• Whatever approach countries take to coordinating AMR, good communication and consultation is
essential for successfully cascading action from governing bodies to implementing units.
Practical
management • Clear institutional mandates, roles and deliverables strengthen the transparency and accountability
of NAP implementation efforts.
• Regular progress updates or technical briefings help keep politicians and collaborators informed,
interested and engaged.
• AMR initiatives can build on existing programmes and activities by: using existing structures, such
as One Health committees, for coordination; and linking to broader plans, such as Universal Health
Coverage, to leverage AMR action.
• A simple monitoring framework and feedback mechanism can help track progress and keep
collaborators on course.
126
Part 3B. Implementation of each strategic direction
Fig. 3B.2. Creating the conditions needed to foster multi-sectoral collaboration takes time, money, people
power and technical assistance
Joint commitment
Trust and recognition
MONEY TECH
SUPPORT
Creating the
conditions needed
to foster Early groundwork Skills and capacity
multisectoral
collaboration takes
time, money,
people power and
technical
assistance.
Source: WHO (87).
• Investigate how to ensure that the multi-sectoral taskforce can be chaired by a senior official (ministry-level) on
an ongoing basis to acknowledge the importance of collaborations with IPC.
• Draft/update objectives for the collaborating agenda, including how to address joint activities with stakeholders
in line with local needs, and the potential impact of coordinated efforts. This could be done while working with
leaders from other programmes of work on this, if appropriate.
• Outline roles and responsibilities for ongoing stakeholder mapping exercises, including mechanisms and a
timeline for updates that reflect the profiles of national stakeholders.
• Prepare to communicate on the national collaborating agenda (see also strategic direction 6 SD6 ).
• See additional tools and resources in Table 3B.27 .
Stakeholder engagement
• Refer to Part 3A , gather the stakeholder list and mapping matrix developed (if already done).
• Consider all stakeholders, including those to be added to existing list, if appropriate.
• Revisit the process for stakeholder engagement approvals.
• Revisit the tools introduced in Part 3A which are critical to your successful stakeholder engagement (8, 25). The
WHO implementation handbook for NAPs on AMR (10) includes a list of essential people skills for an effective
collaboration (page 11), a sample terms of reference (page 59), and an example of a stakeholder analysis (Annex 3).
127
Development and implementation of national action plans for infection prevention and control: practical guide
128
Part 3B. Implementation of each strategic direction
• Outline a plan for regular stakeholder mapping updates (at least annually) to meet the collaboration agenda
objectives – including in the IPC NAP. The aim of this is to ensure that it includes relevant, current sectors
outside of IPC that would be applicable to effective collaborations and to meet the national collaboration
agenda. Refer to tools and resources used in Part 3A, step 2.
• Describe in detail the agreed collaboration agenda activities and include as part of the overall IPC NAP to
outline how they will be achieved and based on identified priorities. Include specific common goals, objectives,
indicators, metrics and timeline, and the approach for the collaborating agenda, both vertical (within a sector)
and horizontal (between sectors).
• Outline the mechanism for reporting and approvals.
• Outline a range of different methods for maintaining stakeholder collaboration engagement and activities,
monitoring and reporting, for example, face-to-face/virtual meetings at the taskforce level or in sub/working
groups.
• Outline the plans to maintain the regular convening of all identified stakeholders to ensure a functioning multi-
sectoral/multi-partner taskforce.
• Confirm the multi-sectoral taskforce coordination mechanism, roles and responsibilities and meeting agenda in
line with the collaboration agenda objectives.
• Describe the exact monitoring plans to outline the number of joint IPC activities with stakeholders.
• Outline and promote ways for stakeholders to knowledge exchange, for example, using existing communities of
practice, etc.
• Outline and describe ways to promote existing IPC guidance and other such resources, for stakeholders to drive
country support that meets IPC standards and needs (see also strategic direction 2 SD2 ).
“Driven by an empowered workforce and community, and based on a network of civil society
leaders, multi-stakeholder collaborations with aligned strategies are seen as another means to
raise awareness and push policymakers to taken action.”
Box 3B.5. Example of a structure of a national stakeholder collaboration agenda for IPC
The following headings can be used/adapted to form the basis of a collaboration agenda. Add in local
information and use the template to facilitate discussions in relation to an IPC collaboration agenda.
1. Introduction
129
Development and implementation of national action plans for infection prevention and control: practical guide
• Key stakeholders: list the relevant stakeholders involved in IPC collaboration according to the results
of the stakeholder mapping exercise.
• Mapping mechanism: maintain a dynamic database of stakeholders.
• Engagement strategy: describe strategies to be employed.
• Set short- and long-term goals: within the remit of the IPC NAP according to baseline assessment
results, identify areas where collaboration needs to be strengthened.
Abbreviations: IPC, infection prevention and control; NAP, national action plan.
Maintain assessments
• Use the IPC NAP and current stakeholder mapping and collaboration agenda to guide evaluation activities to
provide taskforce and stakeholder reports.
• Activate follow up assessments, that is, those in step 2, including revisiting the mapping exercise. Review the
ongoing availability and willingness of stakeholder groups to participate in the national collaborating agenda.
• Assess the number of taskforce meetings and review the meeting notes with a view to discuss whether main
action points were achieved.
• Collate and describe the number of collaborations and specific implementation and improvement projects and
outputs.
• Analyse and present on financial contributions put towards collaboration activities.
• Establish any impact on the overall improvement of IPC based on stakeholder collaborations and include within
periodic reports (see also strategic direction 5 SD5 ).
130
Part 3B. Implementation of each strategic direction
“Small island states in the PAHO region are a good example of well-organized top-down
systems where local champions are key, but who have also created a community of practice to
share experiences, exchange professionals and share knowledge.”
• Interim practical manual: supporting national implementation of the WHO guidelines on core components of
infection prevention and control programmes. Geneva: World Health Organization; 2017 (https://iris.who.int/
handle/10665/330073). Licence: CC BY-NC-SA 3.0 IGO.
• Health in all policies as part of the primary health care agenda on multisectoral action. Geneva: World Health Organization;
2018 (https://iris.who.int/handle/10665/326463). Licence: CC BY-NC-SA 3.0 IGO.
• Bennett S, Glandon D, Rasanathan, K. Governing multisectoral action for health in low-income and middle-income
countries: unpacking the problem and rising to the challenge. BMJ Glob Health 2018; 3(Suppl 4); e000880. doi.org/10.1136/
bmjgh-2018-000880.
• Draft workplan for the global coordination mechanism on the prevention and control of NCDs, 2022-2025. Geneva: World
Health Organization; 2022 (https://cdn.who.int/media/docs/default-source/documents/gcm-ncd-zero-draft-2022-2025-
workplan.pdf?sfvrsn=7b4741f_12).
131
Development and implementation of national action plans for infection prevention and control: practical guide
• Lack of accountability and leadership to achieve the collaborative agenda: the role of the WHO
country office in supporting the mapping exercises and to set up/maintain collaborations can be
effective in some countries to engage the government at different levels and secure approvals for
collaborative activities, where necessary.
• Lack of promotion of the benefits of a collaboration agenda and joint actions: use of targeted
communications in different formats to reach stakeholders and achieve awareness about the IPC
NAP, other IPC documents, and country needs should be a priority as part of the collaborative
agenda; this links with the advocacy strategy and implementation plan (see strategic direction 6 SD6 ).
• Stakeholders unwilling to be part of the collaborating agenda: winning the hearts and minds of
‘reluctant’ stakeholders will take time and requires a strong narrative on the value of collaboration.
Use other examples where they exist.
• Perception of too many stakeholders involved and that engagement with all will therefore be
a challenge: be sure to revisit the stakeholder mapping and focus on how prioritization has been
undertaken. Priority stakeholders, that is, those to be engaged first, should be those with a high
level of influence over the particular action outlined in the IPC NAP. All stakeholders will likely
contribute to implementing different aspects of the IPC NAP through collaborative activities.
However, it is important to consider the level and phase at which they should be engaged.
Find out more about implementing strategic direction 8 in the country story in Annex 18 .
132
References
Development and implementation of national action plans for infection prevention and control: practical guide
References1
1. Global report on infection prevention and control 2024. Geneva: World Health Organization; 2024 (https://iris.
who.int/handle/10665/379632). Licence: CC BY-NC-SA 3.0 IGO.
2. Global strategy on infection prevention and control. Geneva: World Health Organization; 2023 (https://iris.
who.int/handle/10665/376751). Licence: CC BY-NC-SA 3.0 IGO.
3. Global action plan and monitoring framework on infection prevention and control (IPC), 2024–2030. Geneva:
World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/integrated-health-
services-(ihs)/ipc/ipc-global-action-plan/who_gampf_w_annexes.pdf?sfvrsn=aef723f7_3).
4. Guidelines on core components of infection prevention and control programmes at the national
and acute health care facility level. Geneva: World Health Organization; 2016 (https://iris.who.int/
handle/10665/251730). Licence: CC BY-NC-SA 3.0 IGO.
5. Minimum requirements for infection prevention and control programmes. Geneva: World Health
Organization; 2019 (https://iris.who.int/handle/10665/330080). Licence: CC BY-NC-SA 3.0 IGO.
6. Interim practical manual: supporting national implementation of the WHO guidelines on core components of
infection prevention and control programmes. Geneva: World Health Organization; 2017 (https://iris.who.int/
handle/10665/330073). Licence: CC BY-NC-SA 3.0 IGO.
7. Improving infection prevention and control at the health facility: interim practical manual supporting
implementation of the WHO guidelines on core components of infection prevention and control programmes.
Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/279788). Licence: CC BY-NC-SA
3.0 IGO.
8. Implementation playbook, pocket edition: a quick-reference guide to delivering impact for health, with tools
and templates. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/376467). Licence:
CC BY-NC-SA 3.0 IGO.
9. WHO Toolkit: Stakeholder Mapping Guide. WHO Implementation guide for the medical eligibility criteria and
selected practice recommendations for contraceptive use guidelines.Geneva: World Health Organization;
2018 (https://www.who.int/publications/i/item/9789241513579).
10. WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the
human health sector. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352204).
Licence: CC BY-NC-SA 3.0 IGO.
11. WHO IPC Global portal. Geneva: World Health Organization; 2025 (https://ipcportal.who.int).
12. Core components for infection prevention and control programmes national assessment tool (IPCAT2).
Updated July 2017. Geneva: World Health Organization; 2017 (https://cdn.who.int/media/docs/default-
source/integrated-health-services-(ihs)/core-components/ipcat2.xls?sfvrsn=d087b1de_4).
13. Electronic International Health Regulations (IHR) State Party self-assessment annual reporting tool. Geneva:
World Health Organization; 2022 (https://extranet.who.int/e-spar).
14. International Health Regulations (2005): state party self-assessment annual reporting tool, 2nd ed. Geneva:
World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/350218). Licence: CC BY-NC-SA 3.0
IGO.
15. Assessment tool of the minimum requirements for infection prevention and control programmes at the
national level. Geneva: World Health Organization; 2021 (https://www.who.int/publications/m/item/
assessment-tool-of-the-minimum-requirements-for-infection-prevention-and-control-programmes-at-the-
national-level).
16. Infection prevention and control assessment framework at the facility level. Geneva: World Health
Organization; 2018 (https://apps.who.int/iris/handle/10665/330072). Licence: CC BY-NC-SA 3.0 IGO.
134
References
17. UN-water global analysis and assessment of sanitation and drinking-water (GLAAS) – 2021/2022 cycle.
Geneva: World Health Organization; 2022 (https://www.who.int/teams/environment-climate-change-and-
health/water-sanitation-and-health/monitoring-and-evidence/wash-systems-monitoring/un-water-global-
analysis-and-assessment-of-sanitation-and-drinking-water/2021-2022-cycle).
18. Assessment tool on infection prevention and control minimum requirements for primary health care
facilities. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/367505). Licence: CC
BY-NC-SA 3.0 IGO.
19. Assessment tool on infection prevention and control minimum requirements for secondary health care
facilities. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/374518). Licence: CC
BY-NC-SA 3.0 IGO
20. Assessment tool on infection prevention and control minimum requirements for tertiary health care facilities.
Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/374519). Licence: CC BY-NC-SA
3.0 IGO.
21. Core questions and indicators for monitoring WASH in health care facilities in the Sustainable Development
Goals. Geneva: World Health Organization and the United Nations Children’s Fund; 2018 (https://iris.who.int/
handle/10665/275783). Licence: CC BY-NC-SA 3.0 IGO.
22. Hand hygiene self-assessment framework. Geneva: World Health Organization; 2010 (https://cdn.who.int/
media/docs/default-source/integrated-health-services-(ihs)/hand-hygiene/monitoring/hhsa-framework-
october-2010.pdf?sfvrsn=41ba0450_6).
23. Hand hygiene. Monitoring tools. Geneva: World Health Organization; 2023 (https://www.who.int/teams/
integrated-health-services/infection-prevention-control/hand-hygiene/monitoring-tools).
24. WHO National health planning tools. Geneva: World Health Organization; 2010 (https://extranet.who.int/
nhptool/).
25. WHO Stakeholder network analysis tool to support collaboration for better health: Stakeholder.
Net. Copenhagen: World Health Organization. Regional Office for Europe; 2024 (https://iris.who.int/
handle/10665/379376). Licence: CC BY-NC-SA 3.0 IGO.
26. WHO costing and budgeting tool for national action plans on AMR resistance: user guide. Geneva: World
Health Organization; 2021 (https://iris.who.int/handle/10665/346344). Licence: CC BY-NC-SA 3.0 IGO.
27. The case for investment and action in infection prevention and control. Geneva: World Health Organization;
2025 (https://doi.org/10.2471/B09330). Licence: CC BY-NC-SA 3.0 IGO.
28. WHO infection prevention and control costing tools. Geneva: World Health Organization; 2025 (Access via the
WHO IPC home page: https://www.who.int/teams/integrated-health-services/infection-prevention-control/
core-components).
29. WHO AMR Resource Pack: Resources for in-country development and implementation of national action
plans to address antimicrobial resistance following the people-centred core package of interventions. 2025
Update. Geneva: World Health Organization; 2025 (https://www.who.int/publications/m/item/amr-resource-
pack-2025).
30. Resolve to Save Lives. New York, NY; 2025 (https://resolvetosavelives.org/about/success-stories/how-
ethiopia-established-its-first-ever-national-infection-prevention-and-control-budget/).
31. Tracking AMR country self-assessment survey – TrACSS (7.0) 2023. World Health Organization, Food and
Agriculture Organization, World Organisation of Animal Health; 2023 (https://www.who.int/publications/m/
item/tracking-amr-country-self-assessment-survey-tracss-(7.0)-2023).
32. WHO Global antimicrobial resistance and use surveillance system (GLASS). Geneva: World Health
Organization; 2025 (https://www.who.int/initiatives/glass).
33. Water and sanitation for health facility improvement tool (WASH FIT). Second edition. Geneva: World Health
Organization & United Nations Children’s Fund (UNICEF); 2022 (https://iris.who.int/handle/10665/353411).
Licence: CC BY-NC-SA 3.0 IGO.
135
Development and implementation of national action plans for infection prevention and control: practical guide
34. Patient safety assessment manual: third edition. Cairo: World Health Organization. Regional Office for the
Eastern Mediterranean; 2020 (https://iris.who.int/handle/10665/363992). Licence: CC BY-NC-SA 3.0 IGO.
35. WHO Dissemination tool. WHO Implementation guide for the medical eligibility criteria and selected practice
recommendations for contraceptive use guidelines. Geneva: World Health Organization; 2018 (https://cdn.
who.int/media/docs/default-source/reproductive-health/contraception-family-planning/dissemination-tool-
bw.pdf?sfvrsn=29308960_3; https://www.who.int/publications/i/item/9789241513579).
36. WHO Health Services Learning Hub. Geneva: World Health Organization; 2025 (https://hlh.who.int/).
37. Government of Sierra Leone Ministry of Health and Sanitation, World Health Organisation 2022 National
Infection Prevention and Control Guidelines (https://www.afro.who.int/sites/default/files/2022-08/Sierra%20
Leone%20National%20Infection%20Prevention%20and%20Control%20Guidelines_2022.pdf).
38. Policy Brief for the Legal Framework on Infection Prevention and Control. Addis Ababa; Africa Centres for
Disease Control and Prevention, African Union; 2022 (https://africacdc.org/download/policy-brief-for-the-
legal-framework-on-infection-prevention-and-control/).
39. Implementation of programs for the prevention and control of healthcare-associated infections – a roadmap.
Washington, D.C: World Health Organization. Pan American Health Organization; 2024 (https://iris.paho.org/
handle/10665.2/61435). Licence: CC BY-NC-SA 3.0 IGO.
40. WHO multimodal improvement strategy. Geneva: World Health Organization; 2009 (https://cdn.who.int/
media/docs/default-source/integrated-health-services-(ihs)/infection-prevention-and-control/core-
components/ipc-cc-mis.pdf?sfvrsn=5e06c3d5_10).
41. Surveys on patient safety culture. Rockville, MD: Agency for Healthcare Research and Quality; 2025 (https://
www.ahrq.gov/sops/index.html).
42. WISN: workload indicators of staffing need user’s manual, second edition. Geneva: World Health
Organization; 2023 (https://iris.who.int/handle/10665/373473). Licence: CC BY-NC-SA 3.0 IGO.
43. WHO Early warning, alert and response system (EWARS) resources. Geneva: World Health Organization; 2023
(https://www.who.int/emergencies/surveillance/early-warning-alert-and-response-system-ewars).
44. Health resources and services availability monitoring system (HeRAMS). Geneva: World Health Organization;
2025 (https://www.who.int/initiatives/herams).
45. Quality of care in fragile, conflict-affected and vulnerable settings: taking action. Geneva: World Health
Organization; 2020 (https://iris.who.int/handle/10665/337842). Licence: CC BY-NC-SA 3.0 IGO.
46. Infection prevention and control in-service education and training curriculum. Geneva: World Health
Organization; 2024 (https://iris.who.int/handle/10665/376810). Licence: CC BY-NC-SA 3.0 IGO.
47. Training resources on IPC. Geneva: World Health Organization; 2025 (https://www.who.int/teams/integrated-
health-services/infection-prevention-control/ipc-training-resources).
48. Infection prevention and control core competencies for health care providers. Updated consensus document.
Winnipeg: Infection Prevention and Control (IPAC) Canada; 2022 (https://ipac-canada.org/photos/custom/
pdf/IPAC_CoreCompetencies_2022_web.pdf).
49. Infection prevention and control education framework. NHS England, 7 March 2023 (https://www.england.
nhs.uk/long-read/infection-prevention-and-control-education-framework/).
50. Core competencies for infection prevention and control professionals. Geneva: World Health Organization;
2020 (https://iris.who.int/handle/10665/335821). Licence: CC BY-NC-SA 3.0 IGO.
51. IP Academic pathway. Arlington, VA: Association for Professionals in Infection Control and Epidemiology
(APIC); 2024 (https://apic.org/ip-academic-pathway/).
52. Core competencies for infection control and hospital hygiene professionals in the European Union.
Stockholm; European Centre for Disease Prevention and Control; 2013 (http://ecdc.europa.eu/en/
publications/publications/infection-control-core-competencies.pdf).
53. Health Service Executive AMRIC Competency Framework for Infection Prevention and Control Practitioners
in Ireland. Dublin: Health Service Executive; 2022 (https://www.hse.ie/eng/about/who/healthwellbeing/
136
References
our-priority-programmes/hcai/resources/general/competency-framework-for-infection-prevention-control-
practitioners.pdf).
54. Training resources. Global Infection Prevention and Control Network (GIPCN). Geneva: World Health
Organization; 2025 (https://www.who.int/groups/global-infection-prevention-and-control-network).
55. Infection Preventionist Career Development and Advancement Guide. Arlington, VA: Association for
Professionals in Infection Control and Epidemiology (APIC); 2024 (https://apic.org/professional-practice/
infection-preventionist-career-development-and-advancement-guide/).
56. Definition of ICP and sample job description. Winnipeg: Infection Prevention and Control (IPAC) Canada; 2022
(https://ipac-canada.org/definition-of-an-icp-2).
57. Who are infection preventionists? Association for Professionals in Infection Prevention and Epidemiology
(APIC) (https://apic.org/monthly_alerts/who-are-infection-preventionists/).
58. Certification board of infection prevention and control and epidemiology (CBIC). Arlington, VA. 2025 (https://
www.cbic.org/).
59. Twinning partnerships for improvement. Geneva: World Health Organization; 2025 (https://www.who.int/
initiatives/twinning-partnerships-for-improvement).
60. Surveillance of health care-associated infections at national and facility levels: practical handbook. Geneva:
World Health Organization; 2024 (https://iris.who.int/handle/10665/379248). Licence: CC BY-NC-SA 3.0 IGO.
61. Instructions for the national infection prevention and control assessment tool 2 (IPCAT2). Geneva: World
Health Organization; 2017 (https://iris.who.int/handle/10665/330078). Licence: CC BY-NC-SA 3.0 IGO.
62. Joint External Evaluation (JEE). Geneva: World Health Organization; 2025 (https://www.who.int/emergencies/
operations/international-health-regulations-monitoring-evaluation-framework/joint-external-evaluations).
63. National Health Safety Network (NHSN) patient safety component manual. Atlanta, GA: Centers for Disease
Control and Prevention; 2025 (https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf).
64. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care
hospitals – protocol version 6.1. Stockholm: European Centre for Disease Prevention and Control (ECDC);
2022 (https://www.ecdc.europa.eu/sites/default/files/documents/antimicrobial-use-healthcare-associated-
infections-point-prevalence-survey-version6-1.pdf).
65. Surveillance of healthcare-associated infections and prevention indicators in European intensive care units.
Stockholm: European Centre for Disease Prevention and Control (ECDC); 2017 (https://www.ecdc.europa.eu/
sites/default/files/documents/HAI-Net-ICU-protocol-v2.2_0.pdf).
66. World Hand Hygiene Day. Geneva: World Health Organization; 2025 (https://www.who.int/campaigns/world-
hand-hygiene-day).
67. AMR awareness week (https://www.who.int/campaigns/world-amr-awareness-week).
68. Ethical infection prevention and control (EIPC) decision-making framework. Association for Professionals in
Infection Control and Epidemiology (APIC) & Infection Prevention and Control (IPAC) Canada; 2024 (https://
ipac-canada.org/photos/custom/Members/pdf/2024-03-EthicsFramework-FINAL.pdf).
69. WHO Strategic Communications Framework for effective communications. Geneva: World Health
Organization; 2017 (https://www.who.int/docs/default-source/documents/communicating-for-health/
communication-framework.pdf).
70. Advocacy, communication and social mobilization for TB control: a guide to developing knowledge, attitude
and practice surveys. Geneva: World Health Organization & Stop TB Partnership; 2008 (https://iris.who.int/
handle/10665/43790).
71. SAVE LIVES: Clean Your Hands. WHO’s Global Annual Campaign Advocacy Toolkit. Geneva:
World Health Organization; 2016 (https://cdn.who.int/media/docs/default-source/integrated-
health-services-(ihs)/infection-prevention-and-control/5may-general/5may-advocacy-toolkit.
pdf?sfvrsn=bf983496_4&download=true).
72. Antimicrobial resistance: toolkit for media engagement. Geneva: World Health Organization, Food and
137
Development and implementation of national action plans for infection prevention and control: practical guide
Agriculture Organization, United Nations Environment Programme & World Organisation for Animal Health;
2024 (https://iris.who.int/handle/10665/376945). Licence: CC BY-NC-SA 3.0 IGO.
73. Media release: new WHO guidance aiming to reduce bloodstream infections from catheter use. Geneva:
World Health Organization; 9 May 2024 (https://www.who.int/news/item/09-05-2024-new-guidance-aims-to-
reduce-bloodstream-infections-from-catheter-use).
74. Allegranzi B, Tartari E, Kilpatrick C, Storr J, Bellare N, Bana J et al. WHO global research agenda for hand
hygiene improvement in health care: a Delphi consensus study. Infect Control Hosp Epidemiol. 2025; 1–16.
doi:10.1017/ice.2025.32.
75. Policy brief: The urgent need to foster research on infection prevention and control to improve health
security. European Union-Joint Action AMR and Healthcare-Associated Infections (EU-JAAMRI). 2021 (https://
epha.org/wp-content/uploads/2021/01/eu-jamrai-pb-wp9-the-urgent-need-to-foster-research-on-infection-
prevention-and-control-to-improve-health-security.pdf).
76. Research gaps in patient and healthcare personnel safety. Priority research questions to drive improvements.
Atlanta, GA: United States Centers for Disease Control and Prevention; 2024 (https://www.cdc.gov/healthcare-
associated-infections/media/pdfs/DHQPs-Research-Questions-508.pdf).
77. Global research agenda for antimicrobial resistance in human health. Geneva: World Health Organization;
2024 (https://iris.who.int/handle/10665/379825). License: CC BY-NC-SA 3.0 IGO).
78. Research gaps impacting the practice of infection prevention and control. Priority research questions to drive
improvements. Arlington, VA: Association for Professionals in Infection Control and Epidemiology (APIC);
2024 (https://apic.org/wp-content/uploads/2024/09/2024-08-Research-AgendaFINAL-2-1.pdf).
79. Self-assessment of organisational readiness tool (SORT). A guide to improving nursing research capacity
in health and care. Redditch: NHS England; 26 April 2024 (https://www.england.nhs.uk/long-read/self-
assessment-of-organisational-readiness-tool-sort-guide/).
80. Rudan I. Setting health research priorities using the CHNRI method: IV. Key conceptual advances. J Glob
Health. 2016;6(1):010501. doi: 10.7189/jogh.06.010501.
81. Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common
themes of good practice. Health Res Policy Syst. 2010;8:36. doi: 10.1186/1478-4505-8-36.
82. Montorzi G, de Haan S, IJsselmuiden C. Priority setting for research for health. Geneva, Council on Health
Research for Development (COHRED); 2010 (http://www.cohred.org/downloads/Priority_Setting_COHRED_
approach_August_2010.pdf).
83. Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis.
Cost Eff Resour Alloc 2006; 4:14. doi: 10.1186/1478-7547-4-14.
84. Okello D, Chongtrakul P, the COHRED Working Group on Priority Setting. A manual for research priority setting
using the ENHR approach. Geneva: Council on Health Research Development (COHRED); 2000 (http://www.
cohred.org/publications/library-and-archive/a_manual_for_researc_1_0/).
85. Ghaffar A, Collins T, Matlin SA, Olifson S. The 3D Combined Approach Matrix (CAM). An improved tool for
setting priorities in research for health. Geneva: Global Forum for Health Research; 2009 (https://www.files.
ethz.ch/isn/111447/2009_The-3D-Combined-Approach-Matrix.pdf).
86. WHO training package on environmental cleaning: evaluation methodology guide. Geneva: World Health
Organization; 2024 (https://iris.who.int/handle/10665/379551). License: CC BY-NC-SA 3.0 IGO.
87. Tackling antimicrobial resistance (AMR) together. Working paper 1.0: Multisectoral coordination. Geneva:
World Health Organization; 2018 (https://iris.who.int/handle/10665/336975). Licence: CC BY-NC-SA 3.0.
1
All references were accessed on 10 April 2025.
138
Annexes
Annex 1.
IPC core components and the eight strategic directions
IPC PROGRAMMES
and all relevant programme linkages
MONITORING,
GUIDELINES EDUCATION SURVEILLANCE AUDIT AND
AND TRAINING
FEEDBACK
ENABLING ENVIRONMENT
WORKLOAD, STAFFING, AND BED OCCUPANCY
MUL IES
TIMODAL STRATEG
140
Annexes
Strategic directions
Political commitment
SD1 and policies SD5 Data for action
Advocacy and
SD2 Active IPC programmes SD6 communications
Research and
SD3 Active IPC programmes SD7 development
141
Development and implementation of national action plans for infection prevention and control: practical guide
SD2: active IPC programmes Relevant to all, with specific reference to:
CC 1 IPC programmes
CC 2 National and facility level IPC guidelines
CC 5 Multimodal strategies for implementing IPC activities
SD6: advocacy and communication CC 5 Multimodal strategies for implementing IPC activities
Abbreviations: SD, strategic direction; CC, core component; IPC, infection prevention and control; HAI, health care-associated infection.
Reference
1. Guidelines on core components of infection prevention and control programmes at the national and acute
health care facility level. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/251730).
Licence: CC BY-NC-SA 3.0 IGO
2. Global strategy on infection prevention and control. Geneva: World Health Organization; 2023.(https://iris.who.
int/handle/10665/376751). Licence: CC BY-NC-SA 3.0 IGO.
142
Annexes
Annex 2.
Key WHO documents
Global
strategy
on infection
Global strategy on infection prevention and control: approved
prevention
and control by all Member States, the strategy vision that by 2030, everyone
accessing or providing health care is safe from associated
infections, serves as the backbone of the WHO GAPMF and was
adopted by all countries at the Seventy-seventh World Health
Assembly in May 2024 (1).
1. IPC PROGRAMMES
Core components for IPC programmes: evidence- and expert
and all relevant programme linkages
143
Development and implementation of national action plans for infection prevention and control: practical guide
Part II: How to Successfully Implement Each Core Component of an IPC Programme
Interim Practical Manual supporting national implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes 1
144
Annexes
WHO implementation
handbook for national WHO implementation handbook for national action plans
action plans on
antimicrobial resistance
Guidance for the human health sector
on antimicrobial resistance: guidance for the human
health sector: provides a practical, stepwise approach to the
implementation of the national action plans on AMR and a
process and collation of existing WHO tools to prioritize, cost,
implement, monitor and evaluate NAP activities (10).
145
Development and implementation of national action plans for infection prevention and control: practical guide
Implementation playbook,
pocket edition
Abbreviations: GAPMF, global action plan and monitoring framework; WASH, water, sanitation, waste management and hygiene; IPC, infection
prevention and control; HAI, health care-associated infection; AMR, antimicrobial resistance; NAP, national action plan.
References*
1. Global strategy on infection prevention and control. Geneva: World Health Organization; 2023 (https://iris.who.
int/handle/10665/376751). Licence: CC BY-NC-SA 3.0 IGO)
2. Global action plan and monitoring framework on infection prevention and control (IPC), 2024–2030. Geneva:
World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/integrated-health-services-
(ihs)/ipc/ipc-global-action-plan/who_gampf_w_annexes.pdf?sfvrsn=aef723f7_3).
3. Guidelines on core components of infection prevention and control programmes at the national and acute
health care facility level. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/251730).
Licence: CC BY-NC-SA 3.0 IGO.
4. Minimum requirements for infection prevention and control programmes. Geneva: World Health Organization;
2019 (https://iris.who.int/handle/10665/330080). Licence: CC BY-NC-SA 3.0 IGO.
5. Interim practical manual: supporting national implementation of the WHO guidelines on core components of
infection prevention and control programmes. Geneva: World Health Organization; 2017 (https://iris.who.int/
handle/10665/330073). Licence: CC BY-NC-SA 3.0 IGO.
6. Improving infection prevention and control at the health facility: interim practical manual supporting
implementation of the WHO guidelines on core components of infection prevention and control programmes.
Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/279788). Licence: CC BY-NC-SA 3.0
IGO.
7. Global patient safety action plan 2021–2030: towards eliminating avoidable harm in health care. Geneva: World
Health Organization; 2021 (https://iris.who.int/handle/10665/343477). Licence: CC BY-NC-SA 3.0 IGO.
8. Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response
at the national level. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/345251).
9. Surveillance of health care-associated infections at national and facility levels: practical handbook. Geneva:
World Health Organization; 2024 (https://iris.who.int/handle/10665/379248). Licence: CC BY-NC-SA 3.0 IGO.
10. WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human
health sector. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352204). Licence:
CC BY-NC-SA 3.0 IGO.
146
Annexes
11. Water and sanitation for health facility improvement tool (WASH FIT). Second edition. Geneva: World Health
Organization & United Nations Children’s Fund (UNICEF); 2022 (https://iris.who.int/handle/10665/353411).
Licence: CC BY-NC-SA 3.0 IGO.
12. Quality health services: a planning guide. Geneva: World Health Organization; 2020 (https://iris.who.int/
handle/10665/336661. Licence: CC BY-NC-SA 3.0.
13. Implementation playbook, pocket edition: a quick-reference guide to delivering impact for health, with tools
and templates. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/376467). Licence:
CC BY-NC-SA 3.0 IGO.
* All references were accessed on 10 April 2025.
147
Annex 3.
148
Development and implementation of national action plans for infection prevention and control: practical guide
Stakeholder mapping grid
Based on the WHO stakeholder mapping guide and tools (1).
Names of organizations/entities have been included for illustration – amend according to local situation.
Name of Name of contact Level of Type of influence Priority of Role and type of engagement Strategic
organization/entity person (title/level) influence engagement direction of
relevance
Ministry of health All
Educational/ All, 2, 4, 5
academic institutions
(public and private)
Professional All, 2, 5, 7
and scientific
organizations and
societies
Annexes
149
150
Development and implementation of national action plans for infection prevention and control: practical guide
Name of Name of contact Level of Type of influence Priority of Role and type of engagement Strategic
organization/entity person (title/level) influence engagement direction of
relevance
Unions All, 2
Ministries of All, 1
education,
environment, labour,
water and population
Ministry of research 7
and universities
International All
organizations
relevant for IPC
Donors All, 2, 7
Reference
1. WHO Toolkit: Stakeholder Mapping Guide. WHO Implementation guide for the medical eligibility criteria and selected practice recommendations for
contraceptive use guidelines.Geneva: World Health Organization; 2018 (https://www.who.int/publications/i/item/9789241513579). (Accessed 10 April 2025).
Annexes
151
Development and implementation of national action plans for infection prevention and control: practical guide
Annex 4.
SWOT analysis: example of a national SWOT analysis for
AMR surveillance
Helpful Harmful
Strengths Weaknesses
Awareness and political will Awareness and political will
• Renewed political commitment towards AMR • Limited visibility on the importance of AMU/
surveillance from the ministry of health. AMC surveillance at the subnational and
community level.
Coordination and stakeholder engagement
• Technical working group on AMR surveillance has Coordination and stakeholder engagement
been established with clear TORs and meets on a • No national coordinating mechanism(s) or
regular basis. TWG(s) for AMU/AMC in place.
Financial resources: Financial resources:
• Donor funding is available for selected facility-level • Lack of government funding for improvement in
Present factors
Opportunities Threats
Awareness and political will Awareness and political will
• Generate awareness on AMC surveillance at the • Uncertainty in government about the devolution of
highest political level through presentations in power to the municipality level.
existing AMR governance mechanisms.
Coordination and stakeholder management
Governance and coordination: • Private sector not involved in AMR and AMC/AMU
• Link the TWG on AMR surveillance in human health to surveillance activities and reporting, although the
existing coordinating mechanisms in the animal health private sector covers 60% of health care facilities
sector for information sharing.
Financial resources:
Financial resources: • Some aspects of AMR surveillance programmes are funded
Future factors
• UHC donor support can be channelled to include AMR exclusively by donors, and funding will end in the near
surveillance activities. future.
• Identify internal national funding streams for AMR Technical capacity:
surveillance activities. • Health emergencies may keep technical staff from
Technical capacity: working on AMR surveillance if it is not incorporated into
• Larger tertiary health care facilities have trained the health security agenda.
clinical microbiologists. Implementation of AMR activities:
Implementation of AMR activities: • Competing interests from the private sector.
• New health insurance scheme can be used for Monitoring and data:
making an economic case for AMR surveillance • Limited surveillance data sharing within and between
activities. relevant sectors may lead to inconsistent messaging on
Monitoring and data: AMR.
• Opportunity to leverage existing AMR surveillance IT
systems to integrate AMU/AMC monitoring.
Abbreviations: AMC: antimicrobial consumption; AMR: antimicrobial resistance; AMU: antimicrobial use; EQA/IQA: external quality assurance/
internal quality assurance; GAP: Global Action Plan; GLASS: Global Antimicrobial Resistance Surveillance System; IT: information technology;
NAP AMR: national action plan on AMR; SOPs: standard operating procedures; SWOT: strengths, weaknesses, opportunities and threats; TORs:
terms of reference; TWG: technical working group; UHC: universal health coverage.
Source: WHO (1).
152
Annexes
Reference
1. WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human
health sector. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352204). Licence: CC
BY-NC-SA 3.0 IGO.
153
Annex 5.
154
Development and implementation of national action plans for infection prevention and control: practical guide
Sample evaluation matrix for activity prioritization
Adapted from Table 1: Sample evaluation matrix for activity prioritization (1).
Strategic Activity or sub- Priority as Impact Imminent risk Early wins Feasibility Total
direction activity assigned within (1–5; 1 = low (1–5; 1 = low risk, (1–5; 1 = time- (1–5; 1 = low
stakeholder impact, 5 = high 5 = high risk) intensive; 5 = feasibility, 5 =
discussions impact) quick win) high feasibility)
(1–5; 1 = low
priority, 5 = high
priority)
Reference
1. WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector. Geneva: World Health
Organization; 2022 (https://iris.who.int/handle/10665/352204). Licence: CC BY-NC-SA 3.0 IGO. (Accessed 10 April 2025).
Annex 6.
Sample IPC national action plan template
Strategic direction (insert title of strategic direction)
Priority gaps Action required Lead and Start date End date Budget Monitoring
identified collaborators and evaluating
implementation
progress
(include review/
completion
dates)
List all gaps List the actions that are planned using List the lead person, State when the Estimate deadline For each action, Describe the
identified information gathered as you work through agency, partner or action will start to for action to estimate the budget progress that has
through baseline the 5 steps of the implementation cycle stakeholder driving be addressed (year be completed, required to address been made at
assessment the action or month) including periodic actions & state each review date
review dates if whether funding including decisions
applicable source is available and actions taken,
and the need for
further actions to be
taken to achieve
completion
Annexes
155
Annex 7.
156
Development and implementation of national action plans for infection prevention and control: practical guide
Template for detailed operational plan and budget
Strategic direction (insert title of strategic direction)
Activity:
Implementing Unit and Timeframe Monitoring indicator(s) Resources and Sources of funding
entity quantity including currency (human,
deadline infrastructure,
financial)
Sub-activity
Sub-activity
Sub-activity
Sub-activity
Sub-activity
Sub-activity
Annexes
Annex 8.
Country story: Integrating policies and professionals
to build a robust IPC framework in China (strategic
direction 1, Political commitment and policies)
► What we achieved
Influenced by our continuous political leadership and commitment, we have established a comprehensive
legal framework for IPC in China, ensuring that IPC plans are implemented across all health care facilities.
To support the IPC NAP, we have developed a systematic quality control network that extends from the
national level down to provincial, municipal and county levels. By 31 May 2023, this network included 439
city-level quality control centres and 1554 county-level centres, each with dedicated budgets. Members of
the IPC quality control centre at each level have been elected and appointed by national and local health
commissions from the competent IPC experts voluntarily contributing their expertise and efforts to the
improvement of national and local IPC management. At every level, roles and responsibilities have been
clearly defined to ensure the effective implementation of both national and local IPC projects.
According to the latest data, there are 7247 health care facilities nationwide, including 2164 tertiary and
4938 secondary facilities. Approximately 56 000 IPC professionals are working in secondary and higher-level
health care facilities. The ratio of actual beds to a full-time IPC professional is 132:1 (doctors, 32.8%; nurses,
54.3%; and 11.6% other personnel, such as microbiologists and public health professionals). National
training programmes are conducted annually for IPC professionals at various levels of health care facilities.
Health commissions at all levels, including national, sub-national, and municipal, have been instrumental
in ensuring that IPC policies are effectively implemented. The National Institute of Hospital Administration
and the National Administration of Traditional Chinese Medicine have also contributed to these efforts.
Key government departments have included the National Health Care Security Administration, the National
Administration of Disease Prevention and Control, the Ministry of Ecology and Environment, the Ministry
of Science and Technology, the Ministry of Finance, the Ministry of Education, the Ministry of Agriculture
and Rural Affairs, the Ministry of Industry and Information Technology, and the National Medical Products
Administration, among others.
157
Development and implementation of national action plans for infection prevention and control: practical guide
In 2017, the Standing Committee of the National People’s Congress revised the “Law of the People’s
Republic of China on the Prevention and Control of Occupational Health,” focusing on occupational health
protection for medical personnel, including training and protective measures. This built upon: (1) original
work since 1986 on a three-level IPC management system at national, sub-national and facility levels; (2)
the Standing Committee of the National People’s Congress’s 1989 “Law of the People's Republic of China
on the Prevention and Treatment of Infectious Diseases,” establishing systems for infectious disease
monitoring, early warning and outbreak announcements; this law also strengthened control measures in
health care facilities and improved medical treatment systems; (3) the State Council’s 1994 “Regulation on
the administration of health care facilities,” requiring health care facilities to implement sterilization and
disinfection standards, establish isolation systems and adopt effective waste disposal measures to prevent
hospital-acquired infections; and finally (4) the National Health Commission’s “Regulation on Management
of Health care Associated Infection” in 2006, mandating that health care facilities implement IPC work
according to specified provisions and clarifying accountability.
• Developing: national IPC plans and monitoring and surveillance systems developed by the national
quality control centre. Key actions include “Clean Hands, Protect Health” and “National Action Plan to
Combat AMR”.
• Implementing: quality control centres guide and monitor IPC measures in health care facilities, using
quality control indicators and reporting data to the national centre.
• Auditing: rules and regulations clarify the obligations of health care facilities, including inspection and
accreditation standards, to ensure quality and safety.
• Surveillance: the “Health Care-Associated Infection Medical Quality Control Indicators (2024 Revision)”
guide data analysis and feedback.
In 2006, we mandated the establishment of independent IPC departments in health care facilities with 100+
beds. National guidelines and training programmes support the education of full-time IPC professionals.
► Outputs so far
• A comprehensive IPC legal framework
• Systematic quality control
• Approximately 56 000 IPC professionals working in secondary and higher-level health care facilities,
supported by annual national training programmes.
158
Annexes
159
Development and implementation of national action plans for infection prevention and control: practical guide
► Resources
Legal
framework
Regulation on the Law of the People's Law of the People's Regulation on the
Management of Republic of China on Republic of China on administration of IPC requirements
Health Care the Prevention and the Prevention and health care facilities by laws and
Associated infection Treatment of Control of regulations
Infectious Diseases Occupational Health
160
Annexes
Annex 9.
A new national IPC programme to enhance quality
of care in Nepal (strategic direction 2, Active IPC
programme)
► What we achieved
Over a three-year period, we built an active and sustainable national IPC programme in Nepal, which was
launched in 2023 within the Nursing and Social Security Division under the Department of Health Services
at the Ministry of Health and Population. In 2024, we developed a national IPC strategy, based on the WHO
global strategy, with a long-term vision and an action plan for strengthening the national IPC programme.
• Significant improvement of the national IPC capacity from 2021 to 2024 as shown with the increase of the
SPAR score from 27% to 53%.
• Improvement of IPC scores in 2024 from the IPCAF baseline assessment (2022, lower range (201-400) of
the basic level) in federal and provincial health care facilities to an average score of 300-400 in the upper
range of the basic level.
• Hand hygiene compliance ranging between 70-90% (varying among nurses and doctors) according to
monitoring undertaken daily, weekly and monthly in critical units of federal health care facilities.
161
Development and implementation of national action plans for infection prevention and control: practical guide
► Outputs so far
• New active national IPC programme established within the Nursing and Social Security Division and
supported by a national IPC committee, functioning since 2023.
• Establishment of a national technical working group and steering committee on IPC with defined terms
of reference and a role in advising on IPC programme planning and implementation.
• The IPC guideline and an associated implementation manual launched in February 2023 by the Ministry
of Health and Population.
• An approved annual work plan and budget allocation for the national IPC programme.
• Update and expansion of the IPC training package, both basic and advanced formats, performed by the
Nursing and Social Security Division team in collaboration with the National Health Training Centre.
• IPC training in all provinces for medical doctors, nurses and paramedics using train-the-trainers and
master trainer approaches, including a clinical training skills development course.
• In 2023, Nepal successfully completed a WHO-led pilot point prevalence survey, testing simplified HAI
case definitions adapted for low-resource settings.
• Advanced IPC training on IPC monitoring and HAI surveillance to develop and measure impact of
local action plans. Participants are responsible for carrying out IPC assessment, monitoring and HAI
surveillance regularly at the health care facilities.
• Development of HAI surveillance standard operating procedures by a designated expert team, in
collaboration with the technical working group and through a consultative workshop with major
stakeholders. For the moment, the HAI surveillance programme is implemented in three federal
hospitals.
• Report of the IPC assessment (self and Joint External Evaluation) results.
• On-site coaching and mentoring programme conducted regularly and implemented in 12 federal
hospitals.
162
Annexes
163
Development and implementation of national action plans for infection prevention and control: practical guide
Resources
• Infection Prevention and Control Guideline, 2079 and Infection Prevention and Control Manual, 2080:
https://publichealthupdate.com/infection-prevention-and-control-ipc-guideline-2079/
• First Joint External Evaluation (JEE) in Nepal https://www.who.int/nepal/news/detail/28-11-2022-first-
joint-external-evaluation-%28jee%29-in-nepal
• Nepal Health Sector Strategy https://nepal.unfpa.org/sites/default/files/pub-pdf/NHSS-English-Book-
final-4-21-2016.pdf
164
Annexes
Annex 10.
Insights and suggestions for integration and coordination
between IPC and other key programmes
165
Development and implementation of national action plans for infection prevention and control: practical guide
The WHO strategic and operational priorities for addressing drug-resistant bacterial infections highlights the
need to integrate the AMR response with broader health systems’ strengthening efforts, including primary
health care approaches to achieve Universal Health Coverage. In this regard, national IPC programmes should
be linked to key primary health care operational levers to ensure the sustainability and efficient use of limited
resources and the health workforce (2). These include improving the quality of care at all levels of the health
system, supporting models of care that promote high-quality and essential public health functions, ensuring
an adequate and competent workforce, physical infrastructure, and the supply and access to essential health
products.
2. Establishing a joint coordination structure that oversees both AMR and IPC programmes
To effectively address the interconnected public health challenges of AMR and IPC, countries should ensure
a joint leadership structure that oversees both programmes to achieve their successful integration and
coordination at the country level.
Beyond the key stakeholders identified in the global action plan on IPC, countries should also involve policy-
makers and stakeholders critical for AMR activities as mentioned above, including associations of clinicians and
microbiologists active in the AMR field, drug regulatory bodies, procurement agencies, and those responsible
for the distribution of antimicrobials.
166
Annexes
risk of surgical site infection caused by resistant pathogens. The use of antimicrobial use surveillance data can
inform adherence to best practices with regards to surgical antibiotic prophylaxis and thus help reduce HAIs.
► Resources*
• Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015 (https://iris.who.
int/handle/10665/253236).
• Global Database for Tracking Antimicrobial Resistance (AMR) Country Self- Assessment Survey. Geneva:
World Health Organization; 2023 (https://amrcountryprogress.org/#/map-view).
• Costing and budgeting tool for national action plans on antimicrobial resistance: user guide. Geneva: World
Health Organization; 2021 (https://iris.who.int/handle/10665/346344). Licence: CC BY-NC-SA 3.0 IGO.
• WHO national and facility level assessment tools of the IPC core components and minimum requirements.
Geneva: World Health Organization; 2025 (https://www.who.int/teams/integrated-health-services/infection-
prevention-control/core-components).
167
Development and implementation of national action plans for infection prevention and control: practical guide
Key elements for integrating IPC with public health agencies/emergency management operations include:
• strategic plans: incorporate IPC actions and interventions into national strategic preparedness and
response emergency plans;
• guidelines: develop and/or adapt national IPC guidelines/guidance for disease-specific rapid response
during emergencies;
• surveillance systems: establish surveillance systems and monitor HAIs during preparedness stages, as
well as during public health emergencies, to detect and mitigate threats within health care and community
settings;
• training programmes: provide specialized training to health and care workers for the implementation of
IPC in high-threat scenarios;
• facility assessments: conduct rapid IPC assessments to identify and prioritize gaps for targeted
interventions and to identify required surge capacity for supportive supervision and mentorship;
• simulation exercises: use drills, intra- and/or after-action reviews to refine response capabilities and
enhance preparedness;
• multimodal implementation: tailor IPC measures and varied approaches to country-specific contexts to
ensure effectiveness.
These elements help create a robust framework for managing IPC within public health emergency operations,
ensuring both immediate and long-term benefits.
168
Annexes
2. Linking key players in national IPC and public health emergency response programmes
Strong national IPC programmes promote collaboration among policy-makers, agencies and frontline
workers. Establishing emergency coordination structures, like incident management teams and IPC taskforces
at the start of an outbreak, ensures a rapid and unified response. This approach helps streamline resource
mobilization and facilitates the dissemination of guidance, enhancing the overall emergency preparedness and
response.
5. Conclusion
Effective integration of IPC within emergency preparedness, readiness and response mechanisms is essential
for mitigating and controlling public health emergencies and maintaining health system resilience. Investing in
sustainable IPC and WASH programmes ensures long-term preparedness, reducing outbreaks and the impact of
future public health emergencies.
► Resources*
• All resources and tools on IPC and WASH in health emergencies may be accessed at https://www.who.int/
teams/health-care-readiness/infection-prevention-and-control.
• Framework and toolkit for infection prevention and control in outbreak preparedness, readiness
and response at the national level. Geneva: World Health Organization; 2021 (https://iris.who.int/
handle/10665/345251) Licence: CC BY-NC-SA 3.0 IGO.
• Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and
response at the health care facility level. Geneva: World Health Organization; 2022 (https://apps.who.int/
iris/handle/10665/361522). Licence: CC BY-NC-SA 3.0 IGO.
169
Development and implementation of national action plans for infection prevention and control: practical guide
Integration and coordination of IPC and occupational health and safety of health and care
workers
Introduction
The goal of occupational health and safety in the health sector is to protect health and care workers from
work-related harm. Occupational health and safety services and IPC programmes play an important role in
safeguarding the health, safety and well-being of health workers against avoidable harm caused by infections,
including those caused by antimicrobial-resistant pathogens acquired during the provision of health and care
services. While these programmes have distinct focuses, their integration and coordination are crucial for the
comprehensive protection of health workers, patients and the overall health system. Essential to this integration
are health workforce development programmes designed to ensure that health workers possess the necessary
knowledge through pre- and in-service education to remain in service and meet population health needs.
The following actions could be beneficial to facilitate integration and collaboration at the national and sub-
national levels.
• Promote collaboration between occupational health and safety and IPC programmes by engaging a range
of government and non-government stakeholders. For example, ministries responsible for labour, worker
representatives, civil society organizations, professional associations, labour organizations, employers
(including those in the private health sector), and health workers themselves.
• Implement unified reporting and monitoring systems for HAIs. Ensure that these systems include indicators
for occupational infections among health workers, with disaggregated data on gender, age, occupation and
other relevant factors integrated into health information management systems.
• Expand IPC programmes to include workplaces across all sectors. This approach acknowledges the
interconnectedness of workplaces, care facilities, and communities in the spread and control of infectious
diseases, especially during public health emergencies.
• Incorporate occupational health and safety and IPC considerations into the inspection, auditing and
licensing processes for health care facilities. Utilize common standards to streamline the accreditation and
implementation of both programmes.
The following actions could be beneficial to facilitate integration and collaboration at the facility level.
• Ensure that individuals or teams responsible for both occupational health and safety and IPC in resource-
constrained settings receive sufficient training, support and resources. Advocate for increased staffing
levels to enable dedicated teams for each function.
• Develop collaborative risk assessments and control plans to address infectious hazards in health and care
settings.
170
Annexes
• Work with human resources and management to integrate occupational health and safety and IPC training
into pre- and in-service learning for all health and care workers
• Establish effective communication channels between occupational health and safety and IPC personnel,
where dedicated teams exist, to facilitate information sharing and collaboration.
Combining the strengths of both occupational health and safety and IPC programmes in an integrated approach
not only ensures compliance with legal standards, but also promotes a positive work atmosphere, resulting in
higher health worker retention, better patient outcomes, and a more resilient healthcare system.
► Resources*
• The goal of Occupational health and safety: https://www.who.int/health-topics/occupational-health
• Occupational safety and health in public health emergencies: a manual for protecting health workers and
responders. Geneva: World Health Organization and International Labour Organization 2018 (https://iris.
who.int/handle/10665/275385). Licence: CC BY-NC-SA 3.0 IGO.
• Occupational hazards in the health sector (e-tool). Geneva: World Health Organization; 2025 (http://www.
who.int/tools/occupational-hazards-in-health-sector).
171
Development and implementation of national action plans for infection prevention and control: practical guide
IPC integration and coordination with WASH for implementation of the global action plan
and monitoring framework
Introduction
WASH is critical to achieve IPC implementation and is included in core component 8 of effective IPC
programmes. It provides the necessary infrastructure, procedures and equipment enabling the implementation
of appropriate IPC practices and behavioural change among health workers and the community. The global
action plan and monitoring framework on IPC includes several actions, indicators and targets specifically
related to achieving WASH improvements. On the other hand, the global framework for action (2024–2030)
provides a mechanism to guide and track actions and includes IPC elements and indicators. At the national
level, there are opportunities to jointly address and fund WASH and IPC through AMR NAPs, emergency health
funding, and primary care and quality of care efforts.
2. Resources needed
The main financial resources required to make WASH improvements that can enable IPC practices are those
needed to make infrastructure improvements (for example, installing new water supplies or waste treatment
technologies), as well as costs for their regular operation and maintenance (for example, water treatment and
testing, repairing pipes and toilets). These costs will depend on the local situation and needs. On the human
resources side, all health facility staff should be familiar with WASH and waste management and operations.
Of note, some individuals (staff or private suppliers) should be specifically trained in cleaning and health care
waste management, with the ability to conduct regular water and sanitation monitoring within facilities and
make minor repairs.
Competing priorities in the health and WASH sector, difficulties in working and financing across sectors, and
lack of leadership and support to implement changes are critical barriers to achieving WASH and IPC integration
and goals. Lack of awareness about the situation and the cost of inaction also hamper engagement and
progress in both WASH and IPC.
172
Annexes
• The WHO/UNICEF Joint Monitoring Programme provides data on existing services (water, sanitation, hand
hygiene, cleaning and waste) at the national level.
• Data on national efforts regarding system change to support WASH (for example, costed national plans,
regular monitoring, updated standards).
• Both data sources are updated regularly, with the former linked to regular reporting on Sustainable
Development Goal 6 (safe WASH), and the latter associated with reporting on the United Nations General
Assembly Resolution on Sustainable, Safe and Universal WASH, Waste and Electricity Services in Health Care
Facilities.
► Resources*
• All resources and tools on WASH in health care facilities may be accessed at https://www.who.int/teams/
environment-climate-change-and-health/water-sanitation-and-health-(wash)/health-care-facilities/wash-
in-health-care-facilities.
• Guidelines on core components of infection prevention and control programmes at the national and
acute health care facility level. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/
handle/10665/251730). Licence: CC BY-NC-SA 3.0 IGO.
• Water and sanitation for health facility improvement tool (WASH FIT): a practical guide for improving
quality of care through water, sanitation and hygiene in health care facilities, 2nd ed. Geneva: World Health
Organization; 2022 (https://iris.who.int/handle/10665/353411). Licence: CC BY-NC-SA 3.0 IGO.
• Universal water, sanitation, hygiene, waste and electricity services in all health care facilities to achieve
quality health care services: global framework for action 2024–2030. Geneva: World Health Organization
and UNICEF; 2024 (https://iris.who.int/handle/10665/377776). Licence: CC BY-NC-SA 3.0 IGO.
• WHO/UNICEF Joint Monitoring Programme https://washdata.org/data/healthcare#!/.
173
Development and implementation of national action plans for infection prevention and control: practical guide
References*
1. People-centred approach to addressing antimicrobial resistance in human health: WHO core package of
interventions to support national action plans. Geneva: World Health Organization; 2023 (https://iris.who.
int/handle/10665/373458). Licence: CC BY-NC-SA 3.0 IGO.
2. Primary health care health systems levers for action. Geneva: World Health Organization; 2021 (https://
www.who.int/publications/m/item/primary-health-care-health-systems-levers-for-action).
174
Annexes
Annex 11.
Country story: IPC and role model hospitals: a
demonstration of how coordination and integration
can become a reality to reduce AMR in Egypt (strategic
direction 3, IPC integration and coordination)
► What we achieved
Following the successful completion of a pilot phase in August 2023, we decided to expand the AMR
model hospitals in which cross-disciplinary integration and coordination are a fundamental part, starting
in September 2023. Our model is now operational in 60 public and private hospitals across all Egyptian
governorates.
All 60 participating hospitals showed significant improvements in infection IPC and AMS standards’
implementation, with leadership commitment achieving a 35% increase. Adherence to key IPC practices
improved by 25%, compliance with isolation practices for multidrug-resistant organisms rose by 51%, and
the implementation of device-related, HAI preventive ‘bundles’ increased by 38%. The AMS assessment
score improved by 31%, with notable improvements in compliance with antibiotic restrictions from the
Reserve group, which increased by 49%.
In May 2023, in collaboration with the WHO Country Office in Egypt, we developed and launched the
AMR Operational Plan for the Human Sector. This plan aligns with the AMR NAP endorsed in 2019 and
the WHO global action plan on AMR, focusing on enhancing IPC and antimicrobial stewardship practices,
capacitating microbiology laboratories, and ensuring leadership commitment.
In April 2023, we launched the National One Health Strategy to coordinate efforts between the Ministries of
Health and Population, Agriculture and Environment, demonstrating our commitment to addressing AMR.
175
Development and implementation of national action plans for infection prevention and control: practical guide
Building on our robust IPC governance structure and the national IPC programme, which started in 2003,
was central to our achievements.
The IPC General Department at the Ministry of Health and Population was designated to lead, coordinate
and integrate efforts, as well as to supervise the implementation of national AMR initiatives, including
coordinating activities among Ministry of Health and Population departments, such as the Central Public
Health Laboratories and the General Department of Pharmaceutical Affairs. We also implemented a
comprehensive governance framework for AMR prevention and control at all levels (Ministry of Health
and Population, directorates, and hospitals), with clearly defined roles and responsibilities. This structure
includes representation from IPC, pharmacies, and microbiology laboratories, with IPC teams empowered
to lead and coordinate efforts.
We defined an integrated set of key performance indicators related to both process and outcome measures,
assessed at baseline and at follow-up field visits to track progress and facilitate continuous improvement.
These key performance indicators included leadership commitment, IPC (such as multidrug-resistant
organism incidence rates, adherence to key IPC practices, for example, hand hygiene, device-related
HAI preventive ‘bundles’, isolation precautions for multidrug-resistant organisms, and environmental
cleaning), antimicrobial stewardship (such as the hospital antibiotic consumption rate, and compliance
with WHO Access, Watch, Reserve [AWaRe]) antibiotic classification and surgical prophylaxis protocols), and
microbiology laboratory key performance indicators (such as the percentage of agreement between the
results of the hospital microbiology laboratory and central public health laboratories).
Integration of interventions
To execute the AMR operational plan and improve IPC practices at health care facilities, we implemented a
multifaceted strategy in phases starting in May 2023 and extending over a five-year period until all Ministry
of Health and Population hospitals are enrolled. This strategy encompassed the following key initiatives.
• From May to August 2023, we conducted a pilot phase involving 17 Ministry of Health and Population
hospitals across 13 of the 27 governorates in Egypt. These hospitals were selected as AMR model
hospitals based on predetermined requirements, including the presence of a functioning microbiology
laboratory and clinical pharmacists.
• We conducted baseline assessments for each enrolled hospital using standardized facility-level tools
to evaluate their status in core programme areas, including leadership, IPC, AMS and the microbiology
laboratory.
• We regularly disseminated integrated IPC/AMS/laboratory written feedback reports to hospital
leaderships, highlighting corrective measures, key intervention priorities, suggestions for improving
existing infrastructures, workforce capacities, and necessary equipment and supplies.
• We implemented a comprehensive 6-day training programme in each participating hospital to
capacitate 510 frontline staff, including IPC teams, clinical pharmacists, microbiology laboratory staff,
and clinical and surgical ward directors.
• We conducted continuous monitoring and follow-up visits by central and directorate teams, utilizing
the same standardized, baseline, facility-level tools to assess progress.
176
Annexes
Between August 2023 and May 2024, we developed and disseminated a total of 26 000 information,
education and communication materials to both enrolled and prospective hospitals. These materials
supported the integration of IPC and AMR and included promotional videos and posters focusing on hand
hygiene, isolation precautions, safe injection practices and judicious antibiotic use.
► Outputs so far
By August 2024, we had trained 1428 frontline staff and conducted 185 assessment visits across 60
hospitals, leading to a 35% improvement in leadership commitment to IPC and antimicrobial stewardship
activities. Compliance with isolation practices related to multidrug-resistant organisms increased from 28%
to 79%, and the implementation of device-related, HAI preventive bundles improved from 44% to 82%.
177
Development and implementation of national action plans for infection prevention and control: practical guide
178
Annexes
Annex 12.
Assessment framework summary (national and facility level)
for education and training
IPC education and/ National level Yes/No
or career pathway (Y/N)
components
General IPCAT - 3.2.3: National curricula are informed by international curricula/ □ Yes
networks and adapted to national needs and local resources. □ No
IPCAT - 3.2.4: National curricula are adapted to national needs and local □ Yes
resources. □ No
IPCAT - 3.4.1: Standardized training tools in line with national guidelines and □ Yes
international standards to support implementation of curricula are available. □ No
IPCAT - 3.4.2: The national IPC training supports packages to promote the use of □ Yes
participatory and team- and task-based strategies. □ No
IPCAT - 3.4.3: The national IPC training supports packages to promote the use of □ Yes
simulation. □ No
IPCAT - 3.4.4: The national IPC training supports packages to promote the use of □ Yes
multimodal strategies. □ No
IPCAT - 3.4.5: The national IPC training supports packages to promote the □ Yes
integration and embedding of IPC training within clinical practice and the □ No
training of other disciplines.
Pre-graduate IPCAT - 3.2.1: National IPC curricula, developed (or under development) in □ Yes
collaboration with local academic institutions are available for pre-graduate □ No
courses.
IPCAT2 - 3.2.5: IPC training is integrated into continuing medical, nursing and □ Yes
allied health professional education and training. □ No
IPCAT2 – 3.3.1: a national system and schedule of monitoring and evaluation is □ Yes
in place to check on the effectiveness of training and education, for example, at □ No
least annually.
In-service IPCAT2 – 3.3.1: a national system and schedule of monitoring and evaluation is □ Yes
in place to check on the effectiveness of training and education, for example, at □ No
least annually.
IPCAT2 - 3.4.6: The national IPC training supports packages to promote the □ Yes
importance of involving patients or family members in facility-level training □ No
programmes
Postgraduate IPCAT2 – 3.2.2: national IPC curricula developed (or under development) in □ Yes
collaboration with local academic institutions for postgraduate courses. □ No
Core competencies for IPC professionals provide content for to guide curriculum □ Yes
development, as well as guidance related to IPC professional responsibilities □ No
IPC professional (career) IPCAT2 - 1.1.2: An appointed infection preventionist(s) in charge of the □ Yes
programme can be identified □ No
IPCAT2 - 1.1.4: The appointed infection preventionist(s) have undergone □ Yes
training in IPC in reducing the transmission and prevention of health HAI. □ No
IPCAT2 - 1.1.5: The appointed infection preventionist(s) have dedicated time □ Yes
for the tasks (at least one full-time person). □ No
179
Development and implementation of national action plans for infection prevention and control: practical guide
180
Annexes
Annex 13.
Strategic direction 4: country story – Addressing the
educational needs of the new IPC professional in
Canada (strategic direction 4, IPC knowledge among
health and care workers and career pathways for IPC
professionals)
► What we achieved
Canada was one of the pioneer countries to establish an educational and career pathway for IPC
professionals, with the national professional society (Infection Prevention and Control Association Canada
[IPAC Canada] supporting these efforts for decades. The organization has supported the advancement
of the profession through several activities, including developing resources such as documents defining
the role of an IPC professional, a sample job description and the core competencies for IPC professionals.
IPAC Canada has developed a mentorship programme to support career advancement and organizes an
annual day targeted at advocacy efforts on a national level by bringing IPC professionals together annually
to meet with the federal government on important issues. In addition to these examples, IPAC Canada
has been a leader in supporting the advancement of knowledge and capacity building on the topic of IPC
through several education-related activities, ranging from the annual national conference to multiple
courses designed to educate frontline health and care workers, to more specific certificate courses for IPC
professionals.
Building upon this deeply rooted expertise, IPAC Canada recently responded to a specific demand for
training of newly-designated IPC link persons and focal points in long-term care by developing an online
course (‘Essentials of IPC’) designed to align with the core competencies for IPC professionals. In addition,
due to specific requests regarding the training of new IPC link persons and focal points from the Northwest
Territories and Province of Manitoba, IPAC Canada tailored the content of the ‘Essentials in IPC’ course to
ensure relevance for these provinces/territories, as well as for long-term care facilities. The ‘Essentials in
IPC’ is a six-module course that includes quizzes, examinations and a ‘reflection paper’ (taking the place
of a former on-site practicum). This was offered on three separate occasions, allowing to reach 100 IPC link
persons and focal points.
Due to ongoing demand, this course has now evolved into a new IPAC Canada resource primarily
designed for IPC professionals working in long-term care facilities. This new long-term care certificate
course is aligned with the core competencies for IPC professionals, as well as the domains included in the
Certification Board of Infection Control (CBIC) Long-Term Care Certification in Infection Prevention (LTC-
CIP®) examination. The inaugural course started in 2024 in the form of a one-month self-study programme,
followed by a two-day in-person workshop, and is currently in its third iteration.
181
Development and implementation of national action plans for infection prevention and control: practical guide
► Outputs so far
• The ‘Essentials in IPC’ self-study programme, open to IPC professionals in any health care setting, is
offered twice per year. A regular 10-month programme takes place from September to June.
• A LTC Hybrid Essentials course was held in September 2024, February 2025 and March 2025, including a
month of self-study followed by a three-day in-person workshop in Toronto. This was in response to the
Province of Ontario Long-Term Care Act, which prescribes certification for IPAC Canada leads in long-
term care by April 2025.
• Evaluations of all the courses to date have indicated the excellent appreciation of the quality of the
curriculum and instructors by the students, also commenting that they respond to critical needs for
182
Annexes
basic knowledge in IPC. Furthermore, the high value of the strong peer network created through the
programmes has been recognized.
► Resources
• The original IPAC Canada Acute Care Distance Education Course (now archived) and the APIC Long-term
Care Learning Series https://apic.org/course/ltc-cip-certification-preparation-course/ were utilized as a
resource for instructors in the development of the curriculum for the Long-term Care Hybrid course.
• Role of an IPC professional https://ipac-canada.org/definition-of-an-icp-2
• Sample job description https://ipac-canada.org/photos/custom/pdf/8.73%20-%20Membership%20
-%20ICP%20Job%20Description%20May%202019.pdf
• The IPAC Canada Core Competencies for Infection Prevention and Control Professionals https://ipac-
canada.org/photos/custom/pdf/IPAC_CoreCompetencies_ICPs_2022_revised.pdf
• The IPAC Canada Core Competencies for Healthcare Workers https://ipac-canada.org/photos/custom/
pdf/IPAC_CoreCompetencies_2022_web.pdf
183
Development and implementation of national action plans for infection prevention and control: practical guide
184
Annexes
Annex 14.
Country story: From research to action: strengthening
IPC in Sierra Leone using operational data (strategic
direction 5, Data for action)
► What we achieved
IPC assessments started in Sierra Leone as part of operational research; results were paramount to guide
improvement plans and interventions with remarkable impact. For this reason, the Ministry of Health and
stakeholders decided to institutionalize this approach, leading to the following key policy and practice
changes between 2021 and 2023.
• National IPC performance improvement: IPC performance at the national level improved from
intermediate (58%) to advanced (78%), with four of six core components reaching the advanced level
of IPC using the WHO IPCAT 2 tool. Among 12 district hospitals, median IPC scores increased from basic
(50%) to intermediate (59%), with improvements in six of eight IPC core components of the WHO IPCAF
tool. Three of four gaps identified in 2021 at the national IPC unit and four of seven at hospitals had been
addressed by 2023.
• Tertiary hospital IPC compliance: IPC in three major hospitals improved from basic to intermediate IPC
compliance, with score increases of 16.9%, 18.7%, and 26.9%, respectively.
• Guideline distribution and policy development: 1200 copies of updated national IPC guidelines were
distributed and terms of reference for full-time IPC focal points were introduced.
• Enhanced IPC supply chain: increased availability of essential IPC consumables, including soap and
alcohol-based hand rubs (local production).
• HAI surveillance and research: development of Sierra Leone’s first HAI surveillance strategy, protocol and
pilot case definitions within a point prevalence survey (under peer review).
• Surgical site infection reduction: surgical site infection incidence among Cesarean-section and hernia
patients dropped from 6.7% (2021) to 2.8% (2023) following improvements in medical records and
postoperative maternity ward facilities.
• National IPC framework development: drafting of Sierra Leone’s first IPC framework, toolkit, and
operational guide for priority disease outbreaks (2024).
• Hospital hand hygiene improvement: introduction of a hand hygiene quality improvement intervention
in hospitals.
• Border point IPC institutionalization: hand hygiene, sanitation, screening, and isolation were embedded
into routine protocols at Sierra Leone’s four main border entry points.
185
Development and implementation of national action plans for infection prevention and control: practical guide
of Health in Sierra Leone (including the national AMR programme, national IPC programme, disease
surveillance, and hospital IPC committee). The WHO Country Office and WHO headquarters also played
a role as well as the Special Programme for Research and Training in Tropical Diseases (TDR). In addition,
the Structured Operational Research and Training Initiative (SORT IT) global partnership supported the
achievements. The partnership was comprised of the International Union Against Tuberculosis and Lung
Diseases; Medicins Sans Frontières; ICMR–National Institute of Epidemiology, India; Sustainable Health
Systems, Sierra Leone; University of Guinea, Guinea; Institute of Tropical Medicine, Antwerp, Belgium;
University of Chester, United Kingdom of Great Britain and Northern Ireland; University of Liverpool, United
Kingdom of Great Britain and Northern Ireland; and the University of Washington, United States of America.
• Research prioritization and stakeholder engagement (2019): the IPC technical working group
identified key IPC research priorities, which were subsequently endorsed by the One Health AMR
Committee.
• Selection of trainees: candidates for training were nominated and their research topics were defined.
Selections were reviewed by a TDR-led committee based on specific SORT IT eligibility criteria, including
involvement in IPC and supervisor endorsement (https://tdr.who.int/activities/sort-it-operational-
research-and-training).
• Training and capacity building (2020): seven IPC personnel were trained by TDR and SORT IT partners
in research principles across four one-week modules, that is, research protocol writing, data analysis,
manuscript writing, and research communication.
• Evidence generation (2021-2022): trainees formulated priority IPC research questions using routine
programmatic data to address key challenges. Baseline data were available on surgical site infections,
IPC core component assessments and hand hygiene compliance. Research questions were used to
inform a series of publications (see “outputs so far”)
• Effective communication and advocacy: research findings were effectively communicated through
stakeholder mapping, technical presentations, evidence briefs and consultative meetings to inform
decision-making.
• Impact and follow-up (2023): based on recommendations, national and sub-national stakeholders took
actions to address IPC gaps. In 2023, a new cohort of IPC personnel and frontline workers was trained
to assess the impact of these decisions, identify any remaining gaps and assess the impact of previous
research (“is research evidence inducing change?”). Decisions were agreed upon and actions taken by
various responsible persons/institutions at national and sub-national levels to address the priority gaps
based on the recommendations provided.
► Outputs so far
• Publication and dissemination: findings were published in open-access peer-reviewed journals.
186
Annexes
These studies highlighting strengths, gaps, and policy implications for IPC implementation at national
and facility levels spanned various IPC topics with policy and practice implications. For example,
implementations of the WHO IPC core components at national and health facilities, hand hygiene
compliance and framework assessments, surgical site infection, community IPC during the COVID-19
pandemic (point of entries).
• Reporting and publication on impact (2023): the new trainees published their findings and conducted
evidence dissemination, presenting to the national IPC programme, IPC advisory committee and senior
Ministry of Health stakeholders, including the Deputy Minister of Health. Their work culminated in a high-
level national dissemination event and a compiled research publication (see references Kamara et al,
2023, Table 2).
• The follow-up impact assessment documents changed from the previously identified priority gaps with
further improvement action using the same method of approach and tools.
• strengthening of IPC monitoring, ensuring data quality through quarterly supervision and robust
operational research, all requiring trained personnel and adequate resources;
• supporting capacity-building initiatives and expert mentorship of IPC personnel on implementation
science;
• introducing self-paced and online learning resources for IPC personnel through free online learning
platforms like OpenWHO.
• Limited country budgets result in shortages of IPC infrastructure and resources – highlighting the need
for dedicated investments.
• Lack of government funding for IPC as an integrated health system priority necessitates strategic
budget allocation.
187
Development and implementation of national action plans for infection prevention and control: practical guide
• The need to develop a shared work plan along with other related programmes such as WASH, AMR,
patient safety, and quality improvement programmes.
• Mapping of stakeholders (and donors) to identify the workstream for possible support based on
priorities in the IPC NAP.
• Enhanced donor planning and grant proposal involvement.
• Continue evidence-based advocacy and communication strategies involving using local data on IPC.
In low resources, always start with easily accessible and routinely collected data.
► Resources
• TDR and SORT IT research training resources: presentations, evidence communication tools. https://tdr.
who.int/activities/sort-it-operational-research-and-training
Engagement of
stakeholdeers
Module 4:
Communication Define research Module 1:
priorities Protocol
advocacy and
development
uptake
Train
Conduct and publish
Enhance mechanism Embed operational research
for knowledge
sharing and uptake Retain Build sustainable
research capacity
Enable
Module 3: Module 2:
Manuscript writing Build structures and
processes for Data analysis
and publishing
evidence informed
decision making
188
Annexes
• Fofanah BD, Abrahamyan A, Maruta A, Kallon C, Thekkur P, Kamara IF et al. Achieving Minimum Standards
for Infection Prevention and Control in Sierra Leone: Urgent Need for a Quantum Leap in Progress in the
COVID-19 Era! Int J Environ Res Public Health. 2022; 19(9); 5642. doi: 10.3390/ijerph19095642.
• Kamara IF, Tengbe SM, Fofanah BD, Bunn JE, Njuguna CK, Kallon, C et al. Infection Prevention and Control
in Three Tertiary Healthcare Facilities in Freetown, Sierra Leone during the COVID-19 Pandemic: More
Needs to Be Done! Int J Environ Res Public Health. 2022;19(9): 5275. doi: 10.3390/ijerph19095275.
• Squire JS, Conteh I, Abrahamya A, Maruta A, Grigoryan R, Tweya H et al. Gaps in Infection Prevention and
Control in Public Health Facilities of Sierra Leone after the 2014–2015 Ebola Outbreak. Trop Med Infect
Dis. 2021; 6(2): 89. doi: 10.3390/tropicalmed6020089.
• Kamara GN, Sevalie S, Molleh B, Koroma Z, Kallon C, Maruta A., et al. Hand Hygiene Compliance at Two
Tertiary Hospitals in Freetown, Sierra Leone, in 2021: A Cross-Sectional Study. Int J Environ Res Public
Health. 2022; 19(5): 2978. doi: 10.3390/ijerph19052978.
• Lakoh S, Maruta A, Kallon C, Deen GF, Russell JBW, Fofanah BD., et al. How Well Are Hand Hygiene
Practices and Promotion Implemented in Sierra Leone? A Cross-Sectional Study in 13 Public Hospitals. Int
J Environ Res Public Health. 2022; 19(7); 3787. doi: 10.3390/ijerph19073787.
• Carshon-Marsh, R., Squire, J. S., Kamara, K. N., Sargsyan, A., Delamou, A., Camara, B. S. et al. Incidence
of Surgical Site Infection and Use of Antibiotics among Patients Who Underwent Caesarean Section and
Herniorrhaphy at a Regional Referral Hospital, Sierra Leone. Int J Environ Res Public Health 2022; 19(7):
4048. doi: 10.3390/ijerph19074048.
• Kamara, K. N., Squire, J. S., Kanu, J. S., Carshon-Marsh, R., Koroma, Z., Koroma, A. T et al. Assessment of
Infection Prevention and Control Measures at Points of Entry in Sierra Leone in 2021: A Cross-Sectional
Study. Int J Environ Res Public Health. 2022;19(10): 5936. doi: 10.3390/ijerph19105936.
• Margao, S., Fofanah, B. D., Thekkur, P., Kallon, C., Ngauja, R. E., Kamara, I. F et al. (2023). Improvement in
Infection Prevention and Control Performance Following Operational Research in Sierra Leone: A Before
(2021) and After (2023) Study. Trop Med Infect Dis. 2023; 8(7). doi: 10.3390/tropicalmed8070376.
• Kamara, R. Z., Kamara, I. F., Moses, F., Kanu, J. S., Kallon, C., Kabba, M. et al. (2023). Improvement in
Infection Prevention and Control Compliance at the Three Tertiary Hospitals of Sierra Leone following an
Operational Research Study. Trop Med Infect Dis. 2023; 8(7); 378. doi: 10.3390/tropicalmed8070378.
• Kamara, M. N., Lakoh, S., Kallon, C., Kanu, J. S., Kamara, R. Z., Kamara, I. F et al. Hand Hygiene Practices
and Promotion in Public Hospitals in Western Sierra Leone: Changes Following Operational Research in
2021. Trop Med Infect Dis. 2023; 8(11), 486. doi: 10.3390/tropicalmed8110486.
• Kpagoi, S. S. T. K., Kamara, K. N., Carshon-Marsh, R., Delamou, A., Manzi, M., Kamara, R et al. (2023).
Assessing Changes in Surgical Site Infections and Antibiotic Use among Caesarean Section and
Herniorrhaphy Patients at a Regional Hospital in Sierra Leone Following Operational Research in 2021.
Trop Med Infect Dis. 2023; 8(8): 385. doi: 10.3390/tropicalmed8080385.
• Moiwo, M. M., Kamara, G. N., Kamara, D., Kamara, I. F., Sevalie, S., Koroma, Z et al. Have Hand Hygiene
Practices in Two Tertiary Care Hospitals, Freetown, Sierra Leone, Improved in 2023 following Operational
Research in 2021? Trop Med Infect Dis. 2023; 8(9). doi: 10.3390/tropicalmed8090431.
• Fofanah, B. D., Kamara, I. F., Kallon, C., Kamara, R., Nuwagira, I., Musoke, R et al. Evaluating the tolerability
and acceptability of a locally produced alcohol-based handrub and hand hygiene behaviour among
health workers in Sierra Leone: A longitudinal hospital-based intervention study. BMC Health Serv Res.
2024; 24(1); 940. doi: 10.1186/s12913-024-11368-3.
189
Annex 15.
190
Development and implementation of national action plans for infection prevention and control: practical guide
Communications and advocacy mapping template
Insert if the entities have strengths in/potential for collaboration (C), action (A), influence (I) under the topic headings.
Organization/ Identified from Website Summary of capacity, for example, Programmatic areas. Indicate collaboration (C),
focus number of people Insert IPC, AMR, WASH, action (A), influence (I)
patient safety, quality,
emergencies, occupational
health, other
Annexes
Annex 16.
Country story: A decade of success: strengthening IPC
advocacy and communication during Qatar IPC Week
(strategic direction 6, Advocacy and communication)
► What we achieved
The national IPC) and AMR programme in the State of Qatar was established in 2015 within the Healthcare
Quality Department under The Ministry of Public Health. The programme adopted and shaped around the
six WHO IPC core components recommended at the national level.
The national IPC and AMR programme has successfully organized Qatar Infection Prevention and Control
Week (QIPCW) annually since 2015 as a sustainable, nationwide awareness campaign to highlight the
importance of IPC practices, to catalyse awareness and commitment, and shine a light on IPC.
This has resulted in increased visibility and empowerment of the IPC programme in Qatar across all levels,
engaging thousands of health care practitioners, and resulting in a number of specific achievements.
• Creation and strengthening of the Qatar IPC taskforce since 2015. This consists of a network of IPC
professionals across the country with representatives from government, private and semi-government
health care facilities among which are medical directors, IPC specialists, nurses and IPC link staff, a
microbiologist, infectious disease specialists and quality and patient safety staff.
• Promotion of leadership amongst IPC professionals to take active roles in driving IPC initiatives and
organizing activities within their facilities with Ministry of Public Health support.
• Establishment of the national IPC committee by Ministerial decree since 2019.
191
Development and implementation of national action plans for infection prevention and control: practical guide
through social media platforms using a unified hashtag (#QIPCWeek), sending out periodic newsletters
from the Ministry of Public Health, organizing a range of public events in malls and libraries to engage the
community through games, dancing, and activities for children, along with conducting numerous media
interviews.
• Time investment: our success is the result of many years of effort by the national IPC programme, its
institutionalization within the Ministry of Public Health, and key buy-in by health care providers.
• Tangible activities, as part of QIPCW, to engage stakeholders: it has become an important milestone and
an opportunity.
• Consideration to sustainability: this is crucial for maintaining momentum, engaging our target
audience, and ensuring long-term impact in a strategic coherent and consistent manner.
• Building on an existing global initiative: since the launch of the IPC and AMR programme, the Ministry
of Public Health, in collaboration with the health care sector in the State of Qatar, began the celebration
of QIPCW during the third week of October, inspired by International Infection Prevention Week.
• Building in flexibility: this allowed QIPCW to evolve. It started as a symposium targeting IPC
representatives and has since evolved into a constant annual event celebrated across sectors after the
formulation of Qatar IPC taskforce in 2015 and strengthened after the establishment of the national IPC
committee in 2019.
• Having a clear aim and call to action: QIPCW aims to highlight the importance of IPC practices wherever
health care is delivered by adopting the slogan: “Qatar IPC Week: 365 Days of Commitment 01 Week of
Focus!”
• Adapting and tailoring the focus each year: every year, the QIPCW focus is chosen based upon our
local IPC risk assessment to cover a wide range of specific topics every year. Starting by “Break the
chain of infection” in 2015-2016, highlighting that “Infection Prevention is everyone’s responsibility” in
2017, stressing in 2022 that “The Future is Infection Prevention: Spread Prevention - Not Infection” and
“Celebrating the Fundamentals of Infection Prevention” in 2023.
• Encompassing a diverse array of advocacy efforts led by the Ministry of Public Health:
□ supportive site visits to health care facilities that emphasized leadership support to the local IPC
teams;
□ a 3-day scientific conference including a pre-conference outbreak management workshop, expert-led
presentations, panel discussions, and the official launch of Qatar’s AMR NAP 2024–2030;
□ launching a social media campaign in collaboration with multiple government providers with key
messages related to this year’s theme;
□ empowering IPC focal points across the health sector to actively engage health and care workers,
patients and the broader community through adopting various innovative approaches, such as poster
competitions, face-to-face quizzes, video contests, and educational sessions aimed to raise the IPC
awareness among all the people who have access to health care.
► Outputs so far
• For example, during the 2024 campaign, the following outputs were achieved:
□ over 1000+ participants attended a 3-day scientific conference (IPC staff, doctors, allied health and
care workers, nurses, quality staff, leaders and patient’s representatives).
192
Annexes
□ broad social media engagement with 39 posts across 3 platforms (X, Facebook, and Instagram)
achieving 63 000+ total impressions and 538 engagements;
□ publication of over 12 articles related to QIPCW activities in prominent local newspapers in both
Arabic and English;
□ live Qatar television interview highlighting the activities of the National IPC and AMR Section during
QIPCW;
□ award and recognition of IPC professionals from 13 healt hcare facilities for their outstanding
achievements throughout the year.
Furthermore, the strong visibility achieved through the QIPCW significantly helped the national IPC/AMR
team to convince the Ministry of Public Health leadership and stakeholders to support expansion of the
IPC programme with new activities such as the establishment of an e-Learning platform for continuous,
professional development. This is a national accredited training programme on IPC and AMR developed in
collaboration with the Department of Healthcare Professions at the Ministry of Public Health, with regular
monthly sessions delivered free of charge to all health care professionals in the State of Qatar.
193
Development and implementation of national action plans for infection prevention and control: practical guide
► Resources
Media reports celebrating Qatar Infection Prevention and Control Week 2024
• https://www.gulf-times.com/article/693750/qatar/moph-meet-highlights-best-practices-in-infection-
prevention
• https://thepeninsulaqatar.com/article/03/11/2024/ministry-of-public-health-highlights-importance-of-
infection-prevention-control
• https://qna.org.qa/en/news/news-details?id=0030-moph-concludes-qatar-infection-prevention,-
control-week&date=2/11/2024
• https://www.qatar-tribune.com/article/147511/nation/moph-concludes-qatar-infection-prevention-
control-week-2024
194
Annexes
Annex 17.
Country story: Integrating research into the activities
of the national IPC unit in Norway (strategic direction 7,
Research and development)
► What we achieved
The milestone of this work has been the development of a research strategy based on the identification of
national and international research gaps in IPC, which is now available to inform and inspire IPC research
throughout the country.
The national IPC team has prioritized research among their activities, in particular:
• conducted systematic reviews and identified evidence gaps for the national IPC guidelines that have
been developed so far;
• developed analytical tools and models, as well as automated surveillance systems, to study the burden
of HAI and AMR and the effectiveness of other IPC interventions;
• regularly publishes scientific manuscripts and reports of research results, including conference
presentations, to document and interpret the results;
• regularly discusses emerging IPC research to stay updated and relevant.
The results of this research have been published mainly in peer-reviewed international journals for the
purpose of dissemination and demonstration of the importance of IPC evidence generation and its linkage
with public health programmes and interventions.
The national IPC unit has successfully contributed to a consortium application for the Horizon
Europe “Health” call for a European partnership for pandemic preparedness (HORIZON-HLTH-2024-
DISEASE-12-01). A key project in one of the work packages will be to “Establish and operate a research
network on effective IPC interventions” and will be led by the Norwegian Institute of Public Health.
195
Development and implementation of national action plans for infection prevention and control: practical guide
aligned with strategic direction 7 of the WHO global action plan and monitoring framework on IPC.
Since 2000, having a national IPC network composed of key IPC specialists from health care institutions
across Norway has allowed discussions on IPC issues, including the identification of research gaps and
opportunities. The inclusion of expertise on research in the national multidisciplinary IPC team including
statisticians and epidemiologists (2018-ongoing) has also contributed to this. The national IPC team also
engages with various universities to motivate students to undertake a master/doctoral thesis on AMR/IPC
topics.
• cooperation on developing and publishing several systematic reviews to facilitate the harmonization of
IPC guidelines and advice at both the national and Nordic level (2023-ongoing);
• recognition of the need for IPC research (2019-ongoing) through contributions to the development of
systematic reviews and gap reports internationally and nationally;
• capacity building through developing data structures and research methods (2020-ongoing);
• development of strategies to secure research funding (2024- ongoing);
• active participation in the Horizon Europe Coordination and Support Actions Be Ready and Be Ready
Plus, improving research preparedness by developing a European Strategic Research and Innovation
Agenda and a European Partnership for Pandemic Preparedness, both of which advocated for inclusion
of IPC (2024- ongoing).
► Outputs so far
• A research strategy and reviews to identify research gaps.
• Digital tools to advance research methodologies as well as progress reports.
• An application to lead on work as part of the Horizon Europe call for a European partnership for
pandemic preparedness.
196
Annexes
• Multidisciplinarity focus on integrating the whole research process from ideas and clinical insights to
data processing, analysis and dissemination.
► Resources
• Further information about CEIR is available here: https://www.fhi.no/en/kn/ceir/.
• Lacotte Y, Årdal C, Ploy MC; European Union Joint Action on Antimicrobial Resistance and Healthcare-
Associated Infections (EU-JAMRAI). Infection prevention and control research priorities: what do we
need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative
literature review and survey analysis. Antimicrob Resist Infect Control. 2020;9(1):142. doi: 10.1186/
s13756-020-00801-x.
• Gap report of AMR-research need (in Norwegian). https://www.fhi.no/globalassets/dokumenterfiler/
rapporter/2020/amr-kunnskapshull-rapport.pdf.
• Lindstad CB, Myrbakk T, Fagernes M, Eriksen-Volle HM, Aasheim ET. Sustainable infection control -
gloves off. Tidsskr Nor Laegeforen. 2024;144(10). doi: 10.4045/tidsskr.24.0343. (English, Norwegian).
• Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG et al. Personal protective
effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults:
pragmatic randomised superiority trial. BMJ. 2024;386:e078918. doi: 10.1136/bmj-2023-078918.
• Skjeldestad FE, Bjørnholt JV, Gran JM, Eriksen HM. The effect of antibiotic prophylaxis guidelines on
surgical-site infections associated with cesarean delivery. Int J Gynaecol Obstet. 2015;128(2):126-30.
doi: 10.1016/j.ijgo.2014.08.018.
• Di Ruscio F, Guzzetta G, Bjørnholt JV, Leegaard TM, Moen AEF, Merler S et al. Quantifying the
transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country.
Proc Natl Acad Sci U S A. 2019;116(29):14599-14605. doi: 10.1073/pnas.1900959116.
• Di Ruscio F, Bjørnholt JV, Leegaard TM, Moen AEF, de Blasio BF. MRSA infections in Norway: a
study of the temporal evolution, 2006-2015. PLoS One. 2017;12(6):e0179771. doi: 10.1371/journal.
pone.0179771.
• Skagseth H, Jørgensen SB, Reilly J, Kacelnik O. A new method for near real-time, nationwide
surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare
system, March 2020 to March 2022. Euro Surveill. 2023;28(12):2200493. doi: 10.2807/1560-7917.
ES.2023.28.12.2200493.
197
Development and implementation of national action plans for infection prevention and control: practical guide
• Danielsen AS, Cyr PR, Berg TC, Jønsberg E, Eriksen-Volle HM, Kacelnik O. Register-based surveillance of
COVID-19 in nursing homes. Tidsskr Nor Laegeforen. 2022;142(8). doi: 10.4045/tidsskr.21.0906.
• Molvik M, Danielsen AS, Grøsland M, Telle KE, Kacelnik O, Eriksen-Volle HM. SARS-CoV-2 in health and
care staff in Norway, 2020.Tidsskr Nor Laegeforen. 2021;141(3). doi: 10.4045/tidsskr.20.1048.
• Danielsen AS, Cyr PR, Magnus MC, Gravningen KM, Eriksen-Volle HM, Kacelnik O. Birthing parents had a
lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15th of February 2020
to 15th of May 2021. Infect Prev Pract. 2021;3(4):100183. doi: 10.1016/j.infpip.2021.100183.
• Danielsen AS, Elstrøm P, Eriksen-Volle HM, Hofvind S, Eyre DW, Kacelnik O et al. The epidemiology of
multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding
surveillance using existing laboratory and register data. Eur J Clin Microbiol Infect Dis. 2024;43(1):121-
132. doi: 10.1007/s10096-023-04698-3.
• Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O et al. Clinical outcomes of
antimicrobial resistance in cancer patients: a systematic review of multivariable models. BMC Infect Dis.
2023;23(1):247. doi: 10.1186/s12879-023-08182-3.
• Gravningen K, Kacelnik O, Lingaas E, Pedersen T, Iversen BG; Pseudomonas outbreak group.
Pseudomonas aeruginosa countrywide outbreak in hospitals linked to pre-moistened non-sterile
washcloths, Norway, October 2021 to April 2022. Euro Surveill. 2022;27(18):2200312. doi: 10.2807/1560-
7917.ES.2022.27.18.2200312.
• Gravningen K, Nymark P, Wyller TB, Kacelnik O. A new automated national register-based surveillance
system for outbreaks in long-term care facilities in Norway detected three times more severe acute
respiratory coronavirus virus 2 (SARS-CoV-2) clusters than traditional methods. Infect Control Hosp
Epidemiol. 2023;44(9):1451-1457. doi: 10.1017/ice.2022.297.
• Lindemann PC, Pedersen T, Oma DH, Janice J, Grøvan F, Chedid GM et al. Intraregional
hospital outbreak of OXA-244-producing Escherichia coli ST38 in Norway, 2020. Euro Surveill.
2023;28(27):2200773. doi: 10.2807/1560-7917.ES.2023.28.27.2200773.
198
Annexes
Annex 18.
Country story: Promoting partnership and teamwork
to strengthen IPC across Nigeria (strategic direction 8,
Collaboration and stakeholder support)
► What we achieved
In 2019, Nigeria established its national IPC programme, ‘Turn Nigeria Orange’, under the leadership of
the Nigeria Centre for Disease Control and Prevention (CDC). The strategy entails working with healthcare
facilities through a collaborative network model known as the Orange Network, where participating
facilities, under the Nigeria CDC’s leadership, support one another as peers and mentor other healthcare
facilities. The programme’s approach is anchored in the WHO’s core components of IPC and is guided by
the philosophy of “One Nation, One Plan”—ensuring coordinated action with linkage to other national
programs like AMR and WASH and a unified vision among all stakeholders involved in IPC implementation
across all levels of the health system.
Since its inception, the programme was able to engage with national institutions and to gain support from
multiple international partners. The approach in establishing agreements and collaborations with these
stakeholders and partners has been to request a strong focus on IPC needs emerging from the national
and facility assessments conducted by the national programmes and the priorities established through
the national strategy and action plan. Similarly, allocation of funds was aligned with the national strategy
and action plan, allowing to secure dedicated resources and budgets for IPC at both national and facility
levels.
Most recently, in 2024, the National Council on Health approved the revised 2024 national IPC policy,
which is critical for IPC strengthening and resource mobilization at all levels. The national IPC programme
also has functional, multi-sectoral and diverse technical working groups with all the key players from
the Nigerian government, disease programmes, national and international partner organizations and
academic institutions being part of the national IPC technical working group. This serves as a platform for
strengthening IPC coordination and resource mobilization among stakeholders.
Another main objective of the Turn Nigeria Orange, has been to establish IPC expertise and programmes
at the state and facility levels through collaborative approaches. The Participatory Approach to Learning
in Systems was implemented for health care facilities by training state-level IPC Professionals (trainers)
and Healthcare Facility IPC teams (change agents) in social and organizational skills to strengthen and
sustain interprofessional and inter-cadre collaboration and foster closer communication and engagement
between IPC teams and hospital management. This system was also a result of the partnership between
the Nigeria CDC and the Robert Koch Institute (Berlin, Germany).
In 2020, the Orange Network was launched, a coalition of public tertiary health facilities striving to become
centres of excellence in IPC. Initially, 25 facilities joined the network. By 2022, an additional 16 facilities
were onboarded, thus achieving the goal of having one network facility per state. By the third quarter
199
Development and implementation of national action plans for infection prevention and control: practical guide
of 2024, the Orange Network expanded to include 41 tertiary health care facilities, 111 secondary care
facilities, and 256 primary health care centres, all actively participating in IPC communities of practice.
The national IPC technical working group, a multi-agency and multi-professional group, guided efforts and
engaged with key partners such as WHO, the United States Centers for Disease Control and Prevention, the
Infection Control Africa Network, the United States Agency for International Development, the Africa Field
Epidemiology Network, Aids Prevention Initiative Nigeria Public Health Initiatives, and the Robert Koch
Institute. International collaborations provided essential support and enriched our training programmes.
In the health care facilities that are part of the Orange Network, chief medical directors are supporting IPC
programmes by allocating necessary resources.
A thorough stakeholder mapping exercise led to strong relationships with key partners aligned with our
national IPC programme priorities and the implementation of the Participatory Approach to Learning in
Systems for health care facilities.
In 2020, the Orange Network was launched and further expanded in 2024 to create the Aids Prevention
Initiative Nigeria Orange Network for secondary health facilities and primary health care centres, with support
from the United States Centers for Disease Control and Prevention, Nigeria CDC, the Africa Field Epidemiology
Network, the National Primary Health Care Development Agency, and Resolve To Save Lives. In 2021, we
published the first national IPC guidelines, which were developed with support from the Robert Koch Institute.
Our success in implementing IPC measures has been a result of strategic planning and strong collaborative
efforts to further highlight the following focus elements.
200
Annexes
focusing on WHO core components, hand hygiene improvement and HAI surveillance. We were involved
in global partnerships for HAI surveillance, hand hygiene audits, and validation of WHO case definitions
for HAIs. IPC expertise was gradually built up, in part by growing numbers participating in the national IPC
training programme, which equips health workers with the knowledge and skills to establish and maintain
IPC programmes in their facilities. Graduates become part of a network of health champions and remain
engaged in ongoing communities of practice.
• Advocacy and communication: the Dr. Ameyo Stella Adadevoh Health Trust played a significant
role in advocating for IPC activities and communicating their importance. We routinely engaged with
chief medical directors to advocate for support of IPC within their institutions and for the allocation of
necessary resources.
• Peer-to-peer learning and support: Orange Network participants engaged in peer-to-peer learning
through an active WhatsApp group, webinars, peer site visits and supportive supervision.
• Leveraging existing resources: an emphasis was placed on leveraging existing resources and finding
mutual areas of interest with other programmes to facilitate collaboration.
► Outputs so far
We published our first national IPC manual for health facility implementation in 2021 and updated our
national IPC policy in 2022. By the third quarter of 2024, our Orange Networks expanded to include 41
tertiary health care facilities, 111 secondary care facilities, and 256 primary health care centres. We also
published four Participatory Approach to Learning in Systems training manuals for various categories of
stakeholders, from health workers in the facility, to state trainers and hospital managers.
Improvements in the WHO IPCAF scores: 83% of facilities reached intermediate or advanced IPC levels after
one year (2022), up from the 41% baseline in 2021.
201
Development and implementation of national action plans for infection prevention and control: practical guide
► Resources
• Nigeria CDC. Presentation of the Turn Nigeria Orange programme. 2025 (https://youtube.com/
watch?v=HoFW4C0vAE4&feature=shared).
• Nigeria Capacity Development (NICADE) – IPC. Participatory approach to learning in systems –
Participatory Approach to Learning in Systems. 2025 (https://nicadeipcpals.ncdc.gov.ng/).
• Nigeria CDC. Highlights from the First Participatory Approach to Learning in Systems Conference
(https://nicadeipcpals.ncdc.gov.ng/gallery/).
202
Infection Prevention and Control Unit
Integrated Health Services
World Health Organization
20 Avenue Appia
1211 Geneva 27
Switzerland
www.who.int